PRESS RELEASE
Q2 2026 — Press release
Q2 2026PDF · 99 pages738 KB
Barclays PLC
Interim Results Announcement
30 June 2026
-- 1 of 99 --
Results Announcement Page
Notes 1
Performance Highlights 2
Group Finance Director’s Review 5
Results by Business
• Barclays UK 7
• Barclays UK Corporate Bank 9
• Barclays Private Bank and Wealth Management 10
• Barclays Investment Bank 11
• Barclays US Consumer Bank 13
• Head Office 15
Quarterly Results Summary 16
Quarterly Results by Business 17
Performance Management
• Margins and Balances 24
Risk Management
• Risk Management and Principal Risks 26
• Credit Risk 27
• Market Risk 48
• Treasury and Capital Risk 49
Statement of Directors' Responsibilities 59
Independent Review Report to Barclays PLC 60
Condensed Consolidated Financial Statements 62
Financial Statement Notes 68
Appendix: Non-IFRS Performance Measures 88
Shareholder Information 97
BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839.
Table of Contents
Barclays PLC
-- 2 of 99 --
The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares
the six months ended 30 June 2026 to the corresponding six months of 2025 and balance sheet analysis as at 30 June 2026 with comparatives
relating to 31 December 2025 and 30 June 2025. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling
respectively; the abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and
‘€bn’ represent millions and thousands of millions of Euros respectively.
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing
adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting
Standards (IFRS) are explained in the results glossary, which can be accessed at home.barclays/investor-relations.
The information in this announcement, which was approved by the Board of Directors on 27 July 2026, does not comprise statutory accounts within
the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2025, which contain an unmodified
audit report under Section 495 of the Companies Act 2006 (which does not make any statements under Section 498 of the Companies Act 2006)
have been delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
These results will be furnished on Form 6-K to the US Securities and Exchange Commission (SEC) as soon as practicable following publication of this
document. Once furnished to the SEC, a copy of the Form 6-K will be available from the SEC’s website at www.sec.gov.
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal roadshows and other ad hoc meetings.
Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these
results and other matters relating to the Group.
Non-IFRS performance measures
Barclays’ management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of
the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial
periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence
or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and
performance is monitored by Barclays’ management. However, any non-IFRS performance measures in this document are not a substitute for IFRS
measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 88 to 96 for definitions and calculations of non-IFRS
performance measures included throughout this document, and reconciliations to the most directly comparable IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as
amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-
looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ
materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate
only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’,
‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made
in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in
connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the
Group’s future financial position, business strategy, income levels, costs, assets and liabilities, impairment charges, provisions, capital leverage and
other regulatory ratios, capital distributions (including policy on dividends and share buybacks), return on tangible equity, projected levels of growth
in banking and financial markets, industry trends, any commitments and targets (including sustainability-related commitments and targets), plans
and objectives for future operations, International Financial Reporting Standards (“IFRS”) and other statements that are not historical or current facts.
By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking
statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including,
without limitation: changes in legislation, regulations, governmental and regulatory policies, expectations and actions, voluntary codes of practices
and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application
thereof and emerging and developing sustainability reporting standards (including emissions accounting methodologies); changes in tax laws and
practice; the outcome of current and future legal proceedings and regulatory investigations; the Group’s ability along with governments and other
stakeholders to measure, manage and mitigate the impacts of climate change effectively or navigate inconsistencies and conflicts in the manner in
which climate policy is implemented in the regions where the Group operates, including as a result of the adoption of rules and regulations taking a
different or opposing position on sustainability matters, or other forms of governmental and regulatory action against sustainability policies;
environmental, social and geopolitical risks and incidents and similar events beyond the Group’s control; financial crime; the impact of competition in
the banking and financial services industry; capital, liquidity, leverage and other regulatory rules and requirements applicable to past, current and
future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets;
market related risks such as changes in interest rates and foreign exchange rates; reforms to benchmark interest rates and indices; higher or lower
asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in
consumer behaviour; changes in trade policy, including the imposition of tariffs or other protectionist measures; the direct and indirect consequences
of the conflicts in the Middle East and Ukraine on European and global macroeconomic conditions, political stability and financial markets; changes in
US legislation and policy; developments in the UK’s relationship with the European Union; the risk of cyberattacks, information or security breaches,
technology failures or operational disruptions and any subsequent impact on the Group’s reputation, business or operations; the use of new
technology, including artificial intelligence; the Group’s ability to access funding; and the success of acquisitions, disposals, joint ventures and other
strategic transactions. A number of these factors are beyond the Group’s control. As a result, the Group’s actual financial position, results, financial
and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or
guidance set forth in the Group’s forward-looking statements. In setting its targets and outlook for the period 2026-2028, Barclays has made certain
assumptions about the macroeconomic environment, including, without limitation, inflation, interest and unemployment rates, the different markets
and competitive conditions in which Barclays operates, and its ability to grow certain businesses and achieve costs savings and other structural
actions. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in Barclays PLC’s filings
with the US Securities and Exchange Commission (“SEC”) (including, without limitation, Barclays PLC’s Annual Report on Form 20-F for the financial
year ended 31 December 2025), which are available on the SEC’s website at www.sec.gov.
Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and
the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
Notes
Barclays PLC 1
-- 3 of 99 --
Barclays delivered a return on tangible equity (RoTE) of 14.8% in H126, announced £2.3bn total
capital distributions, and is on track to deliver its 2026 and 2028 targets
C. S. Venkatakrishnan, Group Chief Executive, commented
"I am pleased with another strong quarter for Barclays. Income for Q226 is £8.3bn, up £1.2bn from the same quarter last
year. Profit before tax is £3.3bn, up 31% in the same period. Our earnings per share (EPS) has increased 43% to 16.7p, and
our cost: income ratio improved to 54% from 59% a year earlier. We have a robust common equity tier 1 (CET1) ratio of
14.3%, above our 13% to 14% target range. We also delivered a RoTE of 16.1%. We continued deploying balance sheet in
the UK, with year-on-year loan growth of 5%, and the Investment Bank performed well in a favourable environment, with a
RoTE of 16.0%. Our performance supports distributions of £2.3bn for the first half of 2026, up 61% year-on-year. This
includes a £1.0bn buyback and a c.£0.8bn dividend announced today. We are upgrading the 2026 Group income target to
c.£31.5bn and remain committed to, and confident in, delivering all financial and distribution targets for 2026 and 2028.”
• H126 Group RoTE of 14.8% (H125: 13.2%) and Q226 Group RoTE of 16.1% (Q225: 12.3%)
– All divisions delivered double-digit RoTE for H126 and Q226
• H126 EPS of 30.7p (H125: 24.7p) and Q226 EPS of 16.7p (Q225: 11.7p)
• 2026 Group income target increased to c.£31.5bn (from c.£31bn)
– 2026 Group net interest income (NII) excluding Barclays Investment Bank and Head Office increased to greater than
£13.7bn (from greater than £13.5bn)
• Strong CET1 ratio of 14.3% and announced intention to initiate a share buyback of up to £1.0bn for Q226, and a dividend
of 5.9p per share for H126 (H125: 3.0p)
• 5% growth in UK lending balances year-on-year in H126
– Delivered £25bn of c.£30bn planned UK risk weighted assets (RWAs) growth since 20241 (£3bn in Q226), of which
£18bn was organic growth
Key financial metrics:
Income
Profit
before
tax
Attributable
profit
Cost:
income
ratio
LLR RoTE EPS
TNAV
per
share
CET1
ratio
Total
capital
return2
Q226 £8.3bn £3.3bn £2.3bn 54% 51bps 16.1% 16.7p 423p 14.3% £2.3bn
H126 £16.5bn £6.1bn £4.2bn 55% 62bps 14.8% 30.7p
Q226 Performance highlights:
• Group RoTE was 16.1% (Q225: 12.3%) with profit before tax of £3.3bn (Q225: £2.5bn)
• Group income of £8.3bn increased 16% year-on-year. Group NII excluding IB and Head Office was £3.4bn, up 10%
year-on-year
– Barclays UK income increased 7%, as higher structural hedge income was partially offset by retail deposit dynamics
and mortgage margin compression
– Barclays UK Corporate Bank (UKCB) income increased 8%, reflecting higher average deposit and lending balances,
and higher structural hedge income
– Barclays Private Bank and Wealth Management (PBWM) income increased 5%, reflecting growth in client balances,
partially offset by the impact of deposit mix
– Barclays Investment Bank (IB) income increased 20%, driven by Global Markets and Investment Banking fees
– Barclays US Consumer Bank (USCB) income increased 38%, driven by portfolio changes including a c.£225m gain
from the sale of the American Airlines co-branded credit cards portfolio (AA portfolio) and the impact of the Best Egg
Inc. (Best Egg) acquisition
• Group total operating expenses were £4.5bn, up 7% year-on-year
– Group operating costs increased to £4.5bn (Q225: £4.1bn), reflecting business growth (including higher performance
costs), inflation and further investment spend (including the Best Egg acquisition), partially offset by c.£200m of cost
efficiency savings
• Credit impairment charges were £0.6bn (Q225: £0.5bn) with an LLR of 51bps (Q225: 44bps)
1 Represents RWAs from business growth in Barclays UK, UK Corporate Bank and Private Bank and Wealth Management since January 2024,
excluding the effects of securitisations, model updates and other methodological changes. Also excludes additional Operational Risk RWAs
related to organic growth.
2 H126 total capital return: includes the £500m buyback announced at Q126 Results in addition to the £1.0bn buyback and c.£0.8bn dividend
announced at H126 Results.
Performance Highlights
Barclays PLC 2
-- 4 of 99 --
H126 Performance highlights:
• Group RoTE was 14.8% (H125: 13.2%) with profit before tax of £6.1bn (H125: £5.2bn)
• Group income of £16.5bn increased 11% year-on-year. Group NII excluding IB and Head Office was £6.8bn, up 11%
year-on-year
• Group total operating expenses were £9.1bn, up 6% year-on-year
– Group operating costs increased 6% to £8.9bn, reflecting business growth (including higher performance costs),
inflation, and further investment spend (including the Best Egg acquisition), partially offset by c.£350m of cost
efficiency savings and FX movements
– Litigation and conduct charges of £0.1bn primarily reflected an increase in the provision for the UK Financial Conduct
Authority (FCA) motor finance redress scheme in Q126
• Credit impairment charges were £1.4bn (H125: £1.1bn) with an LLR of 62bps (H125: 52bps), including a £0.2bn single
name charge in the IB in Q126
• Strong balance sheet with CET1 ratio of 14.3% (December 2025: 14.3%), with RWAs of £364.8bn (December 2025:
£356.8bn)
– Taking into account the impact of the £1.0bn share buyback announced today, the CET1 ratio as of 30 June 2026
would be reduced to 14.0%, at the top-end of the 13-14% range
• Tangible net asset value (TNAV) per share of 423p (December 2025: 409p)
Group financial targets1:
2026 targets
• Returns: Group RoTE of greater than 12%
• Capital returns2: plan to return at least £10bn of capital to shareholders between 2024 and 2026, through dividends and
share buybacks, with a continued preference for buybacks
– Progressive increase in total capital returns versus 2025
– Share buybacks announced quarterly
– Dividends to be paid semi-annually, including planned £2bn dividend for 2026
• Income: Group total income of c.£31.5bn
– Group NII excluding IB and Head Office greater than £13.7bn and Barclays UK NII around the middle of the £8.1bn -
£8.3bn guided range
• Costs: Group cost: income ratio of high 50s in percentage terms
• Impairment: expect Group LLR to be around the top of the 50-60bps through the cycle range
• Capital: CET1 ratio target range of 13-14%
– IB RWAs mid 50s% of Group RWAs
– Impact of regulatory change on RWAs in line with our prior guidance of c.£19-26bn
– c.£8-15bn RWAs from Basel 3.1, with implementation expected from 1 January 20273
– c.£11bn RWAs from USCB moving to an Internal Ratings Based (IRB) model, subject to portfolio changes and
regulatory approval, expected in H2 2027
– Expect Pillar 2A capital to reduce upon implementation of Basel 3.1 and USCB IRB
2028 targets
• Returns: Group RoTE of greater than 14%
• Capital returns2: plan to return greater than £15bn of capital to shareholders between 2026 and 2028, through dividends
and share buybacks. This provides capacity for additional investment and growth, exceeding the level of investment in
the current plan
• Income: greater than 5% compound annual growth rate (CAGR) 2025-2028
• Costs: Group cost: income ratio of low 50s in percentage terms. Cost target includes total gross efficiency savings of
greater than £2bn in 2026-2028
• Impairment: expect Group LLR of 50-60bps through the cycle
• Capital: CET1 ratio target range of 13-14%
– IB RWAs of c.50% of Group RWAs
1 Our targets and guidance are based on management's current expectations as to the macroeconomic environment and the business and may
be subject to change.
2 This multi-year plan is subject to supervisory and Board approvals, anticipated financial performance and our published CET1 ratio target range
of 13-14%.
3 Fundamental review of the trading book (FRTB) impact mostly expected in 2027.
Performance Highlights
Barclays PLC 3
-- 5 of 99 --
Barclays Group results Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
£m £m % Change £m £m % Change
Barclays UK 4,517 4,193 8 2,259 2,119 7
Barclays UK Corporate Bank 1,088 1,003 8 558 519 8
Barclays Private Bank and Wealth Management 713 697 2 366 348 5
Barclays Investment Bank 7,986 7,180 11 3,958 3,307 20
Barclays US Consumer Bank 2,119 1,687 26 1,136 823 38
Head Office 78 136 (43) 61 71 (14)
Total income 16,501 14,896 11 8,338 7,187 16
Operating costs (8,873) (8,407) (6) (4,514) (4,149) (9)
UK regulatory levies (84) (96) 13 — — #DIV/0!
Litigation and conduct (108) (87) (24) (4) (76) 95
Total operating expenses (9,065) (8,590) (6) (4,518) (4,225) (7)
Other net income/(expense) 24 9 3 (9)
Profit before impairment 7,460 6,315 18 3,823 2,953 29
Credit impairment charges (1,394) (1,112) (25) (571) (469) (22)
Profit before tax 6,066 5,203 17 3,252 2,484 31
Tax charge (1,369) (1,173) (17) (731) (552) (32)
Profit after tax 4,697 4,030 17 2,521 1,932 30
Non-controlling interests (19) (23) 17 (19) (21) 10
Other equity instrument holders (487) (484) (1) (243) (252) 4
Attributable profit 4,191 3,523 19 2,259 1,659 36
Performance measures
Return on average tangible shareholders' equity 14.8% 13.2% 16.1% 12.3%
Average tangible shareholders' equity (£bn) 56.7 53.5 56.1 53.9
Cost: income ratio 55% 58% 54% 59%
Loan loss rate (bps) 62 52 51 44
Basic earnings per ordinary share 30.7p 24.7p 24 16.7p 11.7p 43
Dividend per ordinary share 5.9p 3.0p 97
Share buybacks announced (£m) 1,500 1,000 50 1,000 1,000 —
Total payout equivalent per share c.16.9p c.10.1p 69
Basic weighted average number of shares (m) 13,645 14,262 (4) 13,565 14,211 (5)
Period end number of shares (m) 13,507 14,180 (5)
Period end tangible shareholders' equity (£bn) 57.2 54.5
As at
30.06.26
As at
31.12.25
As at
30.06.25
Balance sheet and capital management1 £bn £bn £bn
Loans and advances at amortised cost 444.8 430.0 417.8
Loans and advances at amortised cost impairment
coverage ratio 1.2% 1.2% 1.2%
Total assets 1,730.4 1,544.2 1,598.7
Deposits at amortised cost 594.4 585.6 564.5
Tangible net asset value per share 423p 409p 384p
Common equity tier 1 ratio 14.3% 14.3% 14.0%
Common equity tier 1 capital 52.2 51.1 49.5
Risk weighted assets 364.8 356.8 353.0
UK leverage ratio 4.9% 5.1% 5.0%
UK leverage exposure 1,345.6 1,247.3 1,259.8
Funding and liquidity
Group liquidity pool (£bn) 346.7 337.8 333.7
Liquidity coverage ratio2 157.7% 170.0% 177.7%
Net stable funding ratio3 135.8% 135.2% 135.6%
Loan: deposit ratio 75% 73% 74%
1 Refer to pages 54 to 58 for further information on how capital, RWAs and leverage are calculated.
2 Represents average of the last 12 spot month end ratios.
3 Represents average of the last four spot quarter end positions.
Performance Highlights
Barclays PLC 4
-- 6 of 99 --
H126 Group performance
• Barclays delivered a profit before tax of £6,066m (H125: £5,203m), RoTE of 14.8% (H125: 13.2%) and EPS of 30.7p
(H125: 24.7p)
• The Group has a diverse income profile across businesses and geographies. The 4% year-on-year appreciation of
average GBP against USD negatively impacted income and profits, and positively impacted credit impairment charges
and total operating expenses
• Group income increased 11% to £16,501m, due to higher income in Global Markets and Investment Banking fees,
higher structural hedge income and the c.£225m gain from the sale of the AA portfolio
• Group total operating expenses increased to £9,065m (H125: £8,590m)
– Group operating costs increased 6% to £8,873m, reflecting business growth (including higher performance costs),
inflation, and further investment spend (including the Best Egg acquisition), partially offset by c.£350m of cost
efficiency savings and FX movements
– Litigation and conduct charges of £108m primarily reflected a £105m increase in the provision for the FCA motor
finance redress scheme in Q126
• Credit impairment charges increased to £1,394m (H125: £1,112m), primarily driven by a single name charge of £228m
in IB in Q126. Total coverage ratio remained stable at 1.2% (December 2025: 1.2%)
• The effective tax rate (ETR) was 22.6% (H125: 22.5%)
• Attributable profit was £4,191m (H125: £3,523m)
• Total assets increased to £1,730.4bn (December 2025: £1,544.2bn) driven by higher trading activity in IB, growth in
the liquidity pool and higher lending across the Group
• TNAV per share increased to 423p (December 2025: 409p) as EPS of 30.7p was partially offset by a 6p negative
movement in the cash flow hedging reserve, a 6p reduction from FY25 dividends paid in Q126, and a 6p reduction from
share awards vesting in Q126
Group capital and leverage
• The CET1 ratio remained stable at 14.3% (December 2025: 14.3%). Taking into account the impact of the £1.0bn share
buyback announced today, the CET1 ratio as of 30 June 2026 would be reduced to 14.0% (at the top end of the 13-14%
target range)
• Q226 USCB sale of the AA portfolio and acquisition of Best Egg resulted in a marginal increase in the CET1 ratio with a
net release of £3.2bn RWAs partially offset by a £0.2bn decrease in CET1 capital, reflecting the c.£225m gain on sale of
the AA portfolio offset by £0.5bn of goodwill and intangibles from the Best Egg acquisition. Excluding the impacts of
these changes, other movements were:
– 108bps increase from attributable profit
– 68bps decrease driven by shareholder distributions including the now completed £1.5bn total share buybacks
announced with FY25 and Q126 results, and the accrual for the total 2026 dividend
– 40bps decrease due to a £9.8bn increase in RWAs, excluding the impact of foreign exchange movements, primarily
driven by lending growth in UK businesses and higher activity in Global Markets
– A £0.2bn increase in CET1 capital due to an increase in the currency translation reserve was offset by a £1.3bn
increase in RWAs as a result of foreign exchange movements
• The UK leverage ratio decreased to 4.9% (December 2025: 5.1%) as leverage exposure increased by £98.3bn to
£1,345.6bn (December 2025: £1,247.3bn). The increase in leverage exposure was primarily driven by higher trading
activity in IB
Group funding and liquidity
• The liquidity metrics remain above regulatory requirements, underpinned by well-diversified sources of funding, a stable
global deposit franchise and a highly liquid balance sheet
• The liquidity pool was £346.7bn, an increase of £8.9bn from December 2025. The increase in the liquidity pool was
primarily driven by deposit growth across businesses and increased term wholesale funding.
• The average1 LCR was 157.7% (December 2025: 170.0%), equivalent to a surplus of £117.2bn (December 2025:
£131.2bn)
• Total deposits increased to £594.4bn (December 2025: £585.6bn), primarily driven by deposit growth in the
International Corporate Bank (ICB)
• The average2 Net Stable Funding Ratio (NSFR) was 135.8% (December 2025: 135.2%), which represents a £171.7bn
surplus (December 2025: £166.3bn) above the 100% regulatory requirement
1 Represents average of the last 12 spot month end ratios.
2 Represents average of the last four spot quarter end ratios.
Group Finance Director's Review
Barclays PLC 5
-- 7 of 99 --
Group funding and liquidity (continued)
• Wholesale funding outstanding, excluding repurchase agreements, was £236.0bn (December 2025: £220.1bn)
• The Group issued £9.9bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments
from Barclays PLC (the Parent company), completing the targeted 2026 MREL issuance plan within H126. The Group has
a strong MREL position with a ratio of 36.7%, which is in excess of the regulatory requirement of 30.5% excluding any
applicable confidential institution specific Prudential Regulation Authority (PRA) buffer. The Group remains above its
minimum capital regulatory requirements and applicable buffers
Other matters
• Motor finance commission arrangements: In March 2026, the FCA published its final rules for an industry-wide redress
scheme for eligible motor finance customers where a commission was payable by the lender to the broker. Barclays
increased its provision in Q126 by £105m to reflect the expected financial impact of the redress scheme. Barclays holds a
Motor Finance provision of £430m as at 30 June 2026. Barclays decided not to challenge the FCA’s final rules in the
interests of enabling a swift resolution for customers. However, Barclays strongly disagrees with aspects of the rules
which require financial redress even where customers suffered no demonstrable financial harm. On 2 July 2026, the
Upper Tribunal ordered a suspension of parts of the redress scheme following four legal challenges to the FCA’s final
rules. The legal challenges are expected to be heard by the Upper Tribunal in Q426 or Q127. Such challenges will delay
and may otherwise affect the implementation of the redress scheme. The legal and regulatory outcomes and the nature,
extent and timing of any remediation action, therefore remain uncertain
• USCB changes in Q226:
– American Airlines co-branded credit card portfolio exit: On 24 April 2026 Barclays exited its American Airlines co-
branded credit card partnership, releasing £3.6bn of RWAs and generating a gain on sale of c.£225m
– Best Egg acquisition: On 1 May 2026, Barclays completed the acquisition of Best Egg for c.£0.6bn subject to
customary post-completion purchase price adjustments. Best Egg is a leading US direct-to-consumer personal loan
origination platform focused on prime borrowers. Barclays has acquired c.£0.3bn of financial assets and c.£0.2bn of
financial liabilities
– The effect of both transactions is a marginal increase to the Group's CET1 ratio in Q226, with a net release of RWAs
of £3.2bn and the c.£225m gain on sale from the AA portfolio exit, partially offset by a c.£0.5bn increase in goodwill
and intangibles from the Best Egg acquisition
• GoHenry acquisition: On 12 June 2026, Barclays announced that Barclays Bank UK PLC had entered into an agreement to
acquire GoHenry, a money management platform for children and young people in the UK. Completion of the transaction
is expected to occur in Q426, subject to regulatory approvals and other conditions. The transaction is expected to
marginally reduce the Group’s CET1 ratio
• One Churchill Place: On 30 June 2026 Barclays announced it had acquired a 999-year leasehold interest in its global
headquarters at One Churchill Place, London. The transaction secures Barclays’ control in its global headquarters beyond
the current lease term, due to expire in 2039, while providing greater certainty over long-term occupancy costs. The
transaction values the acquired leasehold interest at £750m and is broadly neutral to the Group’s CET1 ratio and
earnings
Anna Cross, Group Finance Director
Group Finance Director's Review
Barclays PLC 6
-- 8 of 99 --
Barclays UK Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
Income statement information £m £m % Change £m £m % Change
Net interest income 3,986 3,677 8 2,000 1,855 8
Net fee, commission and other income 531 516 3 259 264 (2)
Total income 4,517 4,193 8 2,259 2,119 7
Operating costs (2,368) (2,283) (4) (1,194) (1,168) (2)
UK regulatory levies (44) (43) (2) — — #DIV/0!
Litigation and conduct — (29) (1) (27) 96
Total operating expenses (2,412) (2,355) (2) (1,195) (1,195) —
Other net income — — — — — —
Profit before impairment 2,105 1,838 15 1,064 924 15
Credit impairment charges (338) (237) (43) (160) (79)
Profit before tax 1,767 1,601 10 904 845 7
Attributable profit 1,214 1,090 11 623 580 7
Performance measures
Return on average allocated tangible equity 20.1% 18.6% 20.4% 19.7%
Average allocated tangible equity (£bn) 12.1 11.7 12.2 11.8
Cost: income ratio 53% 56% 53% 56%
Loan loss rate (bps) 28 21 27 14
Net interest margin 3.70% 3.55% 3.68% 3.55%
Key facts As at
30.06.26 As at
30.06.25
UK mortgage balances (£bn) 176.7 166.8
Mortgage gross lending flow (£bn) 17.7 15.4
Average LTV of mortgage portfolio1 57% 54%
Average LTV of new mortgage lending1 70% 70%
Number of branches 206 207
Digitally active customers (m)2 14.1 13.7
30 day arrears rate - total UK cards 0.9% 0.7%
90 day arrears rate - total UK cards 0.3% 0.2%
As at
30.06.26 As at
31.12.25 As at
30.06.25
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 220.8 216.5 211.2
Total assets 304.9 299.6 299.7
Customer deposits at amortised cost 245.6 244.6 241.3
Loan: deposit ratio 97% 94% 94%
Risk weighted assets 89.0 85.8 86.1
Period end allocated tangible equity 12.4 11.8 11.8
1 Average loan to value (LTV) of mortgages is balance weighted and reflects both residential and buy-to-let (BTL) mortgage portfolios within the
Home Loans portfolio.
2 Excludes Tesco Bank
Results by Business
Barclays PLC 7
-- 9 of 99 --
Analysis of Barclays UK Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
Analysis of total income £m £m % Change £m £m % Change
Retail Banking 3,436 3,172 8 1,711 1,599 7
Business Banking 1,081 1,021 6 548 520 5
Total income 4,517 4,193 8 2,259 2,119 7
Analysis of credit impairment (charges)/releases
Retail Banking (344) (204) (69) (165) (59)
Business Banking 6 (33) 5 (20)
Total credit impairment charges (338) (237) (43) (160) (79)
As at
30.06.26
As at
31.12.25
As at
30.06.25
Analysis of loans and advances to customers at
amortised cost £bn £bn £bn
Retail Banking 203.1 198.6 192.4
Business Banking 17.7 17.9 18.8
Total loans and advances to customers at
amortised cost 220.8 216.5 211.2
Analysis of customer deposits at amortised cost
Retail Banking 194.5 192.7 189.3
Business Banking 51.1 51.9 52.0
Total customer deposits at amortised cost 245.6 244.6 241.3
Barclays UK delivered a RoTE of 20.1% (H125: 18.6%) supported by robust income, disciplined cost management and
underpinned by strong asset quality.
Income statement - H126 compared to H125
• Profit before tax increased 10% to £1,767m
• Total income increased 8% to £4,517m. NII increased 8% to £3,986m, as higher structural hedge income was partially
offset by retail deposit dynamics and mortgage margin compression. Net fee, commission and other income increased
3% to £531m
• Total operating expenses increased 2% to £2,412m, driven by higher investments and inflation. Ongoing efficiency
savings continue to be reinvested, to drive sustainable improvement to the cost: income ratio
• Credit impairment charges were £338m (H125: £237m), reflecting stable underlying credit performance. Total charges
are higher than those in H125, which benefitted from a recalibration adjustment in the Retail credit cards portfolio to
reflect resilient customer behaviour. Retail credit cards 30 and 90 day arrears rates were 0.9% (H125: 0.7%) and 0.3%
(H125: 0.2%) respectively. The Retail credit cards total coverage ratio increased to 4.5% (December 2025: 4.3%)
Balance sheet - 30 June 2026 compared to 31 December 2025
• Loans and advances to customers at amortised cost increased £4.3bn to £220.8bn, primarily driven by growth in
mortgages, partially offset by the impact of securitisations
• Customer deposits at amortised cost increased by £1.0bn to £245.6bn, driven by an increase in Retail Banking
deposits. The loan: deposit ratio remained broadly stable at 97% (December 2025: 94%)
• RWAs increased to £89.0bn (December 2025: £85.8bn), primarily due to growth in mortgages, partially offset by the
securitisation of credit risk assets
Results by Business
Barclays PLC 8
-- 10 of 99 --
Barclays UK Corporate Bank Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
Income statement information £m £m % Change £m £m % Change
Net interest income 807 701 15 413 359 15
Net fee, commission and other income 281 302 (7) 145 160 (9)
Total income 1,088 1,003 8 558 519 8
Operating costs (488) (474) (3) (249) (240) (4)
UK regulatory levies (15) (24) 38 — — #DIV/0!
Litigation and conduct — (39) — (39)
Total operating expenses (503) (537) 6 (249) (279) 11
Other net income — — — — — —
Profit before impairment 585 466 26 309 240 29
Credit impairment charges (19) (31) 39 (16) (12) (33)
Profit before tax 566 435 30 293 228 29
Attributable profit 388 284 37 201 142 42
Performance measures
Return on average allocated tangible equity 20.6% 16.8% 21.3% 16.6%
Average allocated tangible equity (£bn) 3.8 3.4 3.8 3.4
Cost: income ratio 46% 54% 45% 54%
Loan loss rate (bps) 12 22 20 17
As at
30.06.26
As at
31.12.25
As at
30.06.25
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 31.3 30.0 27.9
Deposits at amortised cost 89.1 88.7 85.3
Risk weighted assets 26.6 26.5 25.3
Period end allocated tangible equity 3.7 3.7 3.5
Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
Analysis of total income £m £m % Change £m £m % Change
Corporate lending 185 170 9 96 90 7
Transaction banking 903 833 8 462 429 8
Total income 1,088 1,003 8 558 519 8
UKCB delivered a RoTE of 20.6% (H125: 16.8%), reflecting increased income from higher average deposit and lending
balances, and positive operating jaws.
Income statement - H126 compared to H125
• Profit before tax increased 30% to £566m
• Total income increased 8% to £1,088m, NII increased 15% to £807m, driven by higher average deposit and lending
balances, and structural hedge income benefit. Net fee, commission and other income decreased 7% to £281m driven by
lower liquidity pool income
• Total operating expenses decreased 6% to £503m, reflecting the non-repeat of prior year litigation and conduct
charges. Operating costs increased 3% to £488m, reflecting higher investment spend to support business growth
strategy, with ongoing efficiency savings offsetting inflationary headwinds
• Credit impairment charges were £19m (H125: £31m), reflecting stable underlying credit performance and limited single
name charges
Balance sheet - 30 June 2026 compared to 31 December 2025
• Loans and advances to customers at amortised cost increased to £31.3bn (December 2025: £30.0bn), reflecting the
strategic focus to grow lending
• Deposits at amortised cost increased to £89.1bn (December 2025: £88.7bn), driven by an inflow of balances from new
and existing clients
• RWAs were stable at £26.6bn (December 2025: £26.5bn)
Results by Business
Barclays PLC 9
-- 11 of 99 --
Barclays Private Bank and Wealth
Management Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
Income statement information £m £m % Change £m £m % Change
Net interest income 420 407 3 216 203 6
Net fee, commission and other income 293 290 1 150 145 3
Total income 713 697 2 366 348 5
Operating costs (521) (472) (10) (267) (238) (12)
UK regulatory levies (3) (2) (50) — —
Litigation and conduct — — — —
Total operating expenses (524) (474) (11) (267) (238) (12)
Other net income — — — — — —
Profit before impairment 189 223 (15) 99 110 (10)
Credit impairment (charges)/ releases (3) 11 (5) 2
Profit before tax 186 234 (21) 94 112 (16)
Attributable profit 148 184 (20) 75 88 (15)
Performance measures
Return on average allocated tangible equity 26.1% 33.2% 26.9% 31.9%
Average allocated tangible equity (£bn) 1.1 1.1 1.1 1.1
Cost: income ratio 73% 68% 73% 68%
Loan loss rate (bps) 4 (15) 13 (5)
Key facts £bn £bn £bn £bn
Net new assets under management1 1.8 1.9 0.3 0.9
As at
30.06.26
As at
31.12.25
As at
30.06.25
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 14.8 14.7 14.5
Deposits at amortised cost 72.7 72.0 66.7
Risk weighted assets 8.0 8.0 7.9
Period end allocated tangible equity 1.1 1.1 1.1
Invested assets2 142.5 140.6 131.9
Of which:
Assets under management1 55.8 52.9 48.5
Assets under supervision1 86.7 87.7 83.4
Client assets and liabilities3 230.2 227.6 213.4
PBWM delivered a RoTE of 26.1% (H125: 33.2%), reflecting higher costs from accelerated investment to support future
growth and efficiency strategy, and a higher impairment charge.
Income statement - H126 compared to H125
• Profit before tax decreased 21% to £186m
• Total income increased 2% to £713m, driven by growth in client balances, partially offset by the impact of deposit mix
• Total operating expenses increased 11% to £524m, reflecting ongoing investment to support business growth strategy
and inflationary headwinds, partially offset by efficiency savings
Balance sheet - 30 June 2026 compared to 31 December 2025
• Client assets and liabilities increased £2.6bn to £230.2bn, driven by higher invested assets due to market movements
and net new inflow of deposit balances
• RWAs were stable at £8.0bn (December 2025: £8.0bn)
1 Refer to page 88 for further information on net new assets under management, assets under management and assets under supervision.
2 Invested assets (held off-balance sheet) represent assets under management and supervision. Uninvested cash held under an investment
mandate and reported within deposits is excluded from invested assets.
3 Client assets and liabilities refers to deposits, lending and invested assets.
Results by Business
Barclays PLC 10
-- 12 of 99 --
Barclays Investment Bank Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
Income statement information £m £m % Change £m £m % Change
Net interest income 794 631 26 411 334 23
Net trading income 4,629 4,322 7 2,271 1,906 19
Net fee, commission and other income 2,563 2,227 15 1,276 1,067 20
Total income 7,986 7,180 11 3,958 3,307 20
Operating costs (4,306) (3,993) (8) (2,199) (1,932) (14)
UK regulatory levies (22) (27) 19 — — #DIV/0!
Litigation and conduct 2 (11) — (8)
Total operating expenses (4,326) (4,031) (7) (2,199) (1,940) (13)
Other net income — — — — — —
Profit before impairment 3,660 3,149 16 1,759 1,367 29
Credit impairment charges (323) (139) (44) (67) 34
Profit before tax 3,337 3,010 11 1,715 1,300 32
Attributable profit 2,315 2,075 12 1,204 876 37
Performance measures
Return on average allocated tangible equity 15.5% 14.2% 16.0% 12.2%
Average allocated tangible equity (£bn) 29.9 29.2 30.0 28.7
Income over average risk weighted assets 7.9% 7.2% 7.7% 6.7%
Cost: income ratio 54% 56% 56% 59%
Loan loss rate (bps) 47 22 13 21
As at
30.06.26
As at
31.12.25 As at
30.06.25
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 70.8 70.0 66.8
Loans and advances to banks at amortised cost 11.0 7.4 7.1
Debt securities at amortised cost 54.5 52.9 52.4
Loans and advances at amortised cost 136.3 130.3 126.3
Trading portfolio assets 208.2 189.5 186.1
Financial assets at fair value through the income
statement 209.9 183.6 215.2
Derivative financial instrument assets 302.6 251.5 279.0
Cash collateral and settlement balances 182.5 121.6 145.0
Deposits at amortised cost 162.3 156.1 148.7
Derivative financial instrument liabilities 291.6 240.6 265.1
Risk weighted assets 204.1 196.7 196.4
Period end allocated tangible equity 30.1 28.9 28.7
Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
Analysis of total income £m £m % Change £m £m % Change
FICC 3,187 3,149 1 1,471 1,450 1
Equities 2,377 1,833 30 1,261 870 45
Global Markets 5,564 4,982 12 2,732 2,320 18
Advisory 443 266 67 188 123 53
Equity capital markets 249 151 65 157 81 94
Debt capital markets 809 795 2 402 364 10
Banking fees and underwriting 1,501 1,212 24 747 568 32
Corporate lending 53 152 (65) 37 (4)
Transaction banking 868 834 4 442 423 4
International Corporate Bank 921 986 (7) 479 419 14
Investment Banking 2,422 2,198 10 1,226 987 24
Total income 7,986 7,180 11 3,958 3,307 20
Results by Business
Barclays PLC 11
-- 13 of 99 --
IB delivered a RoTE of 15.5% (H125: 14.2%), driven by higher Global Markets, Investment Banking fees and underwriting
income, whilst maintaining cost and capital discipline, driving positive operating jaws and improved RWA productivity.
Income statement - H126 compared to H125
• Profit before tax increased to £3,337m (H125: £3,010m)
• IB has a diverse income profile across businesses and geographies. The 4% appreciation of average GBP against USD
adversely impacted income and profits, and positively impacted credit impairment charges and total operating expenses
• Total income increased 11% to £7,986m, including the adverse impact of strengthening average GBP against USD
– Global Markets income increased 12% to £5,564m, driven by increased income in Equities and Credit
– FICC income was stable at £3,187m (H125: £3,149m), despite strong prior year performance, as we continued to
provide support to clients through a range of environments
– Equities income increased 30% to £2,377m, reflecting growth in Prime Financing balances, and Equity Derivatives
– Investment Banking income increased 10% to £2,422m
– Banking fees and underwriting income increased 24% to £1,501m, primarily driven by Advisory and Equity
Capital Markets, up 67% and 65% respectively. Debt Capital Markets were broadly stable
– ICB income decreased 7% to £921m. Transaction banking income increased 4% to £868m, as higher income
from growth in deposit balances was partially offset by margin compression due to change in deposits product
mix. Corporate lending income decreased to £53m, reflecting the non-repeat of fair value gains on leverage
finance lending (c.£105m) in Q125, while underlying business performance was broadly stable
• Total operating expenses increased to £4,326m (H125: £4,031m), driven by higher performance costs partially offset
by efficiency savings and the impact of strengthening average GBP against USD
• Credit impairment charges increased to £323m (H125: £139m), primarily driven by a single name charge of £228m in
Q126
Balance sheet - 30 June 2026 compared to 31 December 2025
• Loans and advances at amortised cost increased to £136.3bn (December 2025: £130.3bn), driven by increased
lending in Investment Banking
• Trading portfolio assets increased to £208.2bn (December 2025: £189.5bn), driven by increased trading activity in
debt securities to facilitate client demand in Global Markets
• Financial assets at fair value through the income statement increased to £209.9bn (December 2025: £183.6bn),
driven by increased secured lending in Global Markets
• Derivative financial instrument assets increased to £302.6bn (December 2025: £251.5bn) and liabilities increased to
£291.6bn (December 2025: £240.6bn), reflecting an increase in client activity and mark-to-market in Equity and FX
Derivatives
• Deposits at amortised cost increased to £162.3bn (December 2025: £156.1bn), driven by growth in deposits primarily
in the ICB
• RWAs increased to £204.1bn (December 2025: £196.7bn), mainly driven by higher activity in Global Markets as we
continued to support clients through a range of environments
Results by Business
Barclays PLC 12
-- 14 of 99 --
Barclays US Consumer Bank Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
Income statement information £m £m % Change £m £m % Change
Net interest income 1,555 1,318 18 732 640 14
Net fee, commission and other income 564 369 53 404 183
Total income 2,119 1,687 26 1,136 823 38
Operating costs (822) (803) (2) (442) (396) (12)
UK regulatory levies — — — — — —
Litigation and conduct (2) (3) 33 (2) —
Total operating expenses (824) (806) (2) (444) (396) (12)
Other net income — — — — — —
Profit before impairment 1,295 881 47 692 427 62
Credit impairment charges (713) (711) — (346) (312) (11)
Profit before tax 582 170 346 115
Attributable profit 429 128 253 87
Performance measures
Return on average allocated tangible equity1 24.2% 7.3% 30.2% 10.2%
Average allocated tangible equity (£bn) 3.5 3.5 3.3 3.4
Cost: income ratio 39% 48% 39% 48%
Loan loss rate (bps)2 575 523 555 456
Net interest margin 12.96% 10.68% 13.20 % 10.83%
Key facts
US cards 30 day arrears rate 2.9% 2.8%
US cards 90 days arrears rate 1.6% 1.6%
US cards customer FICO score distribution3
<660 14% 12%
>660 86% 88%
End net receivables (reported) ($bn) 29.7 32.9
As at
30.06.26
As at
31.12.25
As at
30.06.25
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 21.7 21.1 18.2
Deposits at amortised cost 24.7 24.2 22.5
Risk weighted assets 24.3 27.4 24.7
Period end allocated tangible equity 3.4 3.8 3.4
1 Return on average allocated tangible equity, excluding a c.£225m Q226 gain on sale (recorded in Net fee, commission and other income), from
the AA portfolio exit, was 10.5% for Q226 and 14.9% for H126, as a result of an adjusted attributable profit of £87m and £263m, respectively.
2 H125 and Q225 LLR includes held for sale portfolios to remain consistent with the treatment of impairment.
3 Reflects FICO distribution based on ending net receivables for customer credit cards.
Results by Business
Barclays PLC 13
-- 15 of 99 --
USCB delivered a RoTE of 24.2% (H125: 7.3%), reflecting a c.£225m Q226 gain on sale from the AA portfolio exit,
continued operational progress, with increased income from business growth, higher net interest margin and positive
operating jaws. Excluding the gain on sale of c.£225m (resulting in an adjusted attributable profit of £263m), the H126 RoTE
was 14.9%.
Income statement - H126 compared to H125
• Profit before tax increased to £582m (H125: £170m)
• The 4% appreciation of average GBP against USD adversely impacted income and profits, and positively impacted credit
impairment charges and total operating expenses
• Total income increased 26% to £2,119m, including the adverse impact of the strengthening of average GBP against
USD. NII increased 18% to £1,555m including business growth, repricing initiatives and change in portfolio mix. Net fee,
commission and other income increased 53% to £564m driven by gain on sale from the AA portfolio and the Best Egg
acquisition
• Total operating expenses increased 2% to £824m, driven by the acquisitions of Best Egg and the General Motors co-
branded cards portfolio (GM Portfolio), business growth, and inflationary headwinds, partially offset by lower partner
related expenses, the strengthening of average GBP against USD, and ongoing efficiency savings
• Credit impairment charges were £713m (H125: £711m), reflecting broadly stable underlying credit performance and
the £26m day 1 impact from the Best Egg acquisition. US cards 30 and 90 day arrears rates were 2.9% (H125: 2.8%) and
1.6% (H125: 1.6%) respectively. The USCB total coverage ratio was 11.1% (December 2025: 11.1%)
Balance sheet - 30 June 2026 compared to 31 December 2025
• Loans and advances to customers at amortised cost were broadly stable at £21.7bn (December 2025: £21.1bn)
• Deposits at amortised cost increased to £24.7bn (December 2025: £24.2bn), with growth in retail savings which is in
line with USCB's strategy to grow core deposits
• RWAs decreased to £24.3bn (December 2025: £27.4bn), driven by a net £3.2bn reduction relating to the AA portfolio
sale and Best Egg acquisition
Results by Business
Barclays PLC 14
-- 16 of 99 --
Head Office Half year ended Three months ended
30.06.26 30.06.25 30.06.26 30.06.25
Income statement information £m £m % Change £m £m % Change
Net interest income 96 288 (67) 149 114 31
Net fee, commission and other income (18) (152) 88 (88) (43)
Total income 78 136 (43) 61 71 (14)
Operating costs (368) (382) 4 (163) (175) 7
UK regulatory levies — — #DIV/0! — —
Litigation and conduct (108) (5) (1) (2) 50
Total operating expenses (476) (387) (23) (164) (177) 7
Other net income 24 9 3 (9)
Loss before impairment (374) (242) (55) (100) (115) 13
Credit impairment releases/(charges) 2 (5) — (1)
Loss before tax (372) (247) (51) (100) (116) 14
Attributable loss (303) (238) (27) (97) (114) 15
Performance measures
Average allocated tangible equity (£bn) 6.3 4.6 5.6 5.5
As at
30.06.26
As at
31.12.25
As at
30.06.25
Balance sheet information £bn £bn £bn
Risk weighted assets 12.7 12.3 12.6
Period end allocated tangible equity 6.5 7.5 5.9
Income statement - H126 compared to H125
• Loss before tax was £372m (H125: £247m)
• Total income decreased to £78m (H125: £136m), driven by the impact of the disposal of the German consumer finance
business in Q125, and hedge accounting
• Total operating expenses increased to £476m (H125: £387m), reflecting the £105m increase in the provision for the
FCA motor finance redress scheme in Q126
Balance sheet - 30 June 2026 compared to 31 December 2025
• RWAs increased to £12.7bn (December 2025: £12.3bn) driven by the net impact of the acquisition of the long-term
leasehold interest in One Churchill Place
Results by Business
Barclays PLC 15
-- 17 of 99 --
Barclays Group
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
Income statement information £m £m £m £m £m £m £m £m
Net interest income 3,921 3,737 3,734 3,745 3,505 3,517 3,500 3,308
Net fee, commission and other income 4,417 4,426 3,343 3,422 3,682 4,192 3,464 3,239
Total income 8,338 8,163 7,077 7,167 7,187 7,709 6,964 6,547
Operating costs (4,514) (4,359) (4,379) (4,254) (4,149) (4,258) (4,244) (3,954)
UK regulatory levies — (84) (229) 12 — (96) (227) 27
Litigation and conduct (4) (104) (50) (255) (76) (11) (121) (35)
Total operating expenses (4,518) (4,547) (4,658) (4,497) (4,225) (4,365) (4,592) (3,962)
Other net income/(expenses) 3 21 (25) 39 (9) 18 — 21
Profit before impairment 3,823 3,637 2,394 2,709 2,953 3,362 2,372 2,606
Credit impairment charges (571) (823) (535) (632) (469) (643) (711) (374)
Profit before tax 3,252 2,814 1,859 2,077 2,484 2,719 1,661 2,232
Tax charges (731) (638) (388) (365) (552) (621) (448) (412)
Profit after tax 2,521 2,176 1,471 1,712 1,932 2,098 1,213 1,820
Non-controlling interests (19) — (18) — (21) (2) (20) (3)
Other equity instrument holders (243) (244) (258) (255) (252) (232) (228) (253)
Attributable profit 2,259 1,932 1,195 1,457 1,659 1,864 965 1,564
Performance measures
Return on average tangible shareholders' equity 16.1% 13.5% 8.5% 10.6% 12.3% 14.0% 7.5% 12.3%
Average tangible shareholders' equity (£bn) 56.1 57.2 56.5 55.1 53.9 53.1 51.5 51.0
Cost: income ratio 54% 56% 66% 63% 59% 57% 66% 61%
Loan loss rate (bps) 51 74 48 57 44 61 66 37
Basic earnings per ordinary share 16.7p 14.1 8.6p 10.4p 11.7p 13.0p 6.7p 10.7p
Basic weighted average number of shares (m) 13,565 13,727 13,883 14,045 14,211 14,314 14,432 14,648
Period end number of shares (m) 13,507 13,737 13,867 13,996 14,180 14,336 14,420 14,571
Period end tangible shareholders' equity (£bn) 57.2 55.6 56.8 54.9 54.5 53.4 51.5 51.1
Balance sheet and capital management1 £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 359.3 358.3 352.8 346.4 339.2 338.6 337.9 326.5
Loans and advances to banks at amortised cost 12.0 12.0 8.7 9.4 8.7 9.4 8.3 8.1
Debt securities at amortised cost 73.5 68.3 68.5 70.7 69.9 71.4 68.2 64.6
Loans and advances at amortised cost 444.8 438.6 430.0 426.5 417.8 419.4 414.5 399.2
Loans and advances at amortised cost impairment
coverage ratio 1.2% 1.3% 1.2% 1.2% 1.2% 1.2% 1.2% 1.3%
Total assets 1,730.4 1,694.8 1,544.2 1,629.2 1,598.7 1,593.5 1,518.2 1,531.1
Deposits at amortised cost 594.4 587.6 585.6 575.3 564.5 574.3 560.7 542.8
Tangible net asset value per share 423p 405p 409p 392p 384p 372p 357p 351p
Common equity tier 1 ratio 14.3% 14.1% 14.3% 14.1% 14.0% 13.9% 13.6% 13.8%
Common equity tier 1 capital 52.2 51.2 51.1 50.3 49.5 48.8 48.6 47.0
Risk weighted assets 364.8 364.5 356.8 357.4 353.0 351.3 358.1 340.4
UK leverage ratio 4.9% 4.8% 5.1% 4.9% 5.0% 5.0% 5.0% 4.9%
UK leverage exposure 1,345.6 1,321.3 1,247.3 1,285.3 1,259.8 1,252.8 1,206.5 1,197.4
Funding and liquidity
Group liquidity pool (£bn) 346.7 326.1 337.8 332.9 333.7 336.3 296.9 311.7
Liquidity coverage ratio2 157.7% 165.4% 170.0% 174.6% 177.7% 175.3% 172.4% 170.1%
Net stable funding ratio 135.8% 135.4% 135.2% 135.3% 135.6% 136.2% 134.9% 135.6%
Loan: deposit ratio 75% 75% 73% 74% 74% 73% 74% 74%
1 Refer to pages 54 to 58 for further information on how capital, RWAs and leverage are calculated.
2 Represents average of the last 12 spot month end ratios. In June 2025, Barclays implemented a new methodology for calculating net stress
outflows related to secured financing transactions in the liquidity coverage ratio (LCR).
Quarterly Results Summary
Barclays PLC 16
-- 18 of 99 --
Barclays UK
Q226 Q126 Q425 Q325 Q225 Q125 Q4241 Q324
Income statement information £m £m £m £m £m £m £m £m
Net interest income 2,000 1,986 2,015 1,961 1,855 1,822 1,815 1,666
Net fee, commission and other income 259 272 247 292 264 252 800 280
Total income 2,259 2,258 2,262 2,253 2,119 2,074 2,615 1,946
Operating costs (1,194) (1,174) (1,274) (1,189) (1,168) (1,115) (1,170) (1,017)
UK regulatory levies — (44) (41) (1) — (43) (36) 12
Litigation and conduct (1) 1 (14) (8) (27) (2) (9) (1)
Total operating expenses (1,195) (1,217) (1,329) (1,198) (1,195) (1,160) (1,215) (1,006)
Other net income — — — — — — — —
Profit before impairment 1,064 1,041 933 1,055 924 914 1,400 940
Credit impairment charges (160) (178) (74) (102) (79) (158) (283) (16)
Profit before tax 904 863 859 953 845 756 1,117 924
Attributable profit 623 591 706 647 580 510 781 621
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 220.8 217.8 216.5 213.4 211.2 209.6 207.7 199.3
Customer deposits at amortised cost 245.6 243.9 244.6 241.5 241.3 243.1 244.2 236.3
Loan: deposit ratio 97% 95% 94% 95% 94% 93% 92% 92%
Risk weighted assets 89.0 87.5 85.8 86.7 86.1 85.0 84.5 77.5
Period end allocated tangible equity 12.4 12.0 11.8 11.9 11.8 11.8 11.6 10.7
Performance measures
Return on average allocated tangible equity 20.4% 19.7% 23.8% 21.8% 19.7% 17.4% 28.0% 23.4%
Average allocated tangible equity (£bn) 12.2 12.0 11.9 11.9 11.8 11.7 11.2 10.6
Cost: income ratio 53% 54% 59% 53% 56% 56% 46% 52%
Loan loss rate (bps) 27 31 13 18 14 28 49 3
Net interest margin 3.68% 3.72% 3.72% 3.68% 3.55% 3.55% 3.53% 3.34%
1 Q424 includes the day 1 impacts from the acquisition of Tesco Bank: total Income includes a £556m gain, and credit impairment charges
includes a £209m charge.
Quarterly Results by Business
Barclays PLC 17
-- 19 of 99 --
Analysis of Barclays UK Q226 Q126 Q425 Q325 Q225 Q125 Q4241 Q324
Analysis of total income £m £m £m £m £m £m £m £m
Retail Banking 1,711 1,725 1,702 1,708 1,599 1,573 2,078 1,433
Business Banking 548 533 560 545 520 501 537 513
Total income 2,259 2,258 2,262 2,253 2,119 2,074 2,615 1,946
Analysis of credit impairment (charges)/releases
Retail Banking (165) (179) (72) (98) (59) (145) (279) (12)
Business Banking 5 1 (2) (4) (20) (13) (4) (4)
Total credit impairment charges (160) (178) (74) (102) (79) (158) (283) (16)
Analysis of loans and advances to customers at
amortised cost £bn £bn £bn £bn £bn £bn £bn £bn
Retail Banking 203.1 200.1 198.6 195.2 192.4 190.4 188.0 178.7
Business Banking 17.7 17.7 17.9 18.2 18.8 19.2 19.7 20.6
Total loans and advances to customers at amortised
cost 220.8 217.8 216.5 213.4 211.2 209.6 207.7 199.3
Analysis of customer deposits at amortised cost
Retail Banking 194.5 193.1 192.7 189.3 189.3 190.8 191.4 182.9
Business Banking 51.1 50.8 51.9 52.2 52.0 52.3 52.8 53.4
Total customer deposits at amortised cost 245.6 243.9 244.6 241.5 241.3 243.1 244.2 236.3
1 Q424 includes the day 1 impacts from the acquisition of Tesco Bank: total Income includes a £556m gain, and credit impairment charges
includes a £209m charge.
Quarterly Results by Business
Barclays PLC 18
-- 20 of 99 --
Barclays UK Corporate Bank
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
Income statement information £m £m £m £m £m £m £m £m
Net interest income 413 394 396 383 359 342 324 309
Net fee, commission and other income 145 136 143 139 160 142 134 136
Total income 558 530 539 522 519 484 458 445
Operating costs (249) (239) (272) (243) (240) (234) (250) (229)
UK regulatory levies — (15) (14) 9 — (24) (14) 7
Litigation and conduct — — — — (39) — (1) —
Total operating expenses (249) (254) (286) (234) (279) (258) (265) (222)
Other net income — — — — — — — —
Profit before impairment 309 276 253 288 240 226 193 223
Credit impairment charges (16) (3) (1) (5) (12) (19) (40) (13)
Profit before tax 293 273 252 283 228 207 153 210
Attributable profit 201 187 168 196 142 142 98 144
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 31.3 30.8 30.0 29.0 27.9 26.7 25.4 24.8
Deposits at amortised cost 89.1 88.0 88.7 86.7 85.3 85.3 83.1 82.3
Risk weighted assets 26.6 27.3 26.5 25.2 25.3 24.2 23.9 22.1
Period end allocated tangible equity 3.7 3.7 3.7 3.4 3.5 3.4 3.3 3.0
Performance measures
Return on average allocated tangible equity 21.3% 19.9% 19.1% 22.8% 16.6% 17.1% 12.3% 18.8%
Average allocated tangible equity (£bn) 3.8 3.8 3.5 3.4 3.4 3.3 3.2 3.1
Cost: income ratio 45% 48% 53% 45% 54% 53% 58% 50%
Loan loss rate (bps) 20 4 1 7 17 28 62 21
Analysis of total income £m £m £m £m £m £m £m £m
Corporate lending 96 89 97 90 90 80 71 67
Transaction banking 462 441 442 432 429 404 387 378
Total income 558 530 539 522 519 484 458 445
Quarterly Results by Business
Barclays PLC 19
-- 21 of 99 --
Barclays Private Bank and Wealth
Management
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
Income statement information £m £m £m £m £m £m £m £m
Net interest income 216 204 202 190 203 204 216 189
Net fee, commission and other income 150 143 146 145 145 145 135 137
Total income 366 347 348 335 348 349 351 326
Operating costs (267) (254) (279) (243) (238) (234) (255) (222)
UK regulatory levies — (3) (7) (1) — (2) (7) 1
Litigation and conduct — — (10) 1 — — (1) —
Total operating expenses (267) (257) (296) (243) (238) (236) (263) (221)
Other net income — — — — — — — —
Profit before impairment 99 90 52 92 110 113 88 105
Credit impairment releases/(charges) (5) 2 (2) (1) 2 9 (2) (7)
Profit before tax 94 92 50 91 112 122 86 98
Attributable profit 75 73 35 72 88 96 63 74
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 14.8 14.7 14.7 14.9 14.5 14.5 14.5 14.0
Deposits at amortised cost 72.7 73.3 72.0 70.6 66.7 73.1 69.5 64.8
Risk weighted assets 8.0 8.2 8.0 7.9 7.9 8.0 7.9 7.3
Period end allocated tangible equity 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.0
Client assets and liabilities1 230.2 223.8 227.6 221.5 213.4 212.4 208.9 201.5
Performance measures
Return on average allocated tangible equity 26.9% 25.5 % 12.6 % 26.4% 31.9% 34.5% 23.9% 29.0%
Average allocated tangible equity (£bn) 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.0
Cost: income ratio 73% 74% 85% 73% 68% 68% 75% 68%
Loan loss rate (bps) 13 (6) 5 3 (5) (25) 5 19
1 Client assets and liabilities refers to deposits, lending and invested assets.
Quarterly Results by Business
Barclays PLC 20
-- 22 of 99 --
Barclays Investment Bank
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
Income statement information £m £m £m £m £m £m £m £m
Net interest income 411 383 356 347 334 297 284 282
Net trading income 2,271 2,358 1,294 1,581 1,906 2,416 1,262 1,512
Net fee, commission and other income 1,276 1,287 1,142 1,155 1,067 1,160 1,061 1,057
Total income 3,958 4,028 2,792 3,083 3,307 3,873 2,607 2,851
Operating costs (2,199) (2,107) (1,924) (2,010) (1,932) (2,061) (1,903) (1,906)
UK regulatory levies — (22) (159) 5 — (27) (161) 7
Litigation and conduct — 2 (8) (9) (8) (3) (26) (17)
Total operating expenses (2,199) (2,127) (2,091) (2,014) (1,940) (2,091) (2,090) (1,916)
Other net income — — — — — — — —
Profit before impairment 1,759 1,901 701 1,069 1,367 1,782 517 935
Credit impairment charges (44) (279) (22) (144) (67) (72) (46) (43)
Profit before tax 1,715 1,622 679 925 1,300 1,710 471 892
Attributable profit 1,204 1,111 294 723 876 1,199 247 652
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 70.8 73.6 70.0 68.6 66.8 68.6 69.7 64.5
Loans and advances to banks at amortised cost 11.0 10.0 7.4 7.5 7.1 7.4 6.8 6.7
Debt securities at amortised cost 54.5 52.9 52.9 53.0 52.4 53.1 47.9 44.8
Loans and advances at amortised cost 136.3 136.5 130.3 129.1 126.3 129.1 124.4 116.0
Trading portfolio assets 208.2 189.3 189.5 191.3 186.1 185.5 166.1 185.8
Derivative financial instrument assets 302.6 285.4 251.5 263.8 279.0 253.6 291.6 256.7
Financial assets at fair value through the income
statement 209.9 215.6 183.6 222.8 215.2 209.5 190.4 210.8
Cash collateral and settlement balances 182.5 189.2 121.6 152.1 145.0 148.8 111.1 134.7
Deposits at amortised cost 162.3 157.4 156.1 152.8 148.7 148.9 140.5 139.8
Derivative financial instrument liabilities 291.6 272.6 240.6 252.0 265.1 245.1 279.0 249.4
Risk weighted assets 204.1 201.7 196.7 199.1 196.4 195.9 198.8 194.2
Period end allocated tangible equity 30.1 29.6 28.9 29.1 28.7 28.9 29.3 28.4
Performance measures
Return on average allocated tangible equity 16.0% 15.0 % 4.0 % 10.1 % 12.2% 16.2% 3.4% 8.8 %
Average allocated tangible equity (£bn) 30.0 29.7 29.6 28.6 28.7 29.6 29.3 29.5
Income over average risk weighted assets 7.7% 8.0% 5.5% 6.3% 6.7% 7.7% 5.2% 5.7%
Cost: income ratio 56% 53% 75% 65% 59% 54% 80% 67%
Loan loss rate (bps) 13 82 7 44 21 23 15 15
Analysis of total income £m £m £m £m £m £m £m £m
FICC 1,471 1,716 1,024 1,256 1,450 1,699 934 1,180
Equities 1,261 1,116 703 689 870 963 604 692
Global Markets 2,732 2,832 1,727 1,945 2,320 2,662 1,538 1,872
Advisory 188 255 214 196 123 143 189 186
Equity capital markets 157 92 56 71 81 70 98 64
Debt capital markets 402 407 336 379 364 431 327 344
Banking Fees and Underwriting 747 754 606 646 568 644 614 594
Corporate lending 37 16 27 68 (4) 156 45 (21)
Transaction banking 442 426 432 424 423 411 410 406
International Corporate Banking 479 442 459 492 419 567 455 385
Investment Banking 1,226 1,196 1,065 1,138 987 1,211 1,069 979
Total income 3,958 4,028 2,792 3,083 3,307 3,873 2,607 2,851
Quarterly Results by Business
Barclays PLC 21
-- 23 of 99 --
Barclays US Consumer Bank
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
Income statement information £m £m £m £m £m £m £m £m
Net interest income 732 823 776 726 640 678 678 647
Net fee, commission, trading and other income 404 160 277 215 183 186 179 144
Total income 1,136 983 1,053 941 823 864 857 791
Operating costs (442) (380) (427) (407) (396) (407) (433) (384)
UK regulatory levies — — — — — — — —
Litigation and conduct (2) — (5) — — (3) — (9)
Total operating expenses (444) (380) (432) (407) (396) (410) (433) (393)
Other net income — — — — — — — —
Profit before impairment 692 603 621 534 427 454 424 398
Credit impairment charges (346) (367) (431) (379) (312) (399) (298) (276)
Profit before tax 346 236 190 155 115 55 126 122
Attributable profit 253 176 144 118 87 41 94 89
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised cost 21.7 21.0 21.1 20.0 18.2 18.8 20.0 23.2
Deposits at amortised cost 24.7 25.0 24.2 23.7 22.5 23.8 23.3 19.4
Risk weighted assets 24.3 27.6 27.4 25.8 24.7 25.6 26.8 23.2
Period end allocated tangible equity 3.4 3.8 3.8 3.5 3.4 3.5 3.7 3.2
Performance measures
Return on average allocated tangible equity1 30.2% 18.8% 15.8% 13.5% 10.2% 4.5% 11.2% 10.9%
Average allocated tangible equity (£bn) 3.3 3.8 3.6 3.5 3.4 3.6 3.4 3.3
Cost: income ratio 39% 39% 41% 43% 48% 47% 51% 50%
Loan loss rate (bps)2 555 491 558 505 456 562 395 411
Net interest margin 13.20% 12.76% 11.63% 11.50% 10.83% 10.53% 10.66% 10.38%
1 Return on average allocated tangible equity, excluding a c.£225m Q226 gain on sale (recorded in Net fee, commission and other income) from
the AA portfolio exit, was 10.5% for Q226, as a result of an adjusted attributable profit of £87m.
2 LLR includes held for sale portfolios to remain consistent with the treatment of impairment in Q424 to Q126.
Quarterly Results by Business
Barclays PLC 22
-- 24 of 99 --
Head Office
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
Income statement information £m £m £m £m £m £m £m £m
Net interest income 149 (53) (11) 138 114 174 183 215
Net fee, commission and other income (88) 70 94 (105) (43) (109) (107) (27)
Total income 61 17 83 33 71 65 76 188
Operating costs (163) (205) (203) (162) (175) (207) (233) (197)
UK regulatory levies — — (8) — — — (9) —
Litigation and conduct (1) (107) (13) (239) (2) (3) (84) (7)
Total operating expenses (164) (312) (224) (401) (177) (210) (326) (204)
Other net income/(expenses) 3 21 (25) 39 (9) 18 — 21
(Loss)/profit before impairment (100) (274) (166) (329) (115) (127) (250) 5
Credit impairment releases/(charges) — 2 (5) (1) (1) (4) (42) (19)
Loss before tax (100) (272) (171) (330) (116) (131) (292) (14)
Attributable loss (97) (206) (152) (299) (114) (124) (318) (16)
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Risk weighted assets 12.7 12.3 12.3 12.7 12.6 12.7 16.2 16.1
Period end allocated tangible equity 6.5 5.4 7.5 5.8 5.9 4.7 2.4 4.9
Performance measures
Average allocated tangible equity (£bn) 5.6 6.8 6.7 6.6 5.5 3.8 3.4 3.5
Quarterly Results by Business
Barclays PLC 23
-- 25 of 99 --
Margins and balances
Half year ended 30.06.26 Half year ended 30.06.25
Net interest
income
Average
customer
assets
Net interest
margin
Net interest
income
Average
customer
assets
Net interest
margin
£m £m % £m £m %
Barclays UK 3,986 217,201 3.70 3,677 208,977 3.55
Barclays UK Corporate Bank 807 29,070 5.60 701 25,044 5.64
Barclays Private Bank and Wealth Management 420 14,979 5.65 407 14,701 5.58
Barclays US Consumer Bank 1,555 24,203 12.96 1,318 24,897 10.68
Group excluding IB and Head Office 6,768 285,453 4.78 6,103 273,619 4.50
Barclays Investment Bank 794 631
Head Office 96 288
Barclays Group Net interest income 7,658 7,022
The Group excluding IB and Head Office net interest margin increased by 28bps from 4.50% in H125 to 4.78% in H126 due
to Group structural hedge income, partner reward updates and changes in portfolio mix in USCB.
Quarterly analysis
Q226 Q126 Q425 Q325 Q225
Net interest income £m £m £m £m £m
Barclays UK 2,000 1,986 2,015 1,961 1,855
Barclays UK Corporate Bank 413 394 396 383 359
Barclays Private Bank and Wealth Management 216 204 202 190 203
Barclays US Consumer Bank 732 823 776 726 640
Group excluding IB and Head Office 3,361 3,407 3,389 3,260 3,057
Average customer assets £m £m £m £m £m
Barclays UK 217,778 216,623 214,770 211,384 209,649
Barclays UK Corporate Bank 29,603 28,536 27,841 26,645 25,478
Barclays Private Bank and Wealth Management 14,936 15,022 15,105 14,802 14,729
Barclays US Consumer Bank 22,247 26,163 26,470 25,037 23,713
Group excluding IB and Head Office 284,564 286,344 284,186 277,868 273,569
Net interest margin % % % % %
Barclays UK 3.68 3.72 3.72 3.68 3.55
Barclays UK Corporate Bank 5.60 5.60 5.64 5.70 5.65
Barclays Private Bank and Wealth Management 5.80 5.51 5.31 5.09 5.53
Barclays US Consumer Bank 13.20 12.76 11.63 11.50 10.83
Group excluding IB and Head Office 4.74 4.83 4.73 4.65 4.48
Performance Management
Barclays PLC 24
-- 26 of 99 --
Structural hedge
The Group employs a structural hedge programme designed to stabilise NIM on fixed rate non-maturity balance sheet items
that are behaviourally stable. As interest rates move, such balances would otherwise drive material income volatility where
there is a re-pricing mismatch with floating rate assets.
The structural hedge predominantly covers non-interest-bearing current accounts and the fixed portion of instant access
savings accounts as well as equity, which are invested into either floating rate customer assets or balances at central banks,
creating an exposure to changes in interest rates. The structural hedge is executed primarily via a portfolio of receive-fixed,
pay variable interest rate swaps, with an amortising structure so that a small portion matures and is reinvested each month
at prevailing market rates. The pay-floating leg of the interest rate swaps nets down a proportion of the receive-floating
income from the customer assets, leaving a receive-fixed income stream from the structural hedge.
The purpose of the structural hedge is to smooth the Group NII through time. The floating leg of the swap will re-price
immediately, whereas the fixed rate yield on the portfolio reprices gradually, as a portion of the swap portfolio matures and
the roll is re-invested onto new market rates.
When interest rates are higher than our structural hedge yield, the pay-floating rate will typically be higher than our average
receive-fixed rate. In this scenario, when viewed in isolation, the structural hedge will be a net drag to Group NII. When
floating rates are lower than our structural hedge yield, the hedge in isolation will be a net benefit.
Since the receive-fixed swaps are booked for a specific term, an element of NII is ‘locked in’. The income stabilising feature of
the structural hedge provides greater net interest income certainty through the interest rate cycle.
The structural hedge is one component of a larger portfolio of interest rate risk management activities that includes non-
structural hedging (e.g. pay-fixed and receive-variable flows for asset hedging), and other offsetting flows. The net risk of
these positions is executed externally through interest rate swaps and managed for accounting risk (i.e. income volatility
arising from the accounting mismatch of swaps at fair value through profit and loss and underlying hedged items at
amortised cost) within the cash flow hedging reserve.
Overall the Group has external derivatives designated as cash flow hedges that hedge interest rate risk with a notional of
£121.0bn (December 2025: £114.6bn) which reflects the structural hedge derivatives notional of £239.8bn (December
2025: £236.1bn) netted with non-structural hedging positions of £118.8bn (December 2025: £121.5bn). The majority of
these interest rate swaps are cleared with Central Clearing Counterparties and margined daily with an average structural
hedge duration of c3.5 years.
Gross structural hedge contributions in H126 were £3,456m (H125: £2,778m). Gross structural hedge contributions
primarily represent the absolute interest income earned on the fixed legs of the swaps in the structural hedge as the floating
leg is offset by the base rate funding of the deposits.
Performance Management
Barclays PLC 25
-- 27 of 99 --
Risk management and principal risks
The roles and responsibilities across the Group, including Risk and Compliance, in the management of risk are defined in the
Enterprise Risk Management Framework (ERMF). The purpose of the ERMF is to identify the principal risks of the Group, the
process by which the Group sets its appetite for these risks in its business activities, and the consequent limits which it
places on related risk taking.
The ERMF identifies ten principal risks: climate risk, credit risk, market risk, treasury and capital risk, operational risk, model
risk, compliance risk, financial crime risk, reputation risk and legal risk. Further detail on these principal risks and material
existing and emerging risks and how such risks are managed is available in the Barclays PLC Annual Report 2025, which can
be accessed at home.barclays/annualreport. There have been no significant changes to these principal risks or previously
identified material existing and emerging risks in the period and these risks are expected to be relevant for the remaining six
months of this year.
The following sections give an overview of credit risk, market risk, and treasury and capital risk for the period.
Risk Management
Barclays PLC 26
-- 28 of 99 --
Loans and advances at amortised cost by geography
Total loans and advances at amortised cost in the credit risk section includes loans and advances at amortised cost to banks
and loans and advances at amortised cost to customers.
The table below presents a product and geographical breakdown of loans and advances at amortised cost and the impairment
allowance by stage; and includes purchased or originated credit-impaired (POCI) balances. POCI balances represent a fixed pool
of assets purchased at a deep discount to face value reflecting credit losses incurred from the point of origination to date of
acquisition. The table also presents stage allocation of debt securities and off-balance sheet loan commitments and financial
guarantee contracts.
The impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail
portfolios, the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the
drawn exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For wholesale portfolios,
impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision. .
Gross exposure Impairment allowance
Stage 1 Stage 2
Stage 3
excluding
POCI
Stage 3
POCI Total Stage 1 Stage 2
Stage 3
excluding
POCI
Stage
3 POCI Total
As at 30.06.26 £m £m £m £m £m £m £m £m £m £m
Retail mortgages 163,971 13,869 1,765 — 179,605 16 20 61 — 97
Retail credit cards 15,067 2,085 303 13 17,468 170 430 189 — 789
Retail other 9,683 1,597 352 8 11,640 103 184 218 — 505
Corporate loans1 56,110 6,500 1,628 — 64,238 104 180 638 — 922
Total UK 244,831 24,051 4,048 21 272,951 393 814 1,106 — 2,313
Retail mortgages 1,661 231 172 — 2,064 3 1 26 — 30
Retail credit cards 19,041 2,780 1,814 — 23,635 412 785 1,450 — 2,647
Retail other 2,614 444 73 — 3,131 7 6 18 — 31
Corporate loans 69,582 3,888 1,566 — 75,036 85 135 275 — 495
Total Rest of the World 92,898 7,343 3,625 — 103,866 507 927 1,769 — 3,203
Total loans and advances at amortised
cost 337,729 31,394 7,673 21 376,817 900 1,741 2,875 — 5,516
Debt securities at amortised cost 72,362 1,177 — — 73,539 11 9 — — 20
Total loans and advances at amortised
cost including debt securities 410,091 32,571 7,673 21 450,356 911 1,750 2,875 — 5,536
Off-balance sheet loan commitments
and financial guarantee contracts2 407,202 16,150 838 5 424,195 158 238 37 — 433
Total3,4 817,293 48,721 8,511 26 874,551 1,069 1,988 2,912 — 5,969
Net exposure Coverage ratio
Stage 1 Stage 2
Stage 3
excluding
POCI
Stage 3
POCI Total Stage 1 Stage 2
Stage 3
excluding
POCI
Stage
3 POCI Total
As at 30.06.26 £m £m £m £m £m % % % % %
Retail mortgages 163,955 13,849 1,704 — 179,508 — 0.1 3.5 — 0.1
Retail credit cards 14,897 1,655 114 13 16,679 1.1 20.6 62.4 — 4.5
Retail other 9,580 1,413 134 8 11,135 1.1 11.5 61.9 — 4.3
Corporate loans1 56,006 6,320 990 — 63,316 0.2 2.8 39.2 — 1.4
Total UK 244,438 23,237 2,942 21 270,638 0.2 3.4 27.3 — 0.8
Retail mortgages 1,658 230 146 — 2,034 0.2 0.4 15.1 — 1.5
Retail credit cards 18,629 1,995 364 — 20,988 2.2 28.2 79.9 — 11.2
Retail other 2,607 438 55 — 3,100 0.3 1.4 24.7 — 1.0
Corporate loans 69,497 3,753 1,291 — 74,541 0.1 3.5 17.6 — 0.7
Total Rest of the World 92,391 6,416 1,856 — 100,663 0.5 12.6 48.8 — 3.1
Total loans and advances at amortised
cost 336,829 29,653 4,798 21 371,301 0.3 5.5 37.5 — 1.5
Debt securities at amortised cost 72,351 1,168 — — 73,519 — 0.8 — — —
Total loans and advances at amortised
cost including debt securities 409,180 30,821 4,798 21 444,820 0.2 5.4 37.5 — 1.2
Off-balance sheet loan commitments
and financial guarantee contracts2 407,044 15,912 801 5 423,762 — 1.5 4.4 — 0.1
Total3,4 816,224 46,733 5,599 26 868,582 0.1 4.1 34.2 — 0.7
1 Includes Business Banking, which has a gross exposure of £12.4bn and an impairment allowance of £301m. This comprises £47m impairment
allowance on £9.7bn Stage 1 exposure, £47m on £2.0bn Stage 2 exposure and £207m on £0.7bn Stage 3 exposure. Excluding this, total
coverage for corporate loans in UK is 1.2%.
2 Excludes loan commitments and financial guarantees of £32.3bn carried at fair value.
3 Excludes other financial assets subject to impairment comprising of cash collateral and settlement balances, reverse repurchase agreements and
other similar secured lending, financial assets at fair value through other comprehensive income and other assets. These have a total gross
exposure of £286.4bn and an impairment allowance of £151m. This comprises £17m impairment allowance on £285.5bn Stage 1 exposure,
£10m on £0.8bn Stage 2 exposure and £124m on £127m Stage 3 exposure.
4 The annualised loan loss rate is 62bps after applying the total impairment charges of £1,394m.
Credit Risk
Barclays PLC 27
-- 29 of 99 --
Gross exposure Impairment allowance
Stage 1 Stage 2
Stage 3
excluding
POCI
Stage 3
POCI Total Stage 1 Stage 2
Stage 3
excluding
POCI
Stage 3
POCI Total
As at 31.12.25 £m £m £m £m £m £m £m £m £m £m
Retail mortgages 159,825 13,757 1,836 — 175,418 15 16 60 — 91
Retail credit cards 14,922 1,943 279 24 17,168 171 398 174 — 743
Retail other 9,867 1,512 286 15 11,680 98 178 214 — 490
Corporate loans1 54,182 6,936 1,392 — 62,510 125 180 422 — 727
Total UK 238,796 24,148 3,793 39 266,776 409 772 870 — 2,051
Retail mortgages 1,829 72 131 — 2,032 2 — 24 — 26
Retail credit cards 18,801 2,536 1,776 — 23,113 395 796 1,395 — 2,586
Retail other 2,482 206 63 — 2,751 3 5 19 — 27
Corporate loans 66,671 3,702 1,767 — 72,140 82 135 382 — 599
Total Rest of the World 89,783 6,516 3,737 — 100,036 482 936 1,820 — 3,238
Total loans and advances
at amortised cost 328,579 30,664 7,530 39 366,812 891 1,708 2,690 — 5,289
Debt securities at
amortised cost 68,126 371 — — 68,497 13 9 — — 22
Total loans and advances
at amortised cost
including debt securities
396,705 31,035 7,530 39 435,309 904 1,717 2,690 — 5,311
Off-balance sheet loan
commitments and
financial guarantee
contracts2
410,493 16,473 812 5 427,783 144 240 32 — 416
Total3,4 807,198 47,508 8,342 44 863,092 1,048 1,957 2,722 — 5,727
Net exposure Coverage ratio
Stage 1 Stage 2
Stage 3
excluding
POCI
Stage 3
POCI Total Stage 1 Stage 2
Stage 3
excluding
POCI
Stage 3
POCI Total
As at 31.12.25 £m £m £m £m £m % % % % %
Retail mortgages 159,810 13,741 1,776 — 175,327 — 0.1 3.3 — 0.1
Retail credit cards 14,751 1,545 105 24 16,425 1.1 20.5 62.4 — 4.3
Retail other 9,769 1,334 72 15 11,190 1.0 11.8 74.8 — 4.2
Corporate loans1 54,057 6,756 970 — 61,783 0.2 2.6 30.3 — 1.2
Total UK 238,387 23,376 2,923 39 264,725 0.2 3.2 22.9 — 0.8
Retail mortgages 1,827 72 107 — 2,006 0.1 — 18.3 — 1.3
Retail credit cards 18,406 1,740 381 — 20,527 2.1 31.4 78.5 — 11.2
Retail other 2,479 201 44 — 2,724 0.1 2.4 30.2 — 1.0
Corporate loans 66,589 3,567 1,385 — 71,541 0.1 3.6 21.6 — 0.8
Total Rest of the World 89,301 5,580 1,917 — 96,798 0.5 14.4 48.7 — 3.2
Total loans and advances
at amortised cost 327,688 28,956 4,840 39 361,523 0.3 5.6 35.7 — 1.4
Debt securities at
amortised cost 68,113 362 — — 68,475 — 2.4 — — —
Total loans and advances
at amortised cost
including debt securities
395,801 29,318 4,840 39 429,998 0.2 5.5 35.7 — 1.2
Off-balance sheet loan
commitments and
financial guarantee
contracts2
410,349 16,233 780 5 427,367 — 1.5 3.9 — 0.1
Total3,4 806,150 45,551 5,620 44 857,365 0.1 4.1 32.6 — 0.7
1 Includes Business Banking, which has a gross exposure of £12.4bn and an impairment allowance of £326m. This comprises £62m impairment
allowance on £9.3bn Stage 1 exposure, £50m on £2.3bn Stage 2 exposure and £214m on £0.8bn Stage 3 exposure. Excluding this, total
coverage for corporate loans in UK is 0.8%.
2 Excludes loan commitments and financial guarantees of £22.2bn carried at fair value and includes exposure relating to financial assets classified
as assets held for sale.
3 Excludes other financial assets subject to impairment comprising of cash collateral and settlement balances, reverse repurchase agreements and
other similar secured lending, financial assets at fair value through other comprehensive income and other assets. These have a total gross
exposure of £224.1bn and an impairment allowance of £150m. This comprises £18m impairment allowance on £222.4bn Stage 1 exposure,
£8m on £1.6bn Stage 2 exposure and £124m on £127m Stage 3 exposure.
4 The annualised loan loss rate is 52bps after applying the total impairment charges of £2,279m.
Credit Risk
Barclays PLC 28
-- 30 of 99 --
Loans and advances at amortised cost by product
The table below presents loans and advances at amortised cost by product and stage, including Stage 2 past due balances.
Stage 2
As at 30.06.26 Stage 1
Not past
due
<=30 days
past due
>30 days
past due Total
Stage 3
excluding
POCI
Stage 3
POCI Total
Gross exposure £m £m £m £m £m £m £m £m
Retail mortgages 165,632 11,391 2,031 678 14,100 1,937 — 181,669
Retail credit cards 34,108 4,258 332 275 4,865 2,117 13 41,103
Retail other 12,297 1,711 186 144 2,041 425 8 14,771
Corporate loans 125,692 10,144 92 152 10,388 3,194 — 139,274
Total 337,729 27,504 2,641 1,249 31,394 7,673 21 376,817
Impairment allowance
Retail mortgages 19 14 5 2 21 87 — 127
Retail credit cards 582 896 140 179 1,215 1,639 — 3,436
Retail other 110 122 32 36 190 236 — 536
Corporate loans 189 297 10 8 315 913 — 1,417
Total 900 1,329 187 225 1,741 2,875 — 5,516
Net exposure
Retail mortgages 165,613 11,377 2,026 676 14,079 1,850 — 181,542
Retail credit cards 33,526 3,362 192 96 3,650 478 13 37,667
Retail other 12,187 1,589 154 108 1,851 189 8 14,235
Corporate loans 125,503 9,847 82 144 10,073 2,281 — 137,857
Total 336,829 26,175 2,454 1,024 29,653 4,798 21 371,301
Coverage ratio % % % % % % % %
Retail mortgages — 0.1 0.2 0.3 0.1 4.5 — 0.1
Retail credit cards 1.7 21.0 42.2 65.1 25.0 77.4 — 8.4
Retail other 0.9 7.1 17.2 25.0 9.3 55.5 — 3.6
Corporate loans 0.2 2.9 10.9 5.3 3.0 28.6 — 1.0
Total 0.3 4.8 7.1 18.0 5.5 37.5 — 1.5
As at 31.12.25
Gross exposure £m £m £m £m £m £m £m £m
Retail mortgages 161,654 11,072 2,033 724 13,829 1,967 — 177,450
Retail credit cards 33,723 3,832 317 330 4,479 2,055 24 40,281
Retail other 12,349 1,398 207 113 1,718 349 15 14,431
Corporate loans 120,853 10,409 71 158 10,638 3,159 — 134,650
Total 328,579 26,711 2,628 1,325 30,664 7,530 39 366,812
Impairment allowance
Retail mortgages 17 9 4 3 16 84 — 117
Retail credit cards 566 840 138 216 1,194 1,569 — 3,329
Retail other 101 126 28 29 183 233 — 517
Corporate loans 207 298 7 10 315 804 — 1,326
Total 891 1,273 177 258 1,708 2,690 — 5,289
Net exposure
Retail mortgages 161,637 11,063 2,029 721 13,813 1,883 — 177,333
Retail credit cards 33,157 2,992 179 114 3,285 486 24 36,952
Retail other 12,248 1,272 179 84 1,535 116 15 13,914
Corporate loans 120,646 10,111 64 148 10,323 2,355 — 133,324
Total 327,688 25,438 2,451 1,067 28,956 4,840 39 361,523
Coverage ratio % % % % % % % %
Retail mortgages — 0.1 0.2 0.4 0.1 4.3 — 0.1
Retail credit cards 1.7 21.9 43.5 65.5 26.7 76.4 — 8.3
Retail other 0.8 9.0 13.5 25.7 10.7 66.8 — 3.6
Corporate loans 0.2 2.9 9.9 6.3 3.0 25.5 — 1.0
Total 0.3 4.8 6.7 19.5 5.6 35.7 — 1.4
Credit Risk
Barclays PLC 29
-- 31 of 99 --
Movement in gross exposures and impairment allowance including provisions for loan commitments and
financial guarantees
The following tables present a reconciliation of the opening to the closing balance of the gross exposure and impairment
allowance.
Transfers between stages in the tables have been reflected as if they had taken place at the beginning of the period. 'Net
drawdowns, repayments, net re-measurement and movements due to exposure and risk parameter changes' includes
additional drawdowns and partial repayments from existing facilities. Additionally, the tables below do not include other
financial assets subject to impairment such as debt securities at amortised cost, reverse repurchase agreements and other
similar secured lending, cash collateral and settlement balances, financial assets at fair value through other comprehensive
income and other assets.
The movements in gross exposures and expected credit losses (ECL) are measured over a six-month period.
Loans and advances at amortised cost
Stage 1 Stage 2
Stage 3
excluding POCI Stage 3 POCI Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Retail mortgages £m £m £m £m £m £m £m £m £m £m
As at 01.01.26 161,654 17 13,829 16 1,967 84 — — 177,450 117
Transfers from Stage 1 to Stage 2 (5,412) (1) 5,412 1 — — — — — —
Transfers from Stage 2 to Stage 1 3,648 3 (3,648) (3) — — — — — —
Transfers to Stage 3 (197) — (300) (1) 497 1 — — — —
Transfers from Stage 3 27 — 74 1 (101) (1) — — — —
Business activity in the period 17,491 3 213 — — — — — 17,704 3
Refinements to models used for
calculation — (2) — — — 1 — — — (1)
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(3,815) — (300) 9 (53) 16 — — (4,168) 25
Final repayments (7,385) (1) (760) (1) (210) (7) — — (8,355) (9)
Disposals1 (379) — (420) (1) (158) (2) — — (957) (3)
Write-offs — — — — (5) (5) — — (5) (5)
As at 30.06.26 165,632 19 14,100 21 1,937 87 — — 181,669 127
Retail credit cards
As at 01.01.26 33,723 566 4,479 1,194 2,055 1,569 24 — 40,281 3,329
Transfers from Stage 1 to Stage 2 (2,169) (63) 2,169 63 — — — — — —
Transfers from Stage 2 to Stage 1 1,519 343 (1,519) (343) — — — — — —
Transfers to Stage 3 (331) (15) (708) (325) 1,039 340 — — — —
Transfers from Stage 3 16 10 13 6 (29) (16) — — — —
Business activity in the period2 2,163 60 164 41 3 2 — — 2,330 103
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(708) (314) 313 593 (31) 599 (11) — (437) 878
Final repayments (105) (5) (46) (14) (55) (46) — — (206) (65)
Disposals1 — — — — (250) (194) — — (250) (194)
Write-offs — — — — (615) (615) — — (615) (615)
As at 30.06.26 34,108 582 4,865 1,215 2,117 1,639 13 — 41,103 3,436
1 The £957m of gross disposals reported within Retail mortgages relate to the transfer of facilities to a non-consolidated SPV for the purpose of
securitisation. The £250m of gross disposals reported within Retail credit cards relate to debt sales undertaken during the period.
2 Business activity in the period reported within Retail credit cards includes £101m related to the acquisition of Best Egg within USCB.
Credit Risk
Barclays PLC 30
-- 32 of 99 --
Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 excluding
POCI Stage 3 POCI Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Retail other £m £m £m £m £m £m £m £m £m £m
As at 01.01.26 12,349 101 1,718 183 349 233 15 — 14,431 517
Transfers from Stage 1 to Stage 2 (917) (8) 917 8 — — — — — —
Transfers from Stage 2 to Stage 1 538 46 (538) (46) — — — — — —
Transfers to Stage 3 (124) (1) (121) (27) 245 28 — — — —
Transfers from Stage 3 1 — 9 3 (10) (3) — — — —
Business activity in the period1 3,101 27 238 27 8 4 — — 3,347 58
Refinements to models used for
calculation — (2) — — — — — — — (2)
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter
changes
(845) (43) 143 49 44 101 (7) — (665) 107
Final repayments (1,806) (10) (325) (7) (88) (9) — — (2,219) (26)
Disposals2 — — — — (21) (16) — — (21) (16)
Write-offs — — — — (102) (102) — — (102) (102)
As at 30.06.26 12,297 110 2,041 190 425 236 8 — 14,771 536
Corporate loans
As at 01.01.26 120,853 207 10,638 315 3,159 804 — — 134,650 1,326
Transfers from Stage 1 to Stage 2 (2,679) (14) 2,679 14 — — — — — —
Transfers from Stage 2 to Stage 1 2,186 37 (2,186) (37) — — — — — —
Transfers to Stage 3 (698) (1) (294) (19) 992 20 — — — —
Transfers from Stage 3 157 6 124 12 (281) (18) — — — —
Business activity in the period 21,366 23 214 11 44 11 — — 21,624 45
Refinements to models used for
calculation — (2) — 1 — 1 — — — —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter
changes
1,609 (49) 204 44 (262) 438 — — 1,551 433
Final repayments (17,047) (17) (991) (26) (124) (9) — — (18,162) (52)
Disposals2 (55) (1) — — — — — — (55) (1)
Write-offs — — — — (334) (334) — — (334) (334)
As at 30.06.26 125,692 189 10,388 315 3,194 913 — — 139,274 1,417
1 Business activity in the period reported within Retail other includes £122m related to the acquisition of Best Egg within USCB.
2 The £21m of gross disposals reported within Retail other and £55m of gross disposals reported within Corporate loans relate to debt sales
undertaken during the period.
Credit Risk
Barclays PLC 31
-- 33 of 99 --
Reconciliation of ECL movement to impairment charges for the period
Stage 1 Stage 2
Stage 3
excluding
POCI Stage 3 POCI Total
£m £m £m £m £m
Retail mortgages 2 6 10 — 18
Retail credit cards 16 21 879 — 916
Retail other 9 7 121 — 137
Corporate loans (17) — 443 — 426
ECL movements excluding disposals and write-offs1 10 34 1,453 — 1,497
ECL movement on loan commitments and other financial guarantees 14 (2) 5 — 17
ECL movement on other financial assets (1) 2 — — 1
ECL movement on debt securities at amortised cost (2) — — — (2)
Recoveries and reimbursements2 (13) (11) (84) — (108)
ECL charge on assets held for sale3 50
Total exchange and other adjustments (61)
Total income statement charges for the period 1,394
1 In H126, gross write-offs amounted to £1,056m (H125: £747m) and cash recoveries on previously written off accounts were £66m (H125:
£43m). Net write-offs, representing gross write-offs less recoveries, amounted to £990m (H125: £704m).
2 Recoveries and reimbursements comprised of £66m (H125: £43m) of cash recoveries on previously written off accounts and £42m (H125:
£58m) of reimbursements expected to be received under financial guarantee contracts with third parties.
3 The ECL charges on assets held for sale relates to the AA portfolio within USCB, the sale of which was completed in April 2026.
Credit Risk
Barclays PLC 32
-- 34 of 99 --
Loan commitments and financial guarantees1
Stage 1 Stage 2
Stage 3 excluding
POCI Stage 3 POCI Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Retail mortgages £m £m £m £m £m £m £m £m £m £m
As at 01.01.26 11,755 — 125 — — — — — 11,880 —
Net transfers between stages (41) — 39 — 2 — — — — —
Business activity in the period 12,144 — — — — — — — 12,144 —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
(8,966) — (10) — (1) — — — (8,977) —
Limit management and final
repayments (163) — (12) — — — — — (175) —
As at 30.06.26 14,729 — 142 — 1 — — — 14,872 —
Retail credit cards
As at 01.01.26 163,724 52 2,330 3 94 — 5 — 166,153 55
Net transfers between stages (1,663) 7 1,567 (7) 96 — — — — —
Business activity in the period 8,181 14 105 1 — — — — 8,286 15
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
2,870 (6) (1,243) 9 (94) — — — 1,533 3
Limit management and final
repayments (4,996) (4) (62) (3) (9) — — — (5,067) (7)
Disposals2 (23,511) — (146) — — — — — (23,657) —
As at 30.06.26 144,605 63 2,551 3 87 — 5 — 147,248 66
Retail other
As at 01.01.26 7,116 1 413 — 19 — — — 7,548 1
Net transfers between stages 24 — (34) — 10 — — — — —
Business activity in the period 450 — — — — — — — 450 —
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
228 — (3) — (5) — — — 220 —
Limit management and final
repayments (598) — (4) — — — — — (602) —
As at 30.06.26 7,220 1 372 — 24 — — — 7,616 1
Corporate loans
As at 01.01.26 227,898 91 13,605 237 699 32 — — 242,202 360
Net transfers between stages (573) 4 498 (4) 75 — — — — —
Business activity in the period 33,307 15 720 27 5 — — — 34,032 42
Net drawdowns, repayments, net re-
measurement and movement due to
exposure and risk parameter changes
11,720 (3) (157) 8 36 6 — — 11,599 11
Limit management and final
repayments (31,618) (13) (1,516) (33) (89) (1) — — (33,223) (47)
Disposals2 (86) — (65) — — — — — (151) —
As at 30.06.26 240,648 94 13,085 235 726 37 — — 254,459 366
1 Loan commitments reported also include exposure relating to financial assets classified as held for sale.
2 The gross disposals within Retail credit cards and Corporate loans reflect the sale of the AA portfolio within USCB, which was completed in April
2026.
Credit Risk
Barclays PLC 33
-- 35 of 99 --
Management adjustments to models for impairment
Management adjustments to impairment models are applied in order to factor in certain conditions or changes in policy that
are not fully incorporated into the impairment models, or to reflect additional facts and circumstances at the period end.
Management adjustments are reviewed and incorporated into future model development where applicable.
Management adjustments are captured through “Economic uncertainty” and “Other” adjustments, and are presented by
product and geography below:
Management adjustments to models for impairment allowance presented by product and geography
Impairment
allowance pre
management
adjustments1
Economic
uncertainty
adjustments
Other
adjustments
Management
adjustments2
Total
impairment
allowance3
Proportion of
Management
adjustments
to total
impairment
allowance
(a) (b) (a+b)
As at 30.06.26 £m £m £m £m £m %
Retail mortgages 93 — 4 4 97 4.1
Retail credit cards 812 — — — 812 —
Retail other 409 — 97 97 506 19.2
Corporate loans 936 17 49 66 1,002 6.6
Total UK 2,250 17 150 167 2,417 6.9
Retail mortgages 30 — — — 30 —
Retail credit cards 2,635 — 55 55 2,690 2.0
Retail other 29 — 2 2 31 6.5
Corporate loans 718 57 6 63 781 8.1
Total Rest of the World 3,412 57 63 120 3,532 3.4
Total 5,662 74 213 287 5,949 4.8
Debt securities at amortised cost 18 2 — 2 20 10.0
Total including debt securities at
amortised cost 5,680 76 213 289 5,969 4.8
As at 31.12.25 £m £m £m £m £m %
Retail mortgages 76 — 15 15 91 16.5
Retail credit cards 761 — — — 761 —
Retail other 406 — 85 85 491 17.3
Corporate loans 714 39 53 92 806 11.4
Total UK 1,957 39 153 192 2,149 8.9
Retail mortgages 25 — 1 1 26 3.8
Retail credit cards 2,505 31 87 118 2,623 4.5
Retail other 27 — — — 27 —
Corporate loans 823 44 13 57 880 6.5
Total Rest of the World 3,380 75 101 176 3,556 4.9
Total 5,337 114 254 368 5,705 6.5
Debt securities at amortised cost 21 1 — 1 22 4.5
Total including debt securities at
amortised cost 5,358 115 254 369 5,727 6.4
1 Includes £4.3bn (December 2025: £4.3bn) of modelled ECL, £0.9bn (December 2025: £0.7bn) of individually assessed impairments, £nil
(December 2025: £(0.2)bn) of ECL from the AA portfolio within USCB, the sale of which was completed in April 2026 and £0.5bn (December
2025: £0.6bn) of ECL from benchmarked exposures and debt securities.
2 Management adjustments related to other financial assets subject to impairment excluded in the table above include cash collateral and
settlement balances £1m (December 2025: £1m) and reverse repurchase agreements and other similar secured lending £1m (December 2025:
£1m) within the IB portfolio.
3 Total impairment allowance consists of ECL stock on drawn and undrawn exposures.
Credit Risk
Barclays PLC 34
-- 36 of 99 --
Economic uncertainty adjustments presented by stage
Stage 1 Stage 2 Stage 3 Total
As at 30.06.26 £m £m £m £m
Retail mortgages — — — —
Retail credit cards — — — —
Retail other — — — —
Corporate loans 9 7 1 17
Total UK 9 7 1 17
Retail mortgages — — — —
Retail credit cards — — — —
Retail other — — — —
Corporate loans 16 41 — 57
Total Rest of the World 16 41 — 57
Total 25 48 1 74
Debt securities at amortised cost 1 1 — 2
Total including debt securities at amortised cost 26 49 1 76
As at 31.12.25 £m £m £m £m
Retail mortgages — — — —
Retail credit cards — — — —
Retail other — — — —
Corporate loans 23 10 6 39
Total UK 23 10 6 39
Retail mortgages — — — —
Retail credit cards — 31 — 31
Retail other — — — —
Corporate loans 13 31 — 44
Total Rest of the World 13 62 — 75
Total 36 72 6 114
Debt securities at amortised cost 1 — — 1
Total including debt securities at amortised cost 37 72 6 115
Economic uncertainty adjustments
Economic uncertainty adjustments result from the identification of customers and clients who may be more vulnerable to
economic instability and are applied at a portfolio level.
Economic uncertainty adjustments have decreased from last year, informed by the retirement of tariff-related adjustments of
£81m driven by the lack of tariff-driven credit deterioration and losses. However, geopolitical uncertainty persists and is
reflected through an adjustment of £66m to capture increased downside risk, as any potential impact on corporate earnings
is expected to lag.
Total economic uncertainty adjustments as at 30 June 2026 are £76m (December 2025: £115m) and include:
• Retail credit cards (ROW) £nil (December 2025: £31m): The previously held tariff-related adjustment was retired
following the lack of tariff-driven credit deterioration and losses
• Corporate loans (UK) £17m (December 2025: £39m): This adjustment reflects potential cross-default risk on Barclays’
lending in respect of clients who have taken out Bounce Back Loans and an adjustment to capture increased downside
risk, amid ongoing geopolitical uncertainty. The reduction reflects the partial release of the cross-default risk adjustment,
supported by resilient borrower behaviour
• Corporate loans (ROW) £57m (December 2025: £44m): The previously held tariff-related adjustment was retired due to
the lack of tariff-driven credit deterioration and losses. However, geopolitical uncertainty persists and is reflected through
an adjustment to capture increased downside risk, as any potential impact on corporate earnings is expected to lag
Credit Risk
Barclays PLC 35
-- 37 of 99 --
Other adjustments
Other adjustments are operational and remain in place until incorporated into the underlying models. These adjustments
result from data limitations and model performance related issues identified through model monitoring and other
established governance processes.
Total other adjustments as at 30 June 2026 are £213m (December 2025: £254m) and include:
• Retail mortgages (UK) £4m (December 2025: £15m): The movement reflects the retirement of operational adjustments
following updates to the Private Banking impairment models
• Retail credit cards (ROW) £55m (December 2025: £87m): This adjustment reflects provisioning for the Best Egg
acquisition during the period and the annual update to the high-risk account management (HRAM) framework within
the USCB portfolio. The previously held adjustment relating to the acquisition of the GM consumer cards portfolio was
retired following model implementation
• Retail other (UK) £97m (December 2025: £85m) and Corporate loans (UK) £49m (December 2025: £53m): These
include adjustments for the definition of default (DOD) criteria under the Capital Requirements Regulation and model
monitoring outcomes and have remained broadly stable compared to year-end
• Corporate loans (ROW) £6m (December 2025: £13m): This adjustment reflects operational adjustments within the GM
business cards portfolio
Credit Risk
Barclays PLC 36
-- 38 of 99 --
Measurement uncertainty
Scenarios used to calculate the Group’s modelled ECL charge were refreshed in Q226, with the Baseline scenario reflecting
the latest consensus macroeconomic forecasts available at the time of the scenario refresh. The Baseline scenario continues
to reflect the volatile trade policies of the US administration and ongoing geopolitical uncertainty but with a more
pronounced inflationary backdrop. Global growth slows modestly as higher US tariffs, retaliatory measures and persistent
uncertainty disrupt trade flows, dampen business confidence, and weigh on investment, though domestic demand in
advanced economies remains relatively resilient. UK and US GDP growth in 2026 is expected to be 0.4% and 1.7%,
respectively. Headline inflation remains elevated and sticky, particularly through imported goods and energy-related
components. The softening in labour markets is gradual and insufficient to quickly alleviate underlying price pressures. UK
and US quarterly unemployment rates peak at 5.4% and 4.5%, respectively.
The Downside scenarios have been calibrated to capture a severe escalation in geopolitical tensions, centred on a prolonged
Middle East conflict, alongside intensifying global trade frictions. Early in the scenario, conflict escalates sharply with
disruptions at critical maritime chokepoints, triggering severe shipping disruptions, surging insurance costs and sharp
increases in oil and gas prices amid infrastructure damage. As the shock becomes protracted, firms delay investment,
reassess supply chains and hoard inputs, while business and consumer confidence fall sharply. The deterioration in demand
and investment drives a sharp increase in unemployment, initially concentrated in trade and energy exposed sectors but
increasingly spilling over into services. Inflation dynamics diverge sharply from Baseline, generating a stagflationary impulse.
Energy prices rise sharply and remain structurally elevated, with persistent volatility and recurring supply disruptions.
Monetary policy faces a difficult trade-off between persistent inflation and weakening growth. Central banks initially hike to
ensure inflation expectations remain well anchored, but as the downturn deepens and demand forces weaken price
pressures, they shift towards easing. The scenarios also incorporate climate-related risks through both physical and
transition channels, including more frequent severe weather disruptions and a shift in sentiment around energy security.
These effects amplify volatility, increase costs and further weigh on growth over the medium term.
In the Upside scenarios, a rise in labour force participation and higher productivity contribute to accelerated economic
growth, without creating new inflationary pressures. Central banks lower interest rates stimulating private consumption and
investment growth. Demand for labour increases and unemployment decreases. As geopolitical tensions ease, low inflation
supports consumer purchasing power and contributes further to healthy GDP growth.
The methodology for estimating scenario weights involves simulating a range of future paths for UK and US GDP using
historical data with the five scenarios mapped against the distribution of these future paths. The decrease in Upside weights
is driven by deterioration in UK GDP outlook in the Baseline scenario, moving the Baseline scenario further from the Upside
scenarios. For further details see page 39.
Management adjustments recognised in Q126 in Barclays UK (£10m) and US Consumer Bank (£25m1) to reflect near-term
impacts of the most recent geopolitical escalation, were consumed, as the impacts are now captured through the Q226
scenario refresh. However, the Group has retained the £66m2 management adjustment introduced in Q126 within the
Investment Bank, reflecting increased downside risk amid persistent geopolitical uncertainty, as any potential impact on
corporate earnings is expected to lag. For further details see page 35.
The following tables show the key macroeconomic variables used in the five scenarios (5-year annual paths) and the
weights applied to each scenario.
1 Excludes management adjustment of £4m for held for sale portfolio.
2 Excludes management adjustment of £2m related to other financial assets subject to impairment.
Credit Risk
Barclays PLC 37
-- 39 of 99 --
Macroeconomic variables used in the calculation of ECL
As at 30.06.26 2026 2027 2028 2029 2030
Baseline % % % % %
UK GDP1 0.4 1.1 1.4 1.4 1.5
UK unemployment2 5.3 5.3 5.0 4.9 4.9
UK HPI3 1.3 1.6 3.9 3.0 3.9
UK bank rate6 4.1 4.4 4.3 4.3 4.3
US GDP1 1.7 2.0 2.1 2.1 2.1
US unemployment4 4.4 4.3 4.3 4.3 4.3
US HPI5 2.1 2.1 2.4 2.4 2.4
US federal funds rate6 3.7 3.8 3.8 3.8 3.8
Downside 2
UK GDP1 (0.5) (4.1) 1.9 1.7 1.0
UK unemployment2 6.0 7.8 7.8 6.9 6.0
UK HPI3 (12.0) (19.3) 6.7 9.3 4.6
UK bank rate6 4.2 5.1 4.6 4.5 4.5
US GDP1 0.5 (4.3) — 2.1 1.6
US unemployment4 5.5 8.5 8.3 7.2 6.1
US HPI5 (3.1) (6.3) 5.7 5.0 2.9
US federal funds rate6 3.8 4.9 4.3 4.3 4.3
Downside 1
UK GDP1 (0.1) (1.6) 1.6 1.5 1.2
UK unemployment2 5.6 6.6 6.4 5.9 5.4
UK HPI3 (5.4) (9.2) 5.3 6.1 4.3
UK bank rate6 4.1 4.7 4.5 4.5 4.5
US GDP1 1.1 (1.2) 1.1 2.1 1.9
US unemployment4 5.0 6.4 6.3 5.8 5.2
US HPI5 (0.5) (2.1) 4.0 3.7 2.7
US federal funds rate6 3.8 4.2 4.1 4.0 4.0
Upside 2
UK GDP1 0.9 3.8 3.2 2.6 2.3
UK unemployment2 5.1 4.6 4.1 4.0 4.0
UK HPI3 4.1 14.2 6.8 2.7 3.8
UK bank rate6 4.0 3.8 3.0 3.1 3.3
US GDP1 1.8 3.2 2.9 2.8 2.8
US unemployment4 4.2 3.7 3.6 3.6 3.6
US HPI5 4.9 4.3 5.3 4.9 4.9
US federal funds rate6 3.5 3.0 3.0 3.0 2.8
Upside 1
UK GDP1 0.6 2.4 2.3 2.0 1.9
UK unemployment2 5.2 4.9 4.6 4.5 4.5
UK HPI3 2.7 7.8 5.4 2.9 3.9
UK bank rate6 4.0 4.1 3.5 3.6 3.8
US GDP1 1.8 2.6 2.5 2.5 2.5
US unemployment4 4.3 4.0 4.0 4.0 4.0
US HPI5 3.5 3.2 3.8 3.6 3.6
US federal funds rate6 3.5 3.3 3.3 3.3 3.3
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in year-end UK HPI = Halifax HPI Meth2 All Houses, All Buyers index, relative to prior year-end.
4 Average US civilian unemployment rate 16-year+.
5 Change in year-end US HPI = FHFA House Price Index, relative to prior year-end.
6 Average rate.
Credit Risk
Barclays PLC 38
-- 40 of 99 --
As at 31.12.25 2025 2026 2027 2028 2029
Baseline % % % % %
UK GDP1 1.5 1.1 1.4 1.4 1.4
UK unemployment2 4.7 4.9 4.8 4.8 4.7
UK HPI3 1.5 2.9 2.5 4.3 3.8
UK bank rate6 4.2 3.4 3.4 3.5 3.6
US GDP1 2.1 2.0 2.0 2.0 2.0
US unemployment4 4.2 4.5 4.4 4.4 4.4
US HPI5 3.2 1.7 1.9 2.6 2.6
US federal funds rate6 4.2 3.4 3.3 3.3 3.5
Downside 2
UK GDP1 1.5 (2.5) (1.2) 2.8 1.1
UK unemployment2 4.7 5.8 7.7 6.9 5.7
UK HPI3 1.5 (24.9) (5.1) 9.6 14.2
UK bank rate6 4.2 2.3 0.5 0.4 1.1
US GDP1 2.1 (2.7) (2.8) 1.6 2.4
US unemployment4 4.2 5.7 8.0 7.9 5.9
US HPI5 3.2 (8.2) (1.7) 7.2 7.7
US federal funds rate6 4.2 3.6 2.4 1.4 1.2
Downside 1
UK GDP1 1.5 (0.7) 0.1 2.1 1.3
UK unemployment2 4.7 5.3 6.3 5.8 5.2
UK HPI3 1.5 (11.8) (1.3) 6.9 8.9
UK bank rate6 4.2 2.9 2.0 1.9 2.4
US GDP1 2.1 (0.3) (0.4) 1.8 2.2
US unemployment4 4.2 5.1 6.2 6.1 5.1
US HPI5 3.2 (3.3) 0.1 4.9 5.1
US federal funds rate6 4.2 3.6 2.8 2.4 2.4
Upside 2
UK GDP1 1.5 2.7 3.7 2.9 2.4
UK unemployment2 4.7 4.3 4.0 3.9 3.8
UK HPI3 1.5 11.9 8.4 5.1 4.1
UK bank rate6 4.2 3.1 2.3 2.3 2.6
US GDP1 2.1 2.8 3.1 2.8 2.8
US unemployment4 4.2 3.9 3.7 3.7 3.7
US HPI5 3.2 6.2 4.7 4.8 4.9
US federal funds rate6 4.2 3.0 2.5 2.5 2.5
Upside 1
UK GDP1 1.5 1.9 2.6 2.2 1.9
UK unemployment2 4.7 4.6 4.4 4.4 4.3
UK HPI3 1.5 7.4 5.4 4.7 3.9
UK bank rate6 4.2 3.2 2.8 2.8 3.1
US GDP1 2.1 2.4 2.6 2.4 2.4
US unemployment4 4.2 4.2 4.1 4.1 4.1
US HPI5 3.2 4.0 3.3 3.7 3.7
US federal funds rate6 4.2 3.3 2.8 2.8 3.0
1 Average Real GDP seasonally adjusted change in year.
2 Average UK unemployment rate 16-year+.
3 Change in year-end UK HPI = Halifax HPI Meth2 All Houses, All Buyers index, relative to prior year-end.
4 Average US civilian unemployment rate 16-year+.
5 Change in year-end US HPI = FHFA House Price Index, relative to prior year-end.
6 Average rate.
Scenario weighting Upside 2 Upside 1 Baseline Downside 1 Downside 2
% % % % %
As at 30.06.26
Scenario weighting 13.7 27.3 39.5 12.5 7.0
As at 31.12.25
Scenario weighting 14.4 27.4 38.5 12.7 7.0
Credit Risk
Barclays PLC 39
-- 41 of 99 --
Specific bases show the most extreme position of each variable in the context of the downside/upside scenarios, for
example, the highest unemployment for downside scenarios, average unemployment for baseline scenarios and lowest
unemployment for upside scenarios. GDP and HPI downside and upside scenario data represent the lowest and highest
cumulative positions relative to the start point in the 20 quarter period.
Macroeconomic variables (specific bases)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.26 % % % % %
UK GDP2 14.4 10.2 1.1 (1.9) (5.1)
UK unemployment3 4.0 4.5 5.1 6.7 8.1
UK HPI4 35.4 24.6 2.8 (14.1) (29.3)
UK bank rate3 3.0 3.5 4.3 4.8 5.3
US GDP2 14.5 12.5 2.0 (1.1) (5.2)
US unemployment3 3.6 4.0 4.3 6.6 8.8
US HPI4 26.7 19.1 2.3 (3.0) (9.2)
US federal funds rate3 2.8 3.3 3.7 4.3 5.3
As at 31.12.25 % % % % %
UK GDP2 14.5 10.8 1.4 (0.3) (3.5)
UK unemployment3 3.8 4.3 4.8 6.5 8.1
UK HPI4 34.6 24.9 3.0 (12.6) (28.0)
UK bank rate3 2.3 2.8 3.6 4.6 4.6
US GDP2 14.6 12.4 2.0 (0.2) (4.6)
US unemployment3 3.7 4.1 4.4 6.6 8.8
US HPI4 26.2 19.3 2.4 (1.5) (8.1)
US federal funds rate3 2.5 2.8 3.5 4.3 4.3
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax HPI Meth2 All Houses,
All Buyers index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA
House Price Index. 20 quarter period starts from Q126 (2025: Q125).
2 Maximum growth relative to Q425 (2025: Q424), based on 20 quarter period in Upside scenarios; 5-year yearly average CAGR in Baseline;
minimum growth relative to Q425 (2025: Q424), based on 20 quarter period in Downside scenarios.
3 Lowest quarter in 20 quarter period in Upside scenarios; 5-year average in Baseline; highest quarter 20 quarter period in Downside scenarios.
4 Maximum growth relative to Q425 (2025: Q424), based on 20 quarter period in Upside scenarios; 5-year quarter end CAGR in Baseline;
minimum growth relative to Q425 (2025: Q424), based on 20 quarter period in Downside scenarios.
Average basis represents the average quarterly value of variables in the 20 quarter period with GDP and HPI based on yearly
average and quarterly CAGRs respectively.
Macroeconomic variables (5-year averages)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.26 % % % % %
UK GDP2 2.6 1.8 1.1 0.5 —
UK unemployment3 4.3 4.7 5.1 6.0 6.9
UK HPI4 6.3 4.5 2.8 — (2.8)
UK bank rate3 3.4 3.8 4.3 4.5 4.6
US GDP2 2.7 2.4 2.0 1.0 —
US unemployment3 3.7 4.0 4.3 5.7 7.1
US HPI4 4.9 3.6 2.3 1.5 0.7
US federal funds rate3 3.0 3.3 3.7 4.0 4.3
As at 31.12.25 % % % % %
UK GDP2 2.7 2.0 1.4 0.9 0.3
UK unemployment3 4.1 4.5 4.8 5.5 6.2
UK HPI4 6.1 4.5 3.0 0.6 (2.0)
UK bank rate3 2.9 3.2 3.6 2.7 1.7
US GDP2 2.7 2.4 2.0 1.1 0.1
US unemployment3 3.9 4.1 4.4 5.4 6.3
US HPI4 4.8 3.6 2.4 1.9 1.5
US federal funds rate3 2.9 3.2 3.5 3.1 2.5
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax HPI Meth2 All Houses,
All Buyers index; US GDP = Real GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA
House Price Index. 20 quarter period starts from Q126 (2025: Q125).
2 5-year yearly average CAGR, starting 2025 (2025: 2024).
3 5-year average. Period based on 20 quarters from Q126 (2025: Q125).
4 5-year quarter end CAGR, starting Q425 (2025: Q424).
Credit Risk
Barclays PLC 40
-- 42 of 99 --
ECL sensitivity analysis
The table below shows the modelled ECL assuming each of the five modelled scenarios are 100% weighted with the
dispersion of results around the Baseline, highlighting the impact on exposure and ECL across the scenarios.
Model exposure uses exposure at default (EAD) values and is not directly comparable to gross exposure used in other
disclosures.
Scenarios
As at 30.06.26 Weighted1 Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Retail mortgages 156,076 158,653 157,553 156,010 152,793 148,752
Retail credit cards2 61,160 60,777 60,899 61,019 61,810 62,521
Retail other 13,173 13,298 13,243 13,176 13,019 12,846
Corporate loans2 235,090 236,716 236,161 235,455 233,473 228,609
Stage 1 Model ECL (£m)
Retail mortgages 12 4 5 8 23 58
Retail credit cards2 563 508 526 545 643 761
Retail other 38 35 36 38 39 43
Corporate loans2 249 212 224 236 299 379
Stage 1 Coverage (%)
Retail mortgages — — — — — —
Retail credit cards 0.9 0.8 0.9 0.9 1.0 1.2
Retail other 0.3 0.3 0.3 0.3 0.3 0.3
Corporate loans 0.1 0.1 0.1 0.1 0.1 0.2
Stage 2 Model Exposure (£m)
Retail mortgages 13,985 11,408 12,509 14,051 17,268 21,309
Retail credit cards2 5,004 4,748 4,925 4,985 5,165 5,448
Retail other 1,692 1,567 1,622 1,689 1,846 2,019
Corporate loans2 19,210 17,431 18,046 18,866 20,974 25,984
Stage 2 Model ECL (£m)
Retail mortgages 25 7 11 17 51 131
Retail credit cards2 1,085 1,010 1,040 1,071 1,184 1,339
Retail other 84 73 78 83 97 113
Corporate loans2 453 359 390 428 576 867
Stage 2 Coverage (%)
Retail mortgages 0.2 0.1 0.1 0.1 0.3 0.6
Retail credit cards 21.7 21.3 21.1 21.5 22.9 24.6
Retail other 5.0 4.7 4.8 4.9 5.3 5.6
Corporate loans 2.4 2.1 2.2 2.3 2.7 3.3
Stage 3 Model Exposure (£m)3
Retail mortgages 1,617 1,617 1,617 1,617 1,617 1,617
Retail credit cards2 2,229 2,229 2,229 2,229 2,229 2,229
Retail other 185 185 185 185 185 185
Corporate loans2 3,658 3,658 3,658 3,658 3,658 3,658
Stage 3 Model ECL (£m)
Retail mortgages 44 31 34 38 62 105
Retail credit cards2 1,642 1,596 1,621 1,645 1,686 1,721
Retail other 67 66 66 67 68 69
Corporate loans2,4 66 62 63 64 72 80
Stage 3 Coverage (%)
Retail mortgages 2.7 1.9 2.1 2.4 3.8 6.5
Retail credit cards 73.7 71.6 72.7 73.8 75.6 77.2
Retail other 36.2 35.7 35.7 36.2 36.8 37.3
Corporate loans4 1.8 1.7 1.7 1.7 2.0 2.2
Total Model ECL (£m)
Retail mortgages 81 42 50 63 136 294
Retail credit cards2 3,290 3,114 3,187 3,261 3,513 3,821
Retail other 189 174 180 188 204 225
Corporate loans2,4 768 633 677 728 947 1,326
Total Model ECL 4,328 3,963 4,094 4,240 4,800 5,666
Credit Risk
Barclays PLC 41
-- 43 of 99 --
Reconciliation to total ECL £m
Total weighted model ECL 4,328
ECL from individually assessed exposures4 882
ECL from benchmarked exposures and others5 452
ECL from debt securities at amortised cost 20
ECL from post model management adjustments 287
Of which: ECL from economic uncertainty adjustments 74
Total ECL 5,969
1 Model exposures are allocated to a stage based on an individual scenario rather than a probability-weighted approach as required for Barclays
reported impairment allowances. As a result, it is not possible to back solve the final reported weighted ECL from individual scenarios given
balances may be assigned to a different stage dependent on the scenario.
2 Model exposures and ECL reported within Retail credit cards and Corporate loans exclude the AA portfolio within USCB, the sale of which was
completed in April 2026.
3 Model exposures allocated to Stage 3 do not change in any of the scenarios as the transition criteria relies only on observable evidence of default
as at 30 June 2026 and not on the macroeconomic scenario.
4 Material corporate loan defaults are individually assessed across different recovery strategies. As a result, ECL of £882m is reported as an
individually assessed impairment in the reconciliation table.
5 ECL from benchmarked exposures and others includes ECL on Tesco Bank of £430m calculated using a benchmarked approach based on UK
cards and UK retail loans. The sensitivity of these exposures would materially reflect the sensitivity of the benchmarked model.
The use of five scenarios with associated weightings results in a total weighted ECL uplift from the Baseline ECL of 2.1%.
Retail mortgages: Total weighted ECL of £81m represents a 28.6% increase over the Baseline ECL (£63m). Total ECL
increases to £294m under the Downside 2 scenario, driven by a fall in UK HPI.
Retail credit cards: Total weighted ECL of £3,290m represents a 0.9% increase over the Baseline ECL (£3,261m). Total ECL
increases to £3,821m under the Downside 2 scenario, driven by an increase in UK and US unemployment rate.
Retail other: Total weighted ECL of £189m represents a 0.5% increase over the Baseline ECL (£188m). Total ECL increases to
£225m under the Downside 2 scenario, largely driven by an increase in UK unemployment rate.
Corporate loans: Total weighted ECL of £768m represents a 5.5% increase over the Baseline ECL (£728m). Total ECL
increases to £1,326m under the Downside 2 scenario, driven by a decrease in UK and US GDP.
Credit Risk
Barclays PLC 42
-- 44 of 99 --
Scenarios
As at 31.12.25 Weighted1 Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Retail mortgages 149,004 151,314 150,144 148,760 146,786 144,360
Retail credit cards2 61,320 61,096 61,204 61,325 61,569 61,724
Retail other 6,260 6,378 6,326 6,268 6,106 5,927
Corporate loans2 220,292 222,057 221,337 220,646 218,634 213,827
Stage 1 Model ECL (£m)
Retail mortgages 3 1 2 2 6 13
Retail credit cards2 561 523 541 561 599 637
Retail other 32 30 31 31 35 38
Corporate loans2 231 201 212 221 274 329
Stage 1 Coverage (%)
Retail mortgages — — — — — —
Retail credit cards 0.9 0.9 0.9 0.9 1.0 1.0
Retail other 0.5 0.5 0.5 0.5 0.6 0.6
Corporate loans 0.1 0.1 0.1 0.1 0.1 0.2
Stage 2 Model Exposure (£m)
Retail mortgages 13,586 11,276 12,446 13,830 15,804 18,230
Retail credit cards2 5,307 5,133 5,224 5,301 5,478 5,759
Retail other 1,164 1,046 1,098 1,156 1,318 1,497
Corporate loans2 18,172 16,264 17,037 17,836 19,979 24,927
Stage 2 Model ECL (£m)
Retail mortgages 16 6 8 11 33 79
Retail credit cards2 1,183 1,099 1,138 1,175 1,277 1,415
Retail other 81 67 72 77 102 134
Corporate loans2 477 383 415 454 604 879
Stage 2 Coverage (%)
Retail mortgages 0.1 0.1 0.1 0.1 0.2 0.4
Retail credit cards 22.3 21.4 21.8 22.2 23.3 24.6
Retail other 7.0 6.4 6.6 6.7 7.7 9.0
Corporate loans 2.6 2.4 2.4 2.5 3.0 3.5
Stage 3 Model Exposure (£m)3
Retail mortgages 1,621 1,621 1,621 1,621 1,621 1,621
Retail credit cards2 2,158 2,158 2,158 2,158 2,158 2,158
Retail other 128 128 128 128 128 128
Corporate loans2 3,650 3,650 3,650 3,650 3,650 3,650
Stage 3 Model ECL (£m)
Retail mortgages 43 32 35 38 59 98
Retail credit cards2 1,592 1,548 1,573 1,596 1,632 1,663
Retail other 79 76 77 77 80 87
Corporate loans2,4 60 57 57 59 64 71
Stage 3 Coverage (%)
Retail mortgages 2.7 2.0 2.2 2.3 3.6 6.0
Retail credit cards 73.8 71.7 72.9 74.0 75.6 77.1
Retail other 61.7 59.4 60.2 60.2 62.5 68.0
Corporate loans4 1.6 1.6 1.6 1.6 1.8 1.9
Total Model ECL (£m)
Retail mortgages 62 39 45 51 98 190
Retail credit cards 3,336 3,170 3,252 3,332 3,508 3,715
Retail other 192 173 180 185 217 259
Corporate loans2,4 768 641 684 734 942 1,279
Total Model ECL 4,358 4,023 4,161 4,302 4,765 5,443
Credit Risk
Barclays PLC 43
-- 45 of 99 --
Reconciliation to total ECL £m
Total weighted model ECL 4,358
ECL from individually assessed exposures4 672
ECL from benchmarked exposures and others5 542
ECL from debt securities at amortised cost 22
ECL from held for sale assets (AA portfolio) (235)
ECL from post model management adjustments 368
Of which: ECL from economic uncertainty adjustments 114
Total ECL 5,727
1 Model exposures are allocated to a stage based on an individual scenario rather than a probability-weighted approach as required for Barclays
reported impairment allowances. As a result, it is not possible to back solve the final reported weighted ECL from individual scenarios given
balances may be assigned to a different stage dependent on the scenario.
2 Model exposure and ECL reported within Retail credit cards and Corporate loans continue to include the AA portfolio within USCB, classified as
assets held for sale.
3 Model exposures allocated to Stage 3 do not change in any of the scenarios as the transition criteria relies only on observable evidence of default
as at 31 December 2025 and not on the macroeconomic scenario.
4 Material corporate loan defaults are individually assessed across different recovery strategies. As a result, ECL of £672m is reported as an
individually assessed impairment in the reconciliation table.
5 ECL from benchmarked exposures and others includes ECL on Tesco Bank of £400m calculated using a benchmarked approach based on UK
cards and UK retail loans. The sensitivity of these exposures would materially reflect the sensitivity of the benchmarked model.
Credit Risk
Barclays PLC 44
-- 46 of 99 --
Analysis of specific portfolios and asset types
Secured home loans
The UK home loan portfolio primarily comprises first lien mortgages and accounts for 97% (December 2025: 97%) of the
Group’s total home loans balance.
Barclays UK
Home loans principal portfolios As at 30.06.26 As at 31.12.25
Gross loans and advances (£m) 176,772 172,415
>90 day arrears rate, excluding recovery book (%) 0.1 0.1
Annualised gross charge-off rates - 180 days past due (%) 0.5 0.5
Recovery book proportion of outstanding balances (%) 0.5 0.6
Recovery book impairment coverage ratio (%)1 4.3 4.3
Average marked to market LTV
Balance weighted % 56.5 55.2
Valuation weighted % 42.7 41.5
New lending
Half year
ended
30.06.26
Half year
ended
30.06.25
New home loan bookings (£m) 17,654 15,448
New home loan proportion > 90% LTV (%) 4.4 1.6
Average LTV on new home loans: balance weighted (%) 70.2 69.5
Average LTV on new home loans: valuation weighted (%) 62.2 60.7
1 Recovery Book Impairment Coverage Ratio for 31.12.25 excludes Kensington Mortgages Company.
Home loans principal portfolios – distribution of balances by LTV1
Distribution of balances Distribution of impairment
allowance Coverage ratio
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
Barclays UK % % % % % % % % % % % %
As at 30.06.26
<=75% 71.0 6.7 0.9 78.6 4.7 15.4 43.7 63.8 — 0.1 2.5 —
>75% and <=90% 18.1 1.1 0.1 19.3 6.2 7.9 9.8 23.9 — 0.4 6.5 0.1
>90% and <=100% 2.0 0.1 — 2.1 1.5 0.7 6.0 8.2 — 0.7 21.0 0.2
>100% — — — — — 0.1 4.0 4.1 0.1 2.7 37.3 8.0
As at 31.12.25
<=75% 73.4 6.9 0.9 81.2 3.3 14.1 49.9 67.3 — 0.1 2.5 —
>75% and <=90% 16.0 1.0 0.1 17.1 4.3 6.3 11.7 22.3 — 0.3 7.3 0.1
>90% and <=100% 1.7 — — 1.7 0.8 0.5 5.4 6.7 — 0.7 22.7 0.2
>100% — — — — — 0.1 3.6 3.7 — 2.9 31.3 5.9
1 Portfolio marked to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of
the latest HPI available as at 30 June 2026.
New home loan bookings increased 14.3% to £17.7bn (H125: £15.4bn), reflecting a larger share of a larger mortgage
market. Demand for >90% LTV lending increased within the Group’s established risk appetite.
Credit Risk
Barclays PLC 45
-- 47 of 99 --
Retail credit cards and Retail other
The principal portfolios listed below accounted for 91% (December 2025: 91%) of the Group’s total retail credit cards and
retail other.
Principal portfolios
Gross
exposure
30 day
arrears rate,
excluding
recovery
book
90 day
arrears rate,
excluding
recovery
book
Annualised
gross write-
off rate
Annualised
net write-off
rate
As at 30.06.26 £m % % % %
Barclays UK
UK cards1 17,468 0.9 0.3 1.6 1.4
UK personal loans1 8,860 1.2 0.5 1.7 1.6
Barclays Partner Finance 814 1.0 0.6 1.5 1.5
Barclays US Consumer Bank
US cards 23,634 2.9 1.6 4.0 3.8
As at 31.12.25
Barclays UK
UK cards1 17,169 0.8 0.2 1.0 0.8
UK personal loans1 8,515 1.1 0.5 0.7 0.6
Barclays Partner Finance 1,210 0.7 0.3 1.2 1.2
Barclays US Consumer Bank
US cards2 29,100 3.0 1.6 3.4 3.2
1 Includes Tesco Bank. Tesco Bank arrears rates are calculated using POCI balances adjusted to fair value.
2 Includes AA portfolio in USCB, classified as held for sale (see table below).
UK cards: Gross exposure increased from £17.2bn to £17.5bn following a growth in spend and new promotional balance
lending. 30 and 90 day arrears rates remained broadly stable at 0.9% (2025: 0.8%) and 0.3% (2025: 0.2%) respectively.
Gross and net write-off rates increased to 1.6% (2025: 1.0%) and 1.4% (2025: 0.8%) respectively, reflecting sufficient
maturing of the Tesco default book, post-acquisition, for accounts to qualify for write-off.
UK personal loans: Gross exposure increased from £8.5bn to £8.9bn due to growth in new lending. 30 and 90 day arrears
rates remained stable at 1.2% (2025: 1.1%) and 0.5% (2025: 0.5%) respectively. Gross and net write off rates increased to
1.7% (2025: 0.7%) and 1.6% (2025: 0.6%) respectively, reflecting sufficient maturing of the Tesco default book, post-
acquisition, for accounts to qualify for write-off.
Barclays Partner Finance: 30 and 90 day arrears rates increased to 1.0% (2025: 0.7%) and 0.6% (2025: 0.3%) respectively
as total exposure reduced to £0.8bn (2025: £1.2bn) due to a strategic decision to reduce the number of active partner
businesses. Both annualised gross and net write off rates increased to 1.5% (2025: 1.2%) following the reduction in gross
exposure.
US cards: 30 day arrears rates decreased slightly to 2.9% (2025: 3.0%) following the expected impact of seasonality. Gross
and net write off rates increased to 4.0% (2025: 3.4%) and 3.8% (2025: 3.2%) respectively reflecting the impact of the exit
of the AA portfolio in the period.
Retail Credit Cards and Retail Other held for
sale
Gross
exposure
30 day
arrears rate,
excluding
recovery
book
90 day
arrears rate,
excluding
recovery
book
Annualised
gross write-
off rate
Annualised
net write-off
rate
As at 31.12.25 £m % % % %
Barclays US Consumer Bank 5,988 1.8 0.9 2.1 1.9
Credit Risk
Barclays PLC 46
-- 48 of 99 --
Assets held for sale
The prior period presents gross loans and advances and the related impairment allowance for the AA portfolio in USCB
classified as assets held for sale in the condensed consolidated balance sheet. The sale of this portfolio was completed on 24
April 2026.
Loans and advances by product
Stage 1 Stage 2 Stage 3 Total
Gross ECL Coverage Gross ECL Coverage Gross ECL Coverage Gross ECL Coverage
As at 31.12.25 £m £m % £m £m % £m £m % £m £m %
Retail credit cards -
US 5,468 65 1.2 466 124 26.6 54 44 81.5 5,988 233 3.9
Corporate loans -
US 43 1 2.3 6 2 33.3 — — — 49 3 6.1
Total Rest of the
World 5,511 66 1.2 472 126 26.7 54 44 81.5 6,037 236 3.9
Management adjustments to models for impairment allowance presented by product
Impairment
allowance pre
management
adjustments
Economic
uncertainty
adjustments1
Other
adjustments
Management
adjustments
Total
impairment
allowance
Proportion of
Management
adjustments
to total
impairment
allowance
As at 31.12.25 £m £m £m £m £m %
Retail credit cards - US 232 5 — 5 237 2.1
Corporate loans - US 3 — — — 3 —
Total Rest of the World 235 5 — 5 240 2.1
1 Reflects a Stage 2 adjustment for elevated US macroeconomic uncertainty; with impacts yet to materialise in consumer behaviour.
Credit Risk
Barclays PLC 47
-- 49 of 99 --
Analysis of management value at risk (VaR)
The table below shows the total management VaR on a diversified basis by risk factor. Total management VaR
includes all trading positions in the Group and it is calculated with a one-day holding period. VaR limits are applied to
total management VaR and by risk factor. Additionally, the market risk management function applies VaR sub-limits to
material businesses and trading desks.
Management VaR (95%) by risk factor
Half year ended 30.06.26 Half year ended 31.12.25 Half year ended 30.06.25
Average High Low Average High Low Average High Low
£m £m £m £m £m £m £m £m £m
Credit risk 17 20 14 14 21 11 16 20 13
Interest rate risk 13 22 5 15 23 6 15 25 5
Equity risk 7 11 4 6 10 4 8 14 5
Basis risk 6 8 4 6 9 4 5 7 4
Spread risk 4 6 3 5 6 3 5 7 4
Foreign exchange risk 7 13 4 6 10 3 4 7 3
Commodity risk 1 2 — — 1 — — 1 —
Inflation risk 4 6 3 5 6 4 5 8 3
Diversification effect1 (39) n/a n/a (39) n/a n/a (39) n/a n/a
Total management VaR 20 29 13 18 26 8 19 30 10
1 Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the
expected aggregate loss is lower than the sum of the expected losses from each area. Historical correlations between losses are taken into
account in making these assessments. The high and low VaR figures reported for each category did not necessarily occur on the same day
as the high and low total management VaR. Consequently, a diversification effect balance for the high and low VaR figures would not be
meaningful and is therefore omitted from the above table.
Average Management VaR remained relatively stable at £20m (H225: £18m) driven by a small increase in credit risk,
partially offset by a slight decrease in interest rate risk.
Market Risk
Barclays PLC 48
-- 50 of 99 --
The Group has established a comprehensive set of policies, standards and controls for managing its liquidity risk; together
these set out the requirements for Barclays’ liquidity risk framework. The liquidity risk framework meets the PRA standards
and enables Barclays to maintain liquidity resources that are sufficient in amount and quality, and a funding profile that is
appropriate to meet the Group’s Liquidity Risk Appetite. The liquidity risk framework is delivered via a combination of policy
formation, review and challenge, governance, analysis, stress testing, limit setting and monitoring.
Liquidity risk stress testing
The Internal Liquidity Stress Tests (ILST) measure the potential contractual and contingent stress outflows under a range of
scenarios, which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated
outflows if a stress occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90 day market-wide
stress event and a 30 day combined scenario consisting of both a Barclays specific and market-wide stress event. The Group
also runs a liquidity stress test which measures the anticipated outflows over a 12 month market-wide scenario.
The LCR requirement takes into account the relative stability of different sources of funding and potential incremental
funding requirements in a stress. The LCR is designed to promote short-term resilience of a bank’s liquidity risk profile by
holding sufficient high quality liquid assets to survive an acute stress scenario lasting for 30 days.
Barclays implemented a new methodology for calculating net stress outflows related to secured financing transactions in
the LCR. This change materialised from June 2025, with the Group headline ratio contracting over time from previously
elevated levels whilst remaining broadly within ranges reported over recent years. The revised methodology models a more
asymmetric unwind of client activity, resulting in a higher net outflow calculation. Barclays has always maintained, and
intends to continue to maintain, a significant liquidity buffer which allows for this impact to be readily absorbed within the
Group surplus.
As at 30 June 2026 the average LCR was 157.7% (December 2025: 170.0%). The Group held eligible liquid assets in excess
of 100% of net stress outflows as measured according to both its internal ILST and external regulatory requirements.
Liquidity coverage ratio1 As at
30.06.26
As at
31.12.25
£bn £bn
LCR Eligible High Quality Liquid Assets (HQLA) 321.2 321.4
Net stress outflows (204.0) (190.2)
Surplus 117.2 131.2
Liquidity coverage ratio 157.7% 170.0%
1 Represents the average of the last 12 spot month end ratios. In June 2025, Barclays implemented a new methodology for calculating net stress
outflows related to secured financing transactions in the liquidity coverage ratio.
Net Stable Funding Ratio
The external NSFR metric requires banks to maintain a stable funding profile taking into account both on and certain off-
balance sheet exposures over a medium to long term period. The ratio is defined as the Available Stable Funding (capital and
certain liabilities which are treated as stable sources of funding) relative to the Required Stable Funding (a measure of assets
on the balance sheet and certain off-balance sheet exposures which may require longer term funding). The NSFR (average
of last four quarter ends) as at 30 June 2026 was 135.8%, which was a surplus above the regulatory requirement of
£171.7bn.
Net Stable Funding Ratio2 As at
30.06.26
As at
31.12.25
£bn £bn
Total Available Stable Funding 650.9 639.4
Total Required Stable Funding 479.2 473.1
Surplus 171.7 166.3
Net Stable Funding Ratio 135.8% 135.2%
2 Represents average of the last four spot quarter end ratios.
As part of the liquidity risk appetite, Barclays establishes minimum LCR, NSFR and internal liquidity stress test limits. Risks to
market funding conditions, the Group’s liquidity position and funding profile are assessed continuously, and actions are
taken to manage the size of the liquidity pool and the funding profile as appropriate.
Treasury and Capital Risk
Barclays PLC 49
-- 51 of 99 --
Composition of the Group liquidity pool
LCR eligible1 High Quality Liquid Assets (HQLA) Liquidity pool
Cash Level 1 Level 2A Level 2B Total 2026 2025
£bn £bn £bn £bn £bn £bn £bn
Cash and deposits with central banks2 237 — — — 237 255 237
Government bonds3
AAA to AA- — 56 2 — 58 54 62
A+ to A- — 14 — — 14 14 14
BBB+ to BBB- — — — — — — 2
Total government bonds — 70 2 — 72 68 78
Other
Government Guaranteed Issuers, PSEs and GSEs — 4 — — 4 8 7
International Organisations and MDBs — 8 — — 8 7 7
Covered bonds — 5 4 — 9 8 8
Other — — — 4 4 1 1
Total other — 17 4 4 25 24 23
Total as at 30 June 2026 237 87 6 4 334 347
Total as at 31 December 2025 219 85 11 5 320 338
1 The LCR eligible HQLA is adjusted under the Liquidity Coverage Ratio (CRR) Part of the PRA Rulebook for operational restrictions upon
consolidation, such as trapped liquidity within Barclays subsidiaries. It also reflects differences in eligibility of assets between the LCR and
Barclays’ Liquidity Pool.
2 Includes cash held at central banks and surplus cash at central banks related to payment schemes. Over 99.7% (December 2025: over 99.5%)
was placed with the Bank of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.
3 Of which over 85% (December 2025: over 85%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.
The Group liquidity pool was £346.7bn as at June 2026, an increase of £8.9bn versus December 2025 (December 2025:
£337.8bn).
In H1 2026, the month-end liquidity pool ranged from £321bn to £347bn (2025: £326bn to £352bn), and the month-end
average balance was £332bn (2025: £337bn). The liquidity pool is held unencumbered and represents readily accessible
funds to meet potential cash outflows during stress periods.
As at 30 June 2026, 70% (December 2025: 68%) of the liquidity pool was located in Barclays Bank PLC, 15% (December
2025: 17%) in Barclays Bank UK PLC and 8% (December 2025: 9%) in Barclays Bank Ireland PLC. The residual portion of the
liquidity pool is held outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress outflows and
local regulatory requirements. To the extent the use of this residual portion of the liquidity pool is restricted due to local
regulatory requirements, it is assumed to be unavailable to the rest of the Group in calculating the LCR.
The composition of the pool is subject to limits set by the Board and the second-line liquidity, credit and market risk
functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset type.
Given returns generated by these highly liquid assets, the risk and reward profile is continuously managed.
Treasury and Capital Risk
Barclays PLC 50
-- 52 of 99 --
Deposit funding
As at 30.06.26 As at 31.12.25
Loans and
advances, debt
securities at
amortised cost Deposits at
amortised cost2
Loan: deposit
ratio1
Loan: deposit
ratio1
Funding of loans and advances £bn £bn % %
Barclays UK 238 246 97 94
Barclays UK Corporate Bank 31 89 35 34
Barclays Private Bank and Wealth Management 15 73 21 21
Barclays Investment Bank 136 162 84 83
Barclays US consumer Bank 22 25 88 92
Head Office 3 —
Barclays Group 445 594 75 73
1 The loan: deposit ratio is calculated as loans and advances at amortised cost and debt securities at amortised cost divided by deposits at
amortised cost.
2 Totals may not sum due to rounding.
Funding structure and funding relationships
The basis for sound liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading
to an inability to meet funding obligations as they fall due. The Group’s overall funding strategy is to develop a diversified
funding base (geographically, by type and by counterparty) and maintain access to a variety of alternative funding sources,
to provide protection against unexpected fluctuations, while minimising the cost of funding.
Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances are
largely funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of
reverse repurchase agreements are matched by repurchase agreements. Derivative liabilities and assets are largely matched.
A substantial proportion of balance sheet derivative positions qualify for counterparty netting and the remaining portions are
largely offset when netted against cash collateral received and paid. Wholesale debt and equity is used to fund residual
assets.
These funding relationships as at 30 June 2026 are summarised below:
As at
30.06.26
As at
31.12.25
As at
30.06.26
As at
31.12.25
Assets £bn £bn Liabilities and equity £bn £bn
Loans and advances at amortised cost1 418 400 Deposits at amortised cost 594 586
Group liquidity pool 347 338 <1 Year wholesale funding 89 84
>1 Year wholesale funding 147 136
Reverse repurchase agreements, trading
portfolio assets, cash collateral and
settlement balances 567 471
Repurchase agreements, trading portfolio
liabilities, cash collateral and settlement
balances 458 359
Derivative financial instruments 304 252 Derivative financial instruments 292 241
Other assets2 94 83 Other liabilities 70 60
Equity 80 78
Total assets 1,730 1,544 Total liabilities and equity 1,730 1,544
1 Adjusted for liquidity pool debt securities reported at amortised cost of £27bn (December 2025: £30bn).
2 Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories.
Treasury and Capital Risk
Barclays PLC 51
-- 53 of 99 --
Composition of wholesale funding
Wholesale funding outstanding (excluding repurchase agreements) was £236.0bn (December 2025: £220.1bn). In H126,
the Group issued £9.9bn1 of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and
currencies, completing the targeted 2026 MREL issuance plan within H126.
Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases.
Barclays Bank PLC continued to issue in the shorter-term and medium-term notes markets. In addition, Barclays Bank UK
PLC continued to issue in the shorter-term markets and maintains active secured funding programmes.
Wholesale funding of £88.7bn (December 2025: £83.9bn) matures in less than one year, representing 38% (December
2025: 38%) of total wholesale funding outstanding. This includes £32.6bn (December 2025: £28.4bn) related to term
funding2.
Maturity profile of wholesale funding3,4
<1
month
1-3
months
3-6
months
6-12
months
<1
year
1-2
years
2-3
years
3-4
years
4-5
years
>5
years Total
£bn £bn £bn £bn £bn £bn £bn £bn £bn £bn £bn
Barclays PLC (the Parent company)
Senior unsecured (Public benchmark) — — — 1.2 1.2 6.9 6.8 9.3 5.9 29.1 59.2
Senior unsecured (Privately placed) — — — — — — — 0.2 0.1 0.8 1.1
Subordinated liabilities — — — — — 1.5 — 1.1 — 6.8 9.4
Barclays Bank Group
Senior unsecured (Public benchmark) — — — — — 1.5 1.1 — — — 2.6
Senior unsecured (Privately placed)5 2.8 4.6 7.7 14.9 30.0 14.6 14.1 8.6 8.2 23.7 99.2
Certificates of deposit and commercial
paper 2.0 8.5 19.4 13.1 43.0 — — — — — 43.0
Asset backed commercial paper 4.2 4.5 0.5 — 9.2 — — — — — 9.2
Asset backed securities — 0.1 — 0.8 0.9 0.3 1.1 — 0.1 2.1 4.5
Subordinated liabilities — 0.4 — 0.1 0.5 0.2 — — — 0.3 1.0
Barclays Bank UK Group
Senior unsecured (Privately placed) — — — — — — — — 0.1 0.1 0.2
Certificates of deposit and commercial
paper 3.6 — — — 3.6 — — — — — 3.6
Covered bonds — — — — — 0.5 0.7 0.7 — 0.1 2.0
Asset backed securities — — 0.3 — 0.3 — — — — — 0.3
Subordinated liabilities — — — — — — — — — 0.7 0.7
Total as at 30 June 2026 12.6 18.1 27.9 30.1 88.7 25.5 23.8 19.9 14.4 63.7 236.0
Of which secured 4.2 4.6 0.8 0.8 10.4 0.8 1.8 0.7 0.1 2.9 16.7
Of which unsecured 8.4 13.5 27.1 29.3 78.3 24.7 22.0 19.2 14.3 60.8 219.3
Total as at 31 December 2025 10.4 17.0 31.5 25.0 83.9 21.2 22.7 19.3 13.8 59.2 220.1
Of which secured 2.3 8.9 1.8 0.3 13.3 0.7 1.5 0.7 0.7 3.5 20.4
Of which unsecured 8.1 8.1 29.7 24.7 70.6 20.5 21.2 18.6 13.1 55.7 199.7
1 Includes £0.5bn of AT1
2 Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and
subordinated debt where the original maturity of the instrument is more than 1 year.
3 The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and
subordinated liabilities. It does not include participation in the central bank facilities reported within repurchase agreements and other similar
secured borrowing.
4 Excludes £0.5bn of AT1
5 Includes structured notes of £84.5bn, of which £27.0bn matures within one year.
Treasury and Capital Risk
Barclays PLC 52
-- 54 of 99 --
Credit ratings
In addition to monitoring and managing key metrics related to the financial strength of the Group, Barclays solicits
independent credit ratings from agencies such as Standard & Poor’s Global (S&P), Moody’s and Fitch. These ratings assess
the creditworthiness of the Group, its subsidiaries and its branches, and are based on reviews of a broad range of business
and financial attributes including capital strength, profitability, funding, liquidity, asset quality, strategy and governance.
Barclays PLC Standard & Poor's Moody's Fitch
Long-term BBB+ / Stable Baa1 / Stable A / Stable
Short-term A-2 P-2 F1
Barclays Bank PLC
Long-term A+ / Stable A1 / Stable AA- / Stable
Short-term A-1 P-1 F1+
Barclays Bank UK PLC
Long-term A+ / Stable A11 / Stable AA- / Stable
Short-term A-1 P-11 F1+
1 Deposit ratings.
In H126, Fitch upgraded the long and short term ratings for Barclays Bank PLC and Barclays Bank UK PLC, whilst affirming
the ratings for Barclays PLC. S&P also affirmed all ratings for all entities.
A credit rating downgrade could result in outflows to meet collateral requirements on existing contracts. Outflows related to
credit rating downgrades are included in the ILST scenarios and a portion of the liquidity pool is held against this risk. Credit
ratings downgrades could also result in reduced funding capacity and increased funding costs.
A one and two-notch long-term downgrade, with associated short-term downgrades, across all credit ratings agencies
would result in outflows of £1bn and £3bn respectively on derivative contracts and other off balance sheet products to
satisfy the contractual collateral requirements. This is provided for in determining an appropriate liquidity pool size given the
Group’s liquidity risk appetite. These numbers do not assume any management or restructuring actions that could be taken
to reduce posting requirements.
Treasury and Capital Risk
Barclays PLC 53
-- 55 of 99 --
Regulatory minimum requirements
Capital
As at 30 June 2026, the Group’s Overall Capital Requirement for CET1, excluding any applicable PRA buffer, was 12.2% and
comprised a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important
Institution (G-SII) buffer, a 2.7% Pillar 2A requirement and a 1.0% Countercyclical Capital Buffer (CCyB).
The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. The buffer
rates set by other national authorities for non-UK exposures are not currently material.
The Group’s Pillar 2A requirement is 4.8% with at least 56.25% to be met with CET1 capital, equating to 2.7% of RWAs. The
Pillar 2A requirement, based on a point in time assessment, has been set as a proportion of RWAs and is subject to at least
annual review.
The Group’s CET1 target ratio of 13-14% takes into account minimum capital requirements and applicable buffers. The
Group remains above its minimum capital regulatory requirements and applicable buffers.
Leverage
As at 30 June 2026, the Group was subject to a UK leverage ratio requirement of 4.1%. This comprised the 3.25% minimum
requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB)
of 0.3%. The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each
month in the quarter and an exposure measure for each day in the quarter.
MREL
As at 30 June 2026, the Group was required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.8% Pillar 2A
equating to 25.5% of RWAs; and (ii) 6.75% of leverage exposures. CET1 capital cannot be counted towards both MREL and
the buffers, meaning that the buffers, including any applicable PRA buffer, will effectively be applied above MREL
requirements.
Significant regulatory updates in the period
In January 2026, the PRA confirmed the final implementation timetable for the UK Basel 3.1 framework. The PRA’s final rules
reaffirm that Basel 3.1 will be implemented from 1 January 2027.
The PRA also confirmed its approach to the Fundamental Review of the Trading Book (FRTB), under which implementation
of the Internal Models Approach (IMA) will be deferred to 1 January 2028, while all other FRTB components will take effect
from 1 January 2027.
Treasury and Capital Risk
Barclays PLC 54
-- 56 of 99 --
Capital ratios As at
30.06.26
As at
31.03.26
As at
31.12.25
CET1 14.3% 14.1% 14.3%
T1 18.0% 17.5% 17.9%
Total regulatory capital 20.3% 19.7% 20.4%
MREL ratio as a percentage of total RWAs 36.7% 35.4% 35.8%
Own funds and eligible liabilities £m £m £m
Total equity excluding non-controlling interests per the balance sheet 79,358 76,668 77,784
Less: other equity instruments (recognised as AT1 capital) (13,275) (12,714) (12,725)
Adjustment to retained earnings for foreseeable ordinary share dividends (1,000) (500) (778)
Adjustment to retained earnings for foreseeable repurchase of shares — (507) (271)
Adjustment to retained earnings for foreseeable other equity coupons (38) (45) (36)
Other regulatory adjustments and deductions
Additional value adjustments (PVA) (2,086) (2,103) (1,956)
Goodwill and intangible assets (8,845) (8,327) (8,255)
Deferred tax assets that rely on future profitability excluding temporary differences (892) (958) (1,069)
Fair value reserves related to gains or losses on cash flow hedges 1,548 2,147 666
Excess of expected losses over impairment (505) (446) (436)
Gains or losses on liabilities at fair value resulting from own credit 577 507 904
Defined benefit pension fund assets (2,407) (2,352) (2,398)
Direct and indirect holdings by an institution of own CET1 instruments (6) (7) (14)
Other regulatory adjustments (186) (144) (346)
CET1 capital 52,243 51,219 51,070
AT1 capital
Capital instruments and related share premium accounts 13,286 12,758 12,758
Other regulatory adjustments and deductions (10) (44) (33)
AT1 capital 13,275 12,714 12,725
T1 capital 65,519 63,933 63,795
T2 capital
Capital instruments and related share premium accounts 8,479 7,937 8,835
Qualifying T2 capital (including minority interests) issued by subsidiaries 49 53 55
Other regulatory adjustments and deductions (118) (134) (71)
Total regulatory capital 73,929 71,789 72,614
Less : Ineligible T2 capital (including minority interests) issued by subsidiaries (49) (53) (55)
Eligible liabilities 59,973 57,113 55,106
Total own funds and eligible liabilities1 133,852 128,850 127,665
Total RWAs 364,764 364,462 356,774
1 As at 30 June 2026, the Group's MREL requirement, excluding any applicable PRA buffer, was to hold £111.4bn of own funds and eligible
liabilities equating to 30.5% of RWAs. The Group remains above its MREL regulatory requirement including any applicable PRA buffer.
Treasury and Capital Risk
Barclays PLC 55
-- 57 of 99 --
Movement in CET1 capital Three months
ended
30.06.26
Six months
ended
30.06.26
£m £m
Opening CET1 capital 51,219 51,070
Profit for the period attributable to equity holders 2,503 4,678
Own credit relating to derivative liabilities 26 8
Ordinary share dividends paid and foreseen (500) (1,000)
Purchased and foreseeable share repurchase (500) (1,500)
Other equity coupons paid and foreseen (236) (489)
Increase in retained regulatory capital generated from earnings 1,293 1,697
Net impact of share schemes 274 (109)
Fair value through other comprehensive income reserve 140 101
Currency translation reserve (134) 219
Other reserves (3) (8)
Increase in other qualifying reserves 277 203
Pension remeasurements within reserves 41 (24)
Defined benefit pension fund asset deduction (55) (9)
Net impact of pensions (14) (33)
Additional value adjustments (PVA) 16 (131)
Goodwill and intangible assets (519) (590)
Deferred tax assets that rely on future profitability excluding those arising from temporary differences 66 177
Excess of expected loss over impairment (59) (69)
Direct and indirect holdings by an institution of own CET1 instruments 1 8
Other regulatory adjustments (37) (89)
Decrease in regulatory capital due to adjustments and deductions (532) (694)
Closing CET1 capital 52,243 52,243
CET1 capital increased by £1.2bn to £52.2bn (December 2025: £51.1bn). Significant movements in the period were:
• £4.7bn of capital generated from profit partially offset by distributions of £3.0bn comprising:
– £1.5bn completed share buybacks announced with FY25 and Q126 results
– £1.0bn accrual towards the total 2026 dividend
– £0.5bn of equity coupons paid and foreseen
• £0.2bn increase in other qualifying reserves including a £0.2bn increase in the currency translation reserve as a result of
foreign exchange movements
• £0.7bn decrease due to regulatory adjustments and deductions including £0.6bn of goodwill and intangibles deductions
primarily driven by the Best Egg acquisition
Treasury and Capital Risk
Barclays PLC 56
-- 58 of 99 --
RWAs by risk type and business
Credit risk Counterparty credit risk Market Risk
Operational
risk
Total
RWAs
STD IRB STD IRB
Settlement
Risk CVA STD IMA
As at 30.06.26 £m £m £m £m £m £m £m £m £m £m
Barclays UK 16,987 57,919 118 9 — 33 135 — 13,804 89,005
Barclays UK Corporate Bank 3,866 18,522 97 260 — 3 16 274 3,530 26,568
Barclays Private Bank & Wealth
Management 5,002 570 128 25 — 11 37 185 2,062 8,020
Barclays Investment Bank 44,721 51,050 25,723 22,591 336 2,566 12,110 19,772 25,275 204,144
Barclays US Consumer Bank 17,894 1,016 — — — — — — 5,394 24,304
Head Office 5,538 5,883 1 4 — — 175 32 1,090 12,723
Barclays Group 94,008 134,960 26,067 22,889 336 2,613 12,473 20,263 51,155 364,764
As at 31.03.26
Barclays UK 16,737 56,662 117 9 — 37 118 — 13,804 87,484
Barclays UK Corporate Bank 4,097 18,921 87 267 — 3 19 330 3,530 27,254
Barclays Private Bank & Wealth
Management 5,020 678 124 30 1 11 32 225 2,062 8,183
Barclays Investment Bank 42,919 51,782 24,119 21,504 243 2,522 11,978 21,380 25,275 201,722
Barclays US Consumer Bank 21,158 1,017 — — — — — — 5,394 27,569
Head Office 5,441 5,482 — — — — 237 — 1,090 12,250
Barclays Group 95,372 134,542 24,447 21,810 244 2,573 12,384 21,935 51,155 364,462
As at 31.12.25
Barclays UK 16,731 55,037 132 8 — 43 177 — 13,697 85,825
Barclays UK Corporate Bank 3,878 18,341 89 312 1 4 31 343 3,510 26,509
Barclays Private Bank & Wealth
Management 4,981 580 112 19 — 11 39 240 2,054 8,036
Barclays Investment Bank 44,961 49,750 21,986 19,442 165 3,030 12,018 20,111 25,238 196,701
Barclays US Consumer Bank 21,050 1,004 — 1 — — — — 5,393 27,448
Head Office 5,405 5,439 1 5 — — 219 59 1,127 12,255
Barclays Group 97,006 130,151 22,320 19,787 166 3,088 12,484 20,753 51,019 356,774
Movement analysis of RWAs
Credit risk
Counterparty
credit risk Market risk
Operational
risk Total RWAs
£m £m £m £m £m
RWAs as at 31.12.25 227,157 45,361 33,237 51,019 356,774
Book size 3,849 5,944 (680) 136 9,249
Acquisitions and disposals (3,192) — — — (3,192)
Book quality 462 271 — — 733
Model updates — — — — —
Methodology and policy (174) 29 — — (145)
Foreign exchange movements1 866 300 179 — 1,345
Total RWA movements 1,811 6,544 (501) 136 7,990
RWAs as at 30.06.26 228,968 51,905 32,736 51,155 364,764
1 Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk.
Total RWAs increased £8.0bn to £364.8bn (Dec 2025: £356.8bn) primarily driven by:
Credit risk RWAs increased £1.8bn:
• A £3.8bn increase in book size primarily reflecting lending growth in UK businesses; partially offset by
• A £3.2bn decrease in acquisitions and disposals reflecting the net impact of the AA portfolio exit and the Best Egg
acquisition
Counterparty credit risk RWAs increased £6.5bn primarily driven by higher activity in Global Markets
Treasury and Capital Risk
Barclays PLC 57
-- 59 of 99 --
Leverage ratios
As at
30.06.26
As at
31.03.26
As at
31.12.25
£m £m £m
UK leverage ratio1 4.9% 4.8% 5.1%
T1 capital 65,519 63,933 63,795
UK leverage exposure 1,345,596 1,321,321 1,247,313
Average UK leverage ratio 4.6% 4.6% 4.7%
Average T1 capital 63,787 63,239 63,277
Average UK leverage exposure 1,393,843 1,373,842 1,358,364
1 Although the leverage ratio is expressed in terms of T1 capital, the leverage ratio buffers and 75% of the minimum requirement must be covered
solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £7.1bn and against the 0.3% CCLB was £4.0bn.
The UK leverage ratio decreased to 4.9% (December 2025: 5.1%) as the leverage exposure increased by £98.3bn to
£1,345.6bn (December 2025: £1,247.3bn). The increase in leverage exposure was primarily driven by higher trading activity
in IB.
Treasury and Capital Risk
Barclays PLC 58
-- 60 of 99 --
The Directors (the names of whom are set out below) are required to prepare the financial statements on a going concern
basis unless it is not appropriate to do so. In making this assessment, the directors have considered information relating to
present and future conditions. Each of the Directors confirm that to the best of their knowledge, the condensed consolidated
interim financial statements and notes have been prepared in accordance with International Accounting Standard 34,
‘Interim Financial Reporting’, as adopted by the UK, and that the interim management report herein includes a fair review of
the information required by Disclosure Guidance and Transparency Rules 4.2.7R and 4.2.8R namely:
• an indication of important events that have occurred during the six months ended 30 June 2026 and their impact
on the condensed consolidated interim financial statements, and a description of the principal risks and
uncertainties for the remaining six months of the financial year
• any related party transactions in the six months ended 30 June 2026 that have materially affected the financial
position or performance of Barclays during that period and any changes in the related party transactions described
in the last Annual Report that could have a material effect on the financial position or performance of Barclays in
the six months ended 30 June 2026
Signed on 27 July 2026 on behalf of the Board by
C.S. Venkatakrishnan Anna Cross
Group Chief Executive Group Finance Director
Barclays PLC Board of Directors
Chairman Executive Directors Non-Executive Directors
Nigel Higgins C.S. Venkatakrishnan Robert Berry
Anna Cross Dawn Fitzpatrick
Brian Gilvary
Sir John Kingman
Diony Lebot
Mary Mack
Marc Moses
Brian Shea
Julia Wilson
Statement of Directors' Responsibilities
Barclays PLC 59
-- 61 of 99 --
Conclusion
We have been engaged by Barclays PLC (“the Company” or “the Group”) to review the condensed set of financial statements
in the Interim Results Announcement for the six months ended 30 June 2026 which comprises:
• the condensed consolidated income statement and condensed consolidated statement of comprehensive income
for the period then ended;
• the condensed consolidated balance sheet as at 30 June 2026;
• the condensed consolidated statement of changes in equity for the period then ended;
• the condensed consolidated cash flow statement for the period then ended; and
• the related explanatory notes.
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial
statements in the Interim Results Announcement for the six months ended 30 June 2026 is not prepared, in all material
respects, in accordance with IAS 34 Interim Financial Reporting as adopted for use in the UK and the Disclosure Guidance
and Transparency Rules (“the DTR”) of the UK’s Financial Conduct Authority (“the UK FCA”).
Basis for conclusion
We conducted our review in accordance with International Standard on Review Engagements (UK) 2410 Review of Interim
Financial Information Performed by the Independent Auditor of the Entity (“ISRE (UK) 2410”) issued for use in the UK. A
review of interim financial information consists of making enquiries, primarily of persons responsible for financial and
accounting matters, and applying analytical and other review procedures. We read the other information contained in the
Interim Results Announcement and consider whether it contains any apparent misstatements or material inconsistencies
with the information in the condensed set of financial statements.
A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK)
and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might
be identified in an audit. Accordingly, we do not express an audit opinion.
Conclusions relating to going concern
Based on our review procedures, which are less extensive than those performed in an audit as described in the Basis for
conclusion section of this report, nothing has come to our attention that causes us to believe that the directors have
inappropriately adopted the going concern basis of accounting, or that the directors have identified material uncertainties
relating to going concern that have not been appropriately disclosed.
This conclusion is based on the review procedures performed in accordance with ISRE (UK) 2410. However, future events or
conditions may cause the Group to cease to continue as a going concern, and the above conclusions are not a guarantee
that the Group will continue in operation.
Directors’ responsibilities
The Interim Results Announcement is the responsibility of, and has been approved by, the directors. The directors are
responsible for preparing the Interim Results Announcement in accordance with the DTR of the UK FCA.
As disclosed in note 1, the annual financial statements of the Group are prepared in accordance with UK-adopted
international accounting standards.
The directors are responsible for preparing the condensed set of financial statements included in the Interim Results
Announcement in accordance with IAS 34 as adopted for use in the UK.
In preparing the condensed set of financial statements, the directors are responsible for assessing the Group’s ability to
continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the directors either intend to liquidate the Group or to cease operations, or have no realistic alternative
but to do so.
Independent Review Report to Barclays PLC
Barclays PLC 60
-- 62 of 99 --
Our responsibility
Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the Interim
Results Announcement based on our review. Our conclusion, including our conclusions relating to going concern, are based
on procedures that are less extensive than audit procedures, as described in the Basis for conclusion section of this report.
The purpose of our review work and to whom we owe our responsibilities
This report is made solely to the Company in accordance with the terms of our engagement to assist the Company in
meeting the requirements of the DTR of the UK FCA. Our review has been undertaken so that we might state to the
Company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted
by law, we do not accept or assume responsibility to anyone other than the Company for our review work, for this report, or
for the conclusions we have reached.
Stuart Crisp
for and on behalf of KPMG LLP
Chartered Accountants
15 Canada Square
London, E14 5GL
27 July 2026
Independent Review Report to Barclays PLC
Barclays PLC 61
-- 63 of 99 --
Condensed consolidated income statement (unaudited)
Half year
ended
30.06.26
Half year
ended
30.06.25
Notes1 £m £m
Interest and similar income 17,447 18,264
Interest and similar expense (9,789) (11,242)
Net interest income 7,658 7,022
Fee and commission income 3 5,945 5,656
Fee and commission expense 3 (1,986) (1,972)
Net fee and commission income 3 3,959 3,684
Net trading income 4,623 4,171
Net investment income/(expense) 4 (18)
Other income2 257 37
Total income 16,501 14,896
Staff costs 4 (5,670) (5,254)
Infrastructure, administration and general expenses 5 (3,203) (3,153)
UK regulatory levies (84) (96)
Litigation and conduct (108) (87)
Operating expenses (9,065) (8,590)
Share of post-tax results of associates and joint ventures 24 9
Profit before impairment 7,460 6,315
Credit impairment charges (1,394) (1,112)
Profit before tax 6,066 5,203
Tax charge (1,369) (1,173)
Profit after tax 4,697 4,030
Attributable to:
Shareholders of the parent 4,191 3,523
Other equity holders 487 484
Equity holders of the parent 4,678 4,007
Non-controlling interests 19 23
Profit after tax 4,697 4,030
Earnings per share
Basic earnings per ordinary share 6 30.7p 24.7p
Diluted earnings per ordinary share 6 29.8p 23.8p
1 For Notes to the Financial Statements see pages 68 to 87.
2 Other income includes c.£225m gain recognised on sale of the AA portfolio on 24 April 2026.
Condensed Consolidated Financial Statements
Barclays PLC 62
-- 64 of 99 --
Condensed consolidated statement of comprehensive income (unaudited)
Half year
ended
30.06.26
Half year
ended
30.06.25
Notes1 £m £m
Profit after tax 4,697 4,030
Other comprehensive (loss)/income that may be recycled to profit or loss:
Currency translation reserve
Currency translation differences 219 (1,568)
Tax — (3)
Fair value through other comprehensive income reserve
Net (losses)/gains from changes in fair value (578) 1,268
Net losses transferred to net profit on disposal 57 68
Net release of impairment — (2)
Net gains/(losses) due to fair value hedging 662 (769)
Tax (39) (157)
Cash flow hedging reserve
Net (losses)/gains from changes in fair value (1,837) 3,043
Net losses/(gains) transferred to net profit 618 (656)
Tax 337 (667)
Other comprehensive (loss)/income that may be recycled to profit or loss (561) 557
Other comprehensive income/(loss) not recycled to profit or loss:
Retirement benefit remeasurements 13 (37) (283)
Fair value through other comprehensive income reserve (1) —
Own credit 457 710
Tax (110) (111)
Other comprehensive income not recycled to profit or loss 309 316
Other comprehensive (loss)/income for the period (252) 873
Total comprehensive income for the period 4,445 4,903
Attributable to:
Equity holders of the parent 4,426 4,880
Non-controlling interests 19 23
Total comprehensive income for the period 4,445 4,903
1 For Notes to the Financial Statements see pages 68 to 87.
Condensed Consolidated Financial Statements
Barclays PLC 63
-- 65 of 99 --
Condensed consolidated balance sheet (unaudited)
As at
30.06.26
As at
31.12.25
Assets Notes1 £m £m
Cash and balances at central banks 245,859 229,752
Cash collateral and settlement balances 189,461 130,532
Debt securities at amortised cost 73,519 68,475
Loans and advances at amortised cost to banks 11,978 8,638
Loans and advances at amortised cost to customers 359,323 352,885
Reverse repurchase agreements and other similar secured lending at amortised cost 12,100 17,622
Trading portfolio assets 210,102 190,061
Financial assets at fair value through the income statement 213,100 186,857
Derivative financial instruments 8 303,602 252,459
Financial assets at fair value through other comprehensive income 83,012 74,394
Investments in associates and joint ventures 732 739
Goodwill and intangible assets 10 8,912 8,284
Property, plant and equipment 4,226 3,720
Current tax assets 222 276
Deferred tax assets 4,987 4,992
Retirement benefit assets 13 3,316 3,308
Assets included in a disposal group classified as held for sale 18 — 5,932
Other assets 5,907 5,239
Total assets 1,730,358 1,544,165
Liabilities
Deposits at amortised cost from banks 19,921 20,413
Deposits at amortised cost from customers 574,436 565,200
Cash collateral and settlement balances 182,142 117,583
Repurchase agreements and other similar secured borrowings at amortised cost 30,704 25,170
Debt securities in issue 126,837 119,033
Subordinated liabilities 11 11,098 12,954
Trading portfolio liabilities 78,405 57,737
Financial liabilities designated at fair value 321,925 294,108
Derivative financial instruments 8 291,785 240,808
Current tax liabilities 1,020 868
Deferred tax liabilities 13 13
Retirement benefit liabilities 13 266 265
Provisions 12 1,681 1,664
Other liabilities 10,314 10,113
Total liabilities 1,650,547 1,465,929
Equity
Called up share capital and share premium 4,186 4,178
Other equity instruments 13,275 12,725
Other reserves 14 1,493 1,628
Retained earnings 60,404 59,253
Total equity excluding non-controlling interests 79,358 77,784
Non-controlling interests 453 452
Total equity 79,811 78,236
Total liabilities and equity 1,730,358 1,544,165
1 For Notes to the Financial Statements see pages 68 to 87.
Condensed Consolidated Financial Statements
Barclays PLC 64
-- 66 of 99 --
Condensed consolidated statement of changes in equity (unaudited)
Called up
share capital
and share
premium1,2
Other equity
instruments3
Other
reserves4
Retained
earnings Total
Non-
controlling
interests
Total
equity
Half year ended 30.06.2026 £m £m £m £m £m £m £m
Balance as at 1 January 2026 4,178 12,725 1,628 59,253 77,784 452 78,236
Profit after tax — 487 — 4,191 4,678 19 4,697
Currency translation movements — — 219 — 219 — 219
Fair value through other
comprehensive income reserve — — 101 — 101 — 101
Cash flow hedges — — (882) — (882) — (882)
Retirement benefit remeasurements — — — (24) (24) — (24)
Own credit — — 334 — 334 — 334
Total comprehensive income for the
period — 487 (228) 4,167 4,426 19 4,445
Employee share schemes and
hedging thereof 109 — — 479 588 — 588
Issue and redemption of other equity
instruments — 527 — — 527 — 527
Other equity instruments coupon paid — (487) — — (487) — (487)
Redemption of preference shares — — — — — — —
Vesting of employee share schemes
net of purchases — — (11) (948) (959) — (959)
Dividends paid — — — (769) (769) (19) (788)
Repurchase of shares (101) — 101 (1,781) (1,781) — (1,781)
Other movements — 23 3 3 29 1 30
Balance as at 30 June 2026 4,186 13,275 1,493 60,404 79,358 453 79,811
Condensed consolidated statement of changes in equity (unaudited)
Called up
share capital
and share
premium1, 2
Other equity
instruments3
Other
reserves4
Retained
earnings Total
Non-
controlling
interests
Total
equity
Half year ended 31.12.2025 £m £m £m £m £m £m £m
Balance as at 1 July 2025 4,201 13,266 693 57,746 75,906 449 76,355
Profit after tax — 513 — 2,652 3,165 18 3,183
Currency translation movements — — 439 — 439 — 439
Fair value through other
comprehensive income reserve — — 365 — 365 — 365
Cash flow hedges — — 544 — 544 — 544
Retirement benefit remeasurements — — — 186 186 — 186
Own credit — — (453) — (453) — (453)
Total comprehensive income for the
period — 513 895 2,838 4,246 18 4,264
Employee share schemes and
hedging thereof 68 — — 458 526 — 526
Issue and redemption of other equity
instruments — (531) — 1 (530) — (530)
Other equity instruments coupon paid — (513) — — (513) — (513)
Vesting of employee shares scheme
net of purchases — — (55) 31 (24) — (24)
Dividends paid — — — (422) (422) (18) (440)
Repurchase of shares (91) — 91 (1,407) (1,407) — (1,407)
Other movements — (10) 4 8 2 3 5
Balance as at 31 December 2025 4,178 12,725 1,628 59,253 77,784 452 78,236
Condensed Consolidated Financial Statements
Barclays PLC 65
-- 67 of 99 --
Condensed consolidated statement of changes in equity (unaudited)
Called up
share capital
and share
premium1,2
Other equity
instruments3
Other
reserves4
Retained
earnings Total
Non-
controlling
interests
Total
equity
Half year ended 30.06.25 £m £m £m £m £m £m £m
Balance as at 1 January 2025 4,186 12,075 (468) 56,028 71,821 660 72,481
Profit after tax — 484 — 3,523 4,007 23 4,030
Currency translation movements — — (1,571) — (1,571) — (1,571)
Fair value through other
comprehensive income reserve — — 408 — 408 — 408
Cash flow hedges — — 1,720 — 1,720 — 1,720
Retirement benefit remeasurements — — — (200) (200) — (200)
Own credit — — 516 — 516 — 516
Total comprehensive income for the
period — 484 1,073 3,323 4,880 23 4,903
Employee share schemes and
hedging thereof 82 — — 669 751 — 751
Issue and redemption of other equity
instruments — 1,182 — (5) 1,177 — 1,177
Other equity instruments coupon paid — (484) — — (484) — (484)
Redemption of preference shares — — — (59) (59) (211) (270)
Vesting of employee share schemes
net of purchases — — 19 (585) (566) — (566)
Dividends paid — — — (791) (791) (23) (814)
Repurchase of shares (67) — 67 (834) (834) — (834)
Other movements — 9 2 — 11 — 11
Balance as at 30 June 2025 4,201 13,266 693 57,746 75,906 449 76,355
1 As at 30 June 2026, Called up share capital comprises 13,507m (December 2025: 13,867m) ordinary shares of 25p each.
2 During the six months ended 30 June 2026, Barclays PLC announced and fully executed two share buyback programmes and completed the
share buyback programme that had been announced and partially executed in 2025, totalling £1,790m. As part of these buybacks, 403m shares
were repurchased and cancelled in the period. The nominal value of 101m relating to these shares was transferred from Share capital to the
Capital redemption reserve within Other reserves. In the year ended 31 December 2025, Barclays PLC fully executed two share buyback
programmes and partially executed one share buyback programme totalling £2,232m. A total of 636m shares were repurchased and cancelled,
with a nominal value of £158m transferred from Share capital to the Capital redemption reserve within Other reserves.
3 Other equity instruments of £13,275m (December 2025: £12,725m) comprise AT1 securities issued by Barclays PLC. During the six months
ended 30 June 2026, there was one issuance in the form of Fixed Rate Resetting Perpetual Subordinated Contingent Convertible Securities for
£527m (net of £4m issuance costs) and no redemptions. For the six months ended 31 December 2025, there were two issuances totalling
£1,607m (including £6m issuance costs) and two redemptions totalling £2,138m. For the six months ended 30 June 2025, there were two
issuances totalling £2,177m (including £9m of issuance costs) and one redemption of £995m, all relating to Fixed Rate Resetting Perpetual
Subordinated Contingent Convertible Securities.
4 Details are shown in Note 14 - Other reserves on page 81.
Condensed Consolidated Financial Statements
Barclays PLC 66
-- 68 of 99 --
Condensed consolidated cash flow statement (unaudited)
Half year
ended
30.06.26
Half year
ended
30.06.25
£m £m
Profit before tax 6,066 5,203
Adjustment for non-cash and other items 3,108 9,466
Net increase in loans and advances at amortised cost (7,580) (1,950)
Net increase in deposits at amortised cost 8,744 3,872
Net increase in debt securities in issue 3,670 8,195
Changes in other operating assets and liabilities 17,221 (3,772)
Corporate income tax paid (793) (712)
Net cash from operating activities 30,436 20,302
Net cash from investing activities (10,989) (4,184)
Net cash from financing activities1 (1,130) 3,720
Effect of exchange rates on cash and cash equivalents 334 (2,632)
Net increase in cash and cash equivalents 18,651 17,206
Cash and cash equivalents at beginning of the period 256,463 235,611
Cash and cash equivalents at end of the period 275,114 252,817
1 Issuance and redemption of debt securities included in financing activities relate to instruments that qualify as eligible liabilities and satisfy
regulatory requirements for MREL instruments which came into effect during 2019.
Condensed Consolidated Financial Statements
Barclays PLC 67
-- 69 of 99 --
1. Basis of preparation
These condensed consolidated interim financial statements ("the financial statements") for the six months ended 30 June
2026 have been prepared in accordance with the Disclosure Guidance and Transparency Rules (DTR) of the UK’s FCA, and
IAS 34, Interim Financial Reporting, as published by the International Accounting Standards Board (IASB) and adopted by the
UK.
The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements
for the year ended 31 December 2025. The annual financial statements for the year ended 31 December 2025 were prepared
in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006 and
in accordance with International Financial Reporting Standards (IFRS) and interpretations (IFRICs) as issued by the IASB and
adopted by the UK.
The accounting policies and methods of computation applied in these condensed consolidated interim financial statements
are consistent with those set out in the Barclays PLC Annual Report for the year ended 31 December 2025, except for the
adoption of the amendments to IFRS 9, effective from 1 January 2026. The amendments include:
• Additional guidance clarifying when certain financial assets comply with solely payments of principal and interest
(SPPI) requirements, including instruments with contingent features (e.g. Environmental, Social, and Governance
(ESG)-linked financing), as well as contractually-linked instruments and non-recourse financing.
• Clarifications to the derecognition requirements for financial assets and financial liabilities and the introduction of
an accounting policy choice for liabilities settled via an electronic payment system. If the policy choice is elected, a
liability may be derecognised before it is legally extinguished, provided that the entity has initiated a payment
instruction and the specified IFRS 9 criteria are met.
In the limited circumstances where there is a delay between cash being transferred by Barclays via an electronic payment
system and the legal extinguishment of the related liability, Barclays has adopted the policy choice referred to above. There
was no material impact from Barclays' adoption of these IFRS 9 amendments.
i. Going concern
The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Group and parent
company have the resources to continue in business for a period of at least 12 months from approval of the interim financial
statements. In making this assessment, the Directors have considered a wide range of information relating to present and
future conditions and includes a review of a working capital report (WCR). The WCR is used by the Directors to assess the
future performance of the business and that it has the resources in place that are required to meet its ongoing regulatory
requirements. The WCR also includes an assessment of the impact of internally generated stress testing scenarios on the
liquidity and capital requirement forecasts. The stress tests used were based upon an assessment of reasonably possible
downside economic scenarios that the Group could experience.
The WCR indicated that the Group had sufficient capital in place to support its future business requirements and remained
above its regulatory minimum requirements in the internal stress scenarios.
ii. Other disclosures
The Credit risk disclosures on pages 27 to 47 form part of these interim financial statements.
Financial Statement Notes
Barclays PLC 68
-- 70 of 99 --
2. Segmental reporting
Analysis of results by business
Barclays UK
Barclays UK
Corporate
Bank
Barclays
Private Bank
and Wealth
Management
Barclays
Investment
Bank
Barclays US
Consumer
Bank Head Office
Barclays
Group
Half year ended 30.06.26 £m £m £m £m £m £m £m
Net interest income 3,986 807 420 794 1,555 96 7,658
Non-interest income 531 281 293 7,192 564 (18) 8,843
Total income 4,517 1,088 713 7,986 2,119 78 16,501
Of which inter-segmental income/
(expense) (44) 770 888 (1,681) (9) 76 —
Operating costs (2,368) (488) (521) (4,306) (822) (368) (8,873)
UK regulatory levies (44) (15) (3) (22) — — (84)
Litigation and conduct — — — 2 (2) (108) (108)
Total operating expenses (2,412) (503) (524) (4,326) (824) (476) (9,065)
Other net income1 — — — — — 24 24
Profit/(loss) before impairment 2,105 585 189 3,660 1,295 (374) 7,460
Credit impairment (charges)/ releases (338) (19) (3) (323) (713) 2 (1,394)
Profit/(loss) before tax 1,767 566 186 3,337 582 (372) 6,066
As at 30.06.26 £bn £bn £bn £bn £bn £bn £bn
Total assets 304.9 75.6 44.2 1,250.2 32.8 22.7 1,730.4
Total liabilities 287.5 107.9 81.8 1,132.1 25.6 15.6 1,650.5
Barclays UK
Barclays UK
Corporate
Bank
Barclays
Private Bank
and Wealth
Management
Barclays
Investment
Bank
Barclays US
Consumer
Bank Head Office
Barclays
Group
Half year ended 30.06.25 £m £m £m £m £m £m £m
Net interest income 3,677 701 407 631 1,318 288 7,022
Non-interest income 516 302 290 6,549 369 (152) 7,874
Total income 4,193 1,003 697 7,180 1,687 136 14,896
Of which inter-segmental income/
(expense) 1 985 915 (1,895) (3) (3) —
Operating costs (2,283) (474) (472) (3,993) (803) (382) (8,407)
UK regulatory levies (43) (24) (2) (27) — — (96)
Litigation and conduct (29) (39) — (11) (3) (5) (87)
Total operating expenses (2,355) (537) (474) (4,031) (806) (387) (8,590)
Other net income — — — — — 9 9
Profit/(loss) before impairment 1,838 466 223 3,149 881 (242) 6,315
Credit impairment (charges)/releases (237) (31) 11 (139) (711) (5) (1,112)
Profit/(loss) before tax 1,601 435 234 3,010 170 (247) 5,203
As at 31.12.25 £bn £bn £bn £bn £bn £bn £bn
Total assets 299.6 71.3 41.9 1,072.4 34.6 24.4 1,544.2
Total liabilities 280.3 103.7 80.4 965.9 25.4 10.2 1,465.9
Inter-segmental income/(expense) refers to the internal charging of revenues between different business segments,
reflecting how resources such as funding, capital, or services are utilised across the organisation. Segments which operate
with a net customer deposit position contribute surplus deposits as a funding source for other Group segment activities.
1 Other net income represents the share of post-tax results of associates and joint ventures.
Financial Statement Notes
Barclays PLC 69
-- 71 of 99 --
3. Net fee and commission income
Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from
Contracts with Customers.
Barclays UK
Barclays UK
Corporate
Bank
Barclays
Private Bank
and Wealth
Management
Barclays
Investment
Bank
Barclays US
Consumer
Bank Head Office
Barclays
Group
Half year ended 30.06.26 £m £m £m £m £m £m £m
Fee type
Transactional 610 229 14 165 1,205 115 2,338
Advisory — — 174 452 — — 626
Brokerage and execution 95 — 91 1,095 — — 1,281
Underwriting and syndication 18 58 — 1,451 62 — 1,589
Other 2 — — — — 8 10
Total revenue from contracts with
customers 725 287 279 3,163 1,267 123 5,844
Other non-contract fee income — 14 — 87 — — 101
Fee and commission income 725 301 279 3,250 1,267 123 5,945
Fee and commission expense (241) (43) (21) (734) (921) (26) (1,986)
Net fee and commission income 484 258 258 2,516 346 97 3,959
Barclays UK
Barclays UK
Corporate
Bank
Barclays
Private Bank
and Wealth
Management
Barclays
Investment
Bank
Barclays US
Consumer
Bank Head Office
Barclays
Group
Half year ended 30.06.25 £m £m £m £m £m £m £m
Fee type
Transactional 608 229 15 171 1,333 140 2,496
Advisory — — 166 282 — — 448
Brokerage and execution 100 — 79 979 — — 1,158
Underwriting and syndication 18 51 — 1,391 — — 1,460
Other 6 — — — — 9 15
Total revenue from contracts with
customers 732 280 260 2,823 1,333 149 5,577
Other non-contract fee income — 14 — 65 — — 79
Fee and commission income 732 294 260 2,888 1,333 149 5,656
Fee and commission expense (242) (46) (18) (675) (959) (32) (1,972)
Net fee and commission income 490 248 242 2,213 374 117 3,684
Fee types
Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees.
These include interchange and merchant fee income generated from credit and bank card usage.
Advisory fees are generated from wealth management services and investment banking advisory services related to mergers,
acquisitions and financial restructurings.
Brokerage and execution fees are earned for executing client transactions with various exchanges and over-the-counter
markets and assisting clients in clearing transactions and facilitating foreign exchange transactions for spot/forward
contracts.
Underwriting and syndication fees are earned for the distribution of client equity or debt securities and the arrangement and
administration of a loan syndication. These include commitment fees to provide loan financing.
Financial Statement Notes
Barclays PLC 70
-- 72 of 99 --
4. Staff costs
Half year
ended
30.06.26
Half year
ended
30.06.25
Compensation costs £m £m
Upfront bonus charge 887 679
Deferred bonus charge 390 304
Other incentives 35 29
Performance costs 1,312 1,012
Salaries 2,559 2,549
Social security costs 495 442
Post-retirement benefits 287 280
Other compensation costs 362 354
Total compensation costs 5,015 4,637
Other resourcing costs
Outsourcing 457 437
Redundancy and restructuring 101 83
Temporary staff costs 37 33
Other 60 64
Total other resourcing costs 655 617
Total staff costs 5,670 5,254
Barclays Group compensation costs as a % of total income 30.4% 31.1%
5. Infrastructure, administration and general expenses
Half year
ended
30.06.26
Half year
ended
30.06.25
Infrastructure costs £m £m
Property and equipment 1,016 923
Depreciation and amortisation 863 885
Impairment of property, equipment and intangible assets 3 8
Total infrastructure costs 1,882 1,816
Administration and general expenses
Consultancy, legal and professional fees 382 371
Marketing and advertising 330 287
Other administration and general expenses 609 679
Total administration and general expenses 1,321 1,337
Total infrastructure, administration and general expenses 3,203 3,153
Financial Statement Notes
Barclays PLC 71
-- 73 of 99 --
6. Earnings per share
Half year
ended
30.06.26
Half year
ended
30.06.25
£m £m
Profit attributable to ordinary equity holders of the parent 4,191 3,523
m m
Basic weighted average number of shares in issue 13,645 14,262
Number of potential ordinary shares 435 513
Diluted weighted average number of shares 14,080 14,775
p p
Basic earnings per ordinary share 30.7 24.7
Diluted earnings per ordinary share 29.8 23.8
7. Dividends on ordinary shares
Half year ended 30.06.26 Half year ended 30.06.25
Per share Total Per share Total
Dividends paid during the period p £m p £m
Full year dividend paid during period 5.60 769 5.50 791
It is Barclays' policy to declare and pay dividends on a semi-annual basis. The 2025 full year dividend of 5.6p per ordinary
share was paid on 31 March 2026 to the shareholders on the Share Register on 20 February 2026. A half year dividend for
2026 of 5.9p (H125: 3.0p) per ordinary share will be paid on 15 September 2026.
For qualifying American Depositary Receipt (ADR) holders, the half year dividend of 5.9p per ordinary share becomes 23.6p
per American Depositary Share (ADS) (representing four shares). The depositary bank will post the half year dividend on 15
September 2026 to ADR holders on the record at close of business on 7 August 2026.
The Directors have confirmed their intention to initiate a share buyback of up to £1,000m after the balance sheet date. The
share buyback is expected to commence in the third quarter of 2026. The financial statements for the six months ended 30
June 2026 do not reflect the impact of the proposed share buyback, which will be accounted for as and when shares are
repurchased by the Company.
Financial Statement Notes
Barclays PLC 72
-- 74 of 99 --
8. Derivative financial instruments
Contract
notional
amount
Fair value
Assets Liabilities
As at 30.06.26 £m £m £m
Foreign exchange derivatives 10,343,102 88,073 (82,139)
Interest rate derivatives 103,471,652 96,185 (82,336)
Credit derivatives 1,974,655 8,832 (9,520)
Equity and stock index and commodity derivatives 4,586,752 108,290 (117,071)
Derivative assets/(liabilities) held for trading 120,376,161 301,380 (291,066)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 161,205 2,132 (100)
Derivatives designated as fair value hedges 176,326 50 (576)
Derivatives designated as hedges of net investments 4,442 40 (43)
Derivative assets/(liabilities) designated in hedge accounting relationships 341,973 2,222 (719)
Total recognised derivative assets/(liabilities) 120,718,134 303,602 (291,785)
As at 31.12.25
Foreign exchange derivatives 8,534,098 74,246 (71,778)
Interest rate derivatives 86,471,333 93,166 (79,718)
Credit derivatives 1,736,768 7,851 (8,379)
Equity and stock index and commodity derivatives 3,729,728 74,480 (80,252)
Derivative assets/(liabilities) held for trading 100,471,927 249,743 (240,127)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 151,412 2,485 (86)
Derivatives designated as fair value hedges 164,515 75 (552)
Derivatives designated as hedges of net investments 4,389 156 (43)
Derivative assets/(liabilities) designated in hedge accounting relationships 320,316 2,716 (681)
Total recognised derivative assets/(liabilities) 100,792,243 252,459 (240,808)
The IFRS netting posted against derivative assets was £37bn including £5bn of cash collateral netted (December 2025:
£43bn including £6bn cash collateral netted) and £38bn for liabilities including £5bn of cash collateral netted (December
2025: £43bn including £5bn of cash collateral netted). Derivative asset exposures would be £273bn (December 2025:
£226bn) lower than reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or for
which the Group holds cash collateral of £36bn (December 2025: £31bn). Similarly, derivative liabilities would be £265bn
(December 2025: £218bn) lower reflecting counterparty netting and cash collateral placed of £28bn (December 2025:
£23bn). In addition, non-cash collateral of £14bn (December 2025: £13bn) was held in respect of derivative assets £5bn
(December 2025: £5bn) was placed in respect of derivative liabilities. Collateral amounts are limited to net on balance sheet
exposure so as to not include over-collateralisation
Financial Statement Notes
Barclays PLC 73
-- 75 of 99 --
9. Fair value of financial instruments
This note should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual Report
2025 which provides more detail regarding accounting policies adopted, valuation methodologies used in calculating fair
value and the valuation control framework which governs oversight of valuations. There have been no changes in the
accounting policies adopted in the period. During the period, the Group further enhanced its fair value levelling framework.
These enhancements enabled a more granular assessment of input observability and a broader application of significance
assessments in determining the fair value hierarchy classification of financial instruments.
Valuation
The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by the fair value
hierarchy and balance sheet classification:
Assets and liabilities held at fair value
Valuation techniques used
Quoted market
prices
Observable
inputs
Significant
unobservable inputs
Level 1 Level 2 Level 3 Total
As at 30.06.26 £m £m £m £m
Trading portfolio assets 129,002 72,322 8,778 210,102
Financial assets at fair value through the income statement 6,666 201,409 5,025 213,100
Derivative financial instruments 61 301,565 1,976 303,602
Financial assets at fair value through other comprehensive income 55,653 24,918 2,441 83,012
Investment property — — 42 42
Total assets 191,382 600,214 18,262 809,858
Trading portfolio liabilities (63,674) (14,652) (79) (78,405)
Financial liabilities designated at fair value (1,678) (317,749) (2,498) (321,925)
Derivative financial instruments (47) (288,883) (2,855) (291,785)
Total liabilities (65,399) (621,284) (5,432) (692,115)
As at 31.12.25
Trading portfolio assets 111,158 68,556 10,347 190,061
Financial assets at fair value through the income statement 5,140 173,140 8,577 186,857
Derivative financial instruments 108 250,639 1,712 252,459
Financial assets at fair value through other comprehensive income 51,717 19,578 3,099 74,394
Investment property — — 43 43
Total assets 168,123 511,913 23,778 703,814
Trading portfolio liabilities (42,917) (14,733) (87) (57,737)
Financial liabilities designated at fair value (1,702) (287,532) (4,874) (294,108)
Derivative financial instruments (93) (237,650) (3,065) (240,808)
Total liabilities (44,712) (539,915) (8,026) (592,653)
Financial Statement Notes
Barclays PLC 74
-- 76 of 99 --
The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type:
As at 30.06.26 Loans
Corporate
debt
Asset
backed
securities
Government
and
Government
sponsored
debt
Private
equity
investments
Issued
debt
Reverse
repurchase
and
repurchase
agreements
Interest
rate
derivatives
Equity
derivatives
Other
products
1 Total
£m £m £m £m £m £m £m £m £m £m £m
Trading
portfolio assets 3,156 1,873 1,670 1,342 — — — — — 737 8,778
Financial assets
at fair value
through the
income
statement
2,979 465 271 33 1,183 — — — — 94 5,025
Derivative
financial
instruments
— — — — — — — 942 289 745 1,976
Financial assets
at fair value
through other
comprehensive
income
2,192 227 11 7 4 — — — — — 2,441
Investment
property — — — — — — — — — 42 42
Total assets 8,327 2,565 1,952 1,382 1,187 — — 942 289 1,618 18,262
Trading
portfolio
liabilities
— (46) — (4) — — — — — (29) (79)
Financial
liabilities
designated at
fair value
— — — — (20) (2,397) — — — (81) (2,498)
Derivative
financial
instruments
— — — — — — — (1,436) (424) (995) (2,855)
Total liabilities — (46) — (4) (20) (2,397) — (1,436) (424) (1,105) (5,432)
Financial Statement Notes
Barclays PLC 75
-- 77 of 99 --
As at 31.12.25 Loans
Corporate
debt
Asset
backed
securities
Government
and
Government
sponsored
debt
Private
equity
investments
Issued
debt
Reverse
repurchase
and
repurchase
agreements
Interest
rate
derivatives
Equity
derivatives
Other
products1 Total
£m £m £m £m £m £m £m £m £m £m £m
Trading
portfolio assets 5,667 1,849 874 1,513 — — — — — 444 10,347
Financial assets
at fair value
through the
income
statement
5,990 905 188 33 1,260 — 97 — — 104 8,577
Derivative
financial
instruments
— — — — — — — 759 522 431 1,712
Financial assets
at fair value
through other
comprehensive
income
2,235 25 756 79 4 — — — — — 3,099
Investment
property — — — — — — — — — 43 43
Total assets 13,892 2,779 1,818 1,625 1,264 — 97 759 522 1,022 23,778
Trading
portfolio
liabilities
— (36) — (34) — — — — — (17) (87)
Financial
liabilities
designated at
fair value
— — — — (20) (3,760) (887) — — (207) (4,874)
Derivative
financial
instruments
— — — — — — — (612) (1,602) (851) (3,065)
Total liabilities — (36) — (34) (20) (3,760) (887) (612) (1,602) (1,075) (8,026)
1 Other products include certificate of deposits, funds and fund-linked products, equity cash products, investment property, credit derivatives and
foreign exchange derivatives.
Assets and liabilities transferred between Level 1 and Level 2
During the six-month period ended 30 June 2026, there were no assets or liabilities transferred between Level 1 and Level 2
(year ended 31 December 2025: £42.7bn assets and £(9.9)bn liabilities transferred from Level 2 to Level 1).
Level 3 movement analysis
The following table summarises the movements in the Level 3 balances during the six-month period. Transfers have been
reflected as if they had taken place at the beginning of the period.
Assets and liabilities transferred between Level 2 and Level 3 primarily reflect the application of the enhanced fair value
levelling framework, including refinements to observability assessments and significance testing methodologies, together
with the reassessment of fair value hierarchy classifications at the reporting date. Transfers include £4.7bn assets and
£(2.3)bn liabilities transferred from Level 3 to Level 2 reflecting these enhancements.
Financial Statement Notes
Barclays PLC 76
-- 78 of 99 --
Analysis of movements in Level 3 assets and liabilities
As at
01.01.26
Total gains and
(losses) in the
period recognised
in the income
statement
Total gains
and
(losses) in
the period
recognised
in OCI
Transfers
As at
30.06.26 Purchases Sales Issues Settlements
Trading
income2
Other
income In Out
£m £m £m £m £m £m £m £m £m £m £m
Trading portfolio
assets 10,347 4,116 (2,052) — (2,133) 35 — — 586 (2,121) 8,778
Financial assets at fair
value through the
income statement
8,577 1,472 (1,212) — (1,164) (35) 17 — 31 (2,661) 5,025
Financial assets at fair
value through other
comprehensive
income
3,099 466 (246) — (953) 8 — — 146 (79) 2,441
Investment property 43 — — — — (1) — — — — 42
Trading portfolio
liabilities (87) (62) 41 — — 12 — — (15) 32 (79)
Financial liabilities
designated at fair
value
(4,874) — — (1,278) 504 67 — — (265) 3,348 (2,498)
Net derivative
financial instruments1 (1,353) (495) 64 — — 104 1 — (79) 879 (879)
Total 15,752 5,497 (3,405) (1,278) (3,746) 190 18 — 404 (602) 12,830
As at
01.01.25
Total gains and
(losses) in the
period recognised
in the income
statement
Total gains
and
(losses) in
the period
recognised
in OCI
Transfers
As at
30.06.25 Purchases Sales Issues Settlements
Trading
income2
Other
income In Out
£m £m £m £m £m £m £m £m £m £m £m
Trading portfolio
assets 10,115 4,125 (3,524) — (1,147) 136 — — 439 (265) 9,879
Financial assets at fair
value through the
income statement
8,424 2,469 (1,200) — (573) (75) 8 — 63 (285) 8,831
Financial assets at fair
value through other
comprehensive
income
3,739 566 (1,447) — (6) 2 29 — 307 (12) 3,178
Investment property 9 33 — — — — — — — — 42
Trading portfolio
liabilities (395) (46) 28 — — 37 — — (57) 9 (424)
Financial liabilities
designated at fair
value
(3,258) — 91 (617) 31 88 — — (179) 996 (2,848)
Net derivative
financial instruments1 (1,104) (17) 249 — — 166 3 — (34) (135) (872)
Total 17,530 7,130 (5,803) (617) (1,695) 354 40 — 539 308 17,786
1 The derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £1,976m (June 2025:
£1,989m) and derivative financial liabilities were £(2,855)m (June 2025: £(2,861)m).
2 Trading income represents gains and losses on Level 3 financial instruments which in the majority are offset by losses and gains on financial
instruments disclosed in Level 2.
Financial Statement Notes
Barclays PLC 77
-- 79 of 99 --
Unrealised gains and losses on Level 3 assets and liabilities
The following table discloses the unrealised gains and losses recognised in the six-month period arising on Level 3 assets
and liabilities held at the period end.
Half year ended 30.06.26 Half year ended 30.06.25
Income statement Other
comprehensive
income
Total
Income statement Other
comprehensive
income
Total
Trading
income1
Other
income
Trading
income1
Other
income
£m £m £m £m £m £m £m £m
Trading portfolio assets 26 — — 26 21 — — 21
Financial assets at fair value
through the income statement (46) 18 — (28) (74) 7 — (67)
Financial assets at fair value
through other comprehensive
income 8 — — 8 1 28 — 29
Investment property — — — — — — — —
Trading portfolio liabilities 12 — — 12 34 — — 34
Financial liabilities designated at
fair value 70 — — 70 87 — — 87
Net derivative financial
instruments 104 1 — 105 164 3 — 167
Total 174 19 — 193 233 38 — 271
1 Trading income represents gains and losses on Level 3 financial instruments which in the majority are offset by losses and gains on financial
instruments disclosed in Level 2.
Valuation techniques and sensitivity analysis
Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably
possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques
used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative
models. These methodologies primarily leverage the prudent valuation framework when determining sensitivities.
Sensitivities are based on either range or spread data from reliable reference source or a scenario based on relevant market
analysis alongside the impact of using alternative models. Sensitivities are calculated without reflecting the impact of any
diversification in the portfolio.
The valuation and sensitivity methodologies applied in the current period are consistent with those described in Note 17, Fair
value of financial instruments, in the Barclays PLC Annual Report 2025.
Sensitivity analysis of valuations using unobservable inputs (Relates to Level 3 Portfolios)
As at 30.06.26 As at 31.12.25
Favourable changes Unfavourable changes Favourable changes Unfavourable changes
Income
statement Equity
Income
statement Equity
Income
statement Equity
Income
statement Equity
£m £m £m £m £m £m £m £m
Loans 187 3 (229) (40) 245 21 (324) (37)
Corporate debt 72 — (87) — 88 — (68) —
Asset backed securities 110 1 (88) (1) 51 6 (43) (6)
Government and Government
sponsored debt 55 — (53) — 45 — (41) —
Private equity investments 210 — (210) — 218 1 (218) (1)
Interest rate derivatives 127 — (131) — 109 — (134) —
Equity derivatives 375 — (375) — 336 — (336) —
Other products1 60 21 (61) (34) 109 312 (108) (89)
Total 1,196 25 (1,234) (75) 1,201 340 (1,272) (133)
1 Other products include issued debt, certificate of deposits, funds and fund-linked products, equity cash products, reverse repurchase and
repurchase agreements, credit derivatives and foreign exchange derivatives.
Financial Statement Notes
Barclays PLC 78
-- 80 of 99 --
The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact
of using alternative models, would be to increase fair values by up to £1,221m (December 2025: £1,541m) or to decrease
fair values by up to £1,309m (December 2025: £1,405m) with substantially all of the potential effect impacting profit and
loss rather than reserves.
Significant unobservable inputs
The valuation techniques and significant unobservable inputs for Level 3 assets and liabilities recognised at fair value are
broadly consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2025.
Fair value adjustments
Key balance sheet valuation adjustments are quantified below:
As at
30.06.26
As at
31.12.25
£m £m
Exit price adjustments derived from market bid-offer spreads (715) (628)
Uncollateralised derivative funding 49 62
Derivative credit valuation adjustments (162) (155)
Derivative debit valuation adjustments 103 119
Unrecognised gains as a result of the use of valuation models using unobservable inputs
The amount that is yet to be recognised in income, relating to the difference between the transaction price (the fair value at
initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on
initial recognition, is £227m (December 2025: £264m) for financial instruments measured at fair value. These unrecognised
gains decreased by amortisation and releases of £73m (December 2025: £64m) partly offset by additions and FX revaluation
of £36m (December 2025: £55m). For financial instruments carried at amortised cost, the amount that is yet to be
recognised in income is £163m (December 2025: £164m). There are amortisation and releases of £6m (December 2025:
£9m) offset by additions of £5m (December 2025: £nil).
Third party credit enhancements
Structured and brokered certificates of deposit issued by the Group are insured up to $250,000 per depositor by the Federal
Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by fees that Barclays and other banks pay for
deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IFRS 9
fair value option includes this third-party credit enhancement. The on-balance sheet value of these brokered certificates of
deposit amounted to £1,948m (December 2025: £4,156m).
Financial Statement Notes
Barclays PLC 79
-- 81 of 99 --
Comparison of carrying amounts and fair values for assets and liabilities not held at fair value
Valuation methodologies employed in calculating the fair value of financial assets and liabilities not held at fair value are
consistent with those described within Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2025.
The following table summarises the fair value of financial assets and liabilities not held at fair value on the Group’s balance
sheet:
As at 30.06.26 As at 31.12.25
Carrying
amount Fair value
Carrying
amount Fair value
Financial assets £m £m £m £m
Debt securities at amortised cost 73,519 72,595 68,475 67,442
Loans and advances at amortised cost 371,301 368,550 361,523 361,517
Reverse repurchase agreements and other similar secured lending 12,100 12,100 17,622 17,622
Assets included in disposal groups classified as held for sale — — 5,801 6,065
Financial liabilities
Deposits at amortised cost (594,357) (594,358) (585,613) (585,689)
Repurchase agreements and other similar secured borrowing (30,704) (30,704) (25,170) (25,170)
Debt securities in issue (126,837) (129,065) (119,033) (121,439)
Subordinated liabilities (11,098) (11,571) (12,954) (13,483)
10. Goodwill and intangible assets
As part of the preparation of the Barclays Group's financial statements for the year ended 31 December 2025, an impairment
review of its goodwill and intangible asset balances was performed. The outcome of this review is disclosed on pages
452-453 of the Barclays PLC Annual Report 2025. No impairment was recognised as a result of the review as value in use
exceeded carrying amount. A review of the Group's goodwill and intangible assets as at 30 June 2026 did not identify any
factors indicating impairment.
On 1 May 2026, Barclays completed the acquisition of Best Egg, resulting in a £0.1bn increase in intangible assets and the
recognition of £0.4bn of goodwill. As at 30 June 2026, management has not identified any indicators of impairment in
respect of the goodwill arising on acquisition.
11. Subordinated liabilities
Half year
ended
30.06.26
Year ended
31.12.25
£m £m
Opening balance as at 1 January 12,954 11,921
Issuances 750 1,772
Redemptions (2,573) (727)
Other (33) (12)
Closing balance 11,098 12,954
Issuances of £750m comprise GBP 6.174% Fixed Rate Resetting Subordinated Callable Notes issued externally by Barclays
PLC.
Redemptions of £2,573m comprise £862m EUR 1.125% Fixed Rate Resetting Subordinated Callable Notes, £1,505m USD
5.200% Fixed Rate Subordinated Notes issued externally by Barclays PLC, £155m ZAR Floating Rate Notes issued externally
by a Barclays Bank PLC Subsidiary and £51m GBP junior securitisation notes issued externally by a Barclays securitisation
special purpose vehicle (SPV).
Other movements predominantly comprise foreign exchange movements and fair value hedge adjustments.
Financial Statement Notes
Barclays PLC 80
-- 82 of 99 --
12. Provisions
As at
30.06.26 As at
31.12.25
£m £m
Customer redress 623 543
Legal, competition and regulatory matters 44 79
Redundancy and restructuring 168 190
Undrawn contractually committed facilities and guarantees 433 416
Onerous contracts 28 41
Sundry provisions 385 395
Total 1,681 1,664
Further information in respect of customer redress, legal, competition and regulatory matters is provided in Note 16.
13. Retirement benefits
As at 30 June 2026, the Group’s IAS 19 net retirement benefit assets were £3.1bn (December 2025: £3.0bn). The two
Sections of the UK Retirement Fund (UKRF), which are the Group’s main defined benefit pension schemes, had IAS 19 net
retirement benefit assets of £3.2bn (December 2025: £3.3bn).
Following sectionalisation of the UKRF at 1 July 2025, the first triennial valuations of the Barclays Bank and Barclays UK
sections have been completed during 2026. Results for each are shown below.
Barclays Bank Section of the UKRF
The triennial valuation of the Barclays Bank Section showed a funding surplus of £1.9bn at 30 September 2025.
As part of the valuation the Trustee and Barclays Bank PLC agreed an annual adequacy test on a more prudent basis than
IAS 19 and funding. Should the Barclays Bank Section be sufficiently funded on this basis, regular employer contributions to
fund future pension accrual will not be required in the following calendar year. The test was passed at September 2025, so
no regular employer contributions are required for 2026.
Barclays UK Section of the UKRF
The triennial valuation of the Barclays UK Section showed a funding surplus of £83m at 30 September 2025. Barclays Bank
UK PLC will continue to meet the costs of ongoing accrual and administration expenses for this Section.
The next triennial actuarial valuations for both Sections of the UKRF are due to be completed in 2029 with an effective date
of 30 September 2028.
14. Other reserves
Currency translation reserve
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group’s net
investment in foreign operations, net of the effects of hedging.
Fair value through other comprehensive income reserve
The fair value through other comprehensive income reserve represents the changes in the fair value of financial instruments
accounted for at fair value through other comprehensive income since initial recognition.
Cash flow hedging reserve
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that
will be recycled to the income statement when the hedged transactions affect profit or loss.
Own credit reserve
The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the
own credit reserve are not recycled to profit or loss in future periods.
Other reserves and treasury shares
Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays
PLC shares held principally in relation to the Group’s various share schemes. Treasury shares are deducted from
shareholders’ equity within other reserves.
Financial Statement Notes
Barclays PLC 81
-- 83 of 99 --
As at
30.06.26
As at
31.12.25
£m £m
Currency translation reserve 2,712 2,493
Fair value through other comprehensive income reserve (1,000) (1,100)
Cash flow hedging reserve (1,548) (666)
Own credit reserve (652) (990)
Other reserves and treasury shares 1,981 1,891
Total 1,493 1,628
15. Contingent liabilities and commitments
As at
30.06.26
As at
31.12.25
£m £m
Guarantees and letters of credit pledged as collateral security 17,687 16,749
Performance guarantees, acceptances and endorsements 8,235 8,625
Documentary credits and other short-term trade related transactions 1,263 1,103
Standby facilities, credit lines and other commitments 429,277 423,503
Total 1 456,462 449,980
1 Includes exposures relating to financial assets classified as assets held for sale.
Further details on contingent liabilities, where it is not practicable to disclose an estimate of the potential financial effect on
Barclays relating to legal and competition and regulatory matters can be found in Note 16.
16. Legal, competition and regulatory matters
The Group faces legal, competition and regulatory challenges, many of which are beyond our control. The extent of the
impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition
and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision,
or both, depending on the relevant facts and circumstances.
The recognition of provisions in relation to such matters involves critical accounting estimates and judgements in
accordance with the relevant accounting policies applicable to Note 12, Provisions. We have not disclosed an estimate of the
potential financial impact or effect on the Group of contingent liabilities where it is not currently practicable to do so. Various
matters detailed in this note seek damages of an unspecified amount. While certain matters specify the damages claimed,
such claimed amounts do not necessarily reflect the Group’s potential financial exposure in respect of those matters.
Matters are ordered under headings corresponding to the financial statements in which they are disclosed.
1. Barclays PLC and Barclays Bank PLC
Civil actions related to LIBOR and other benchmarks
Various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against the Group and
other banks in relation to the alleged manipulation of LIBOR and/or other benchmarks.
US civil actions related to LIBOR
Multiple civil actions have been filed in the US against the Group and other banks alleging manipulation of USD LIBOR,
Sterling LIBOR and the LIBOR benchmark that was administered by the Intercontinental Exchange Inc. and certain of its
affiliates (ICE LIBOR).
With respect to USD LIBOR, one action alleging that Barclays Bank PLC, Barclays Capital Inc. (BCI) and other financial
institutions individually and collectively violated provisions of the US Sherman Antitrust Act (Sherman Act), the US
Commodity Exchange Act, the US Racketeer Influenced and Corrupt Organizations Act (RICO), the US Securities Exchange
Act of 1934 and various state laws by manipulating USD LIBOR rates remains, seeking unspecified damages. In 2025, the US
federal district court in the Southern District of New York (SDNY) granted the defendants' motion for summary judgment
and dismissed the remaining USD LIBOR litigations, including the action against the Group. The plaintiffs are appealing the
decision.
Financial Statement Notes
Barclays PLC 82
-- 84 of 99 --
Non-US benchmarks civil actions
Proceedings are ongoing in Spain and Italy relating to alleged manipulation of LIBOR and EURIBOR.
Foreign exchange civil actions
Legal proceedings have been brought or are threatened against Barclays PLC, Barclays Bank PLC, BCI and Barclays Execution
Services Limited (BX) in connection with alleged manipulation of foreign exchange in the UK, the Netherlands, Israel and
Brazil. In Israel, a settlement in principle has been agreed subject to court approval. The settlement is not material to the
Group's operating results, cash flows or financial position.
The above-mentioned proceedings include a class action filed against Barclays PLC, Barclays Bank PLC, BX, BCI and other
financial institutions in the UK Competition Appeal Tribunal (CAT) in 2019. The CAT refused to certify the claim in 2022. In
2025, the UK Supreme Court issued a judgment in the defendants' favour, establishing that this claim cannot be brought as
an opt-out class action. The case has been remitted to the CAT for a hearing in July 2026 to determine the defendants'
application to dismiss the claim and the claimant's application for further time to bring an opt-in claim.
Metals-related civil actions
A US civil complaint alleging manipulation of the price of silver in violation of the US Commodity Exchange Act, the Sherman
Act and state antitrust and consumer protection laws was brought by a proposed class of plaintiffs against a number of
banks, including Barclays Bank PLC, BCI and BX. The complaint, which is filed in the SDNY, was dismissed against the
Barclays entities and certain other defendants in 2018, and against the remaining defendants in 2023. The plaintiffs have
appealed the dismissal of the complaint against all defendants.
Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc.
and BCI on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices. The Barclays entities have
reached a settlement which will require court approval. The settlement is not material to the Group's operating results, cash
flows or financial position.
US residential mortgage-related civil action
There remains one US Residential Mortgage-Backed Securities (RMBS) related civil action arising from unresolved
repurchase requests submitted by Trustees for certain RMBS, alleging breaches of various loan-level representations and
warranties made by Barclays Bank PLC and/or a subsidiary acquired in 2007. Barclays’ motion to dismiss the action was
denied in 2023. The parties appealed the decision and in January 2025, the appellate court reversed the lower court’s
decision and dismissed the action. The plaintiff's request for review by the New York State Court of Appeals was denied in
May 2026, concluding the matter.
Government and agency securities civil actions
Treasury auction securities civil actions
A consolidated purported class action filed in US federal court against Barclays Bank PLC, BCI and other financial institutions
under the Sherman Act and state common law was dismissed, which was affirmed on appeal. The plaintiffs did not seek US
Supreme Court review, concluding the matter.
Certain plaintiffs have filed a direct action against BCI and certain other financial institutions, alleging that defendants
conspired to fix and manipulate the US Treasury securities market in violation of the Sherman Act, the US Commodity
Exchange Act and state common law. This action remains stayed.
Variable Rate Demand Obligations civil actions
Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants
conspired or colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are
municipal bonds with interest rates that reset on a periodic basis, most commonly weekly. An action in state court has been
filed by private plaintiffs on behalf of the state of California. A settlement in principle has been agreed in that action, subject
to court approval. This settlement is not material to the Group's operating results, cash flows or financial position. In
addition, three purported class action complaints have been consolidated in the SDNY. In the consolidated SDNY class
action, certain of the plaintiffs’ claims were dismissed in 2020 and 2022 and the plaintiffs’ motion for class certification was
granted in 2023, which means the case may proceed as a class action.
Financial Statement Notes
Barclays PLC 83
-- 85 of 99 --
Credit Default Swap civil action
A purported antitrust class action is pending in New Mexico federal court against Barclays Bank PLC, BCI and various other
financial institutions. The plaintiffs, the New Mexico State Investment Council and certain New Mexico pension funds, allege
that the defendants conspired to manipulate the benchmark price used to value Credit Default Swap (CDS) contracts at
settlement (i.e. the CDS final auction price). The plaintiffs allege violations of US antitrust laws and the US Commodity
Exchange Act, and unjust enrichment under state law. The defendants’ motion to dismiss was denied in 2023. In 2024, the
SDNY ruled that settlement in an earlier CDS antitrust litigation bars these plaintiffs from asserting claims based on conduct
occurring before 30 June 2014. The plaintiffs appealed to the Second Circuit and the appeal was denied in 2025. The case
has returned to New Mexico federal court and the defendants have filed a motion for judgment on the pleadings.
Interest rate swap and credit default swap US civil actions
Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest rate
swaps (IRS), are named as defendants in several antitrust actions brought by certain swap execution facilities, which are
pending in the SDNY. The complaints allege the defendants conspired to prevent the development of exchanges for IRS and
demand unspecified money damages.
BDC Finance L.L.C.
In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the Supreme Court of the State of New York, demanding damages of
$298m, alleging that Barclays Bank PLC had breached a contract in connection with a portfolio of total return swaps
governed by an ISDA Master Agreement. Following a trial, the court ruled in 2018 that Barclays Bank PLC was not a
defaulting party, which was affirmed on appeal. Barclays Bank PLC filed a counterclaim against BDC for damages, legal fees,
expenses and interest. A trial on damages took place in June 2026 and proceedings are ongoing.
Civil actions in respect of the US Anti-Terrorism Act
Since 2014, eight civil actions, on behalf of more than 4,000 plaintiffs, were filed in US federal courts in the US District Court
in the Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks. The
complaints generally allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar-
denominated transactions for the Iranian government and various Iranian banks, which in turn funded acts of terrorism that
injured or killed the plaintiffs or the plaintiffs’ family members. The plaintiffs seek to recover damages for pain, suffering and
mental anguish under the US Anti-Terrorism Act, which allows for the trebling of any proven damages.
The court granted the defendants’ motions to dismiss three out of the six actions in the EDNY. The plaintiffs appealed in one
action and the dismissal was affirmed, and judgment was entered, in 2023. The plaintiffs’ motion to vacate the judgment
was denied in 2025. The other two dismissed actions in the EDNY were consolidated into one action. The plaintiffs in that
action, and in one other action in the EDNY, filed amended complaints. The defendants' motion to dismiss the consolidated
action was granted as to all claims against Barclays and the other defendant banks except for one bank, which is seeking
reconsideration. The other actions in the EDNY are currently stayed. Out of the two actions in the SDNY, the court granted
the defendants’ motion to dismiss the first action. That action is stayed, and the second SDNY action is stayed pending any
appeal on the dismissal of the first.
Shareholder derivative action
In 2020, a purported Barclays shareholder filed a purported derivative action in New York state court against BCI and a
number of current and former members of the Board of Directors of Barclays PLC and senior executives or employees of the
Group. The shareholder plaintiff filed the claim on behalf of nominal defendant Barclays PLC, alleging that the individual
defendants harmed the company through breaches of their duties, including under the Companies Act 2006. The plaintiff
sought damages on behalf of Barclays PLC for the losses that Barclays PLC allegedly suffered as a result of these alleged
breaches. An amended complaint was filed in 2021, which BCI and certain other defendants moved to dismiss. The motion
to dismiss was granted in 2022. The plaintiff appealed the decision, and the dismissal was unanimously affirmed in 2023 by
the First Judicial Department in New York. The plaintiff appealed the First Judicial Department’s decision to the New York
Court of Appeals. The dismissal was affirmed by the New York Court of Appeals in May 2025, concluding the matter. In
November 2025, the same plaintiff filed a new complaint in New York state court against the same defendants. In February
2026, the plaintiff voluntarily dismissed the new complaint. The dismissal received court approval in March 2026, concluding
the matter.
Motor finance commission arrangements
From 2003 to late 2019, Barclays, through Clydesdale Financial Services Limited (CFSL), a wholly-owned subsidiary of the
Group, provided motor finance to customers in the UK. In 2020, CFSL was transferred from Barclays Bank PLC to Barclays
Financial Statement Notes
Barclays PLC 84
-- 86 of 99 --
Principal Investments Ltd (BPIL), another subsidiary of Barclays PLC. Barclays Bank PLC has provided an intragroup
indemnity to BPIL in respect of historical litigation and conduct matters relating to CFSL.
In January 2024, the FCA appointed a skilled person to review the historical use of discretionary commission arrangements
and sales in the UK motor finance market. In October 2025, the FCA consulted on an industry-wide redress scheme for
eligible motor finance customers where a commission was payable by the lender to the broker, and Barclays engaged with
the FCA as part of this process. In March 2026, the FCA published its final rules for such scheme.
Barclays increased its provision in Q1 26 by £105m to reflect the expected financial impact of the redress scheme. The
increase in provision was primarily driven by moving from a multi-scenario approach to a single scenario based on the FCA's
final rules and higher compensatory interest. There has been no further increase in Q2 26 and the provision in respect of this
matter is £430m as at 30 June 2026 (as at 31 December 2025: £325m). The provision as at 30 June 2026 reflects Barclays'
estimate of cases in scope of the FCA redress scheme, the anticipated level of customer redress under the FCA's
methodology (including compensatory interest at a minimum of 3% per annum), the estimated customer response rate
(with reference to prior remediation exercises across the Group), and implementation costs. The ultimate financial impact
could differ from the current estimate due to factors such as customer response rates and average cost of redress.
Barclays decided not to challenge the FCA's final rules in the interests of enabling a swift resolution for customers. However,
Barclays strongly disagrees with aspects of the rules which require financial redress even where customers suffered no
demonstrable financial harm. On 2 July 2026, the Upper Tribunal ordered a suspension of parts of the redress scheme
following four legal challenges to the FCA's final rules. Such challenges will delay and may otherwise affect the
implementation of the redress scheme. The legal and regulatory outcomes and the nature, extent and timing of any
remediation action, therefore remain uncertain. Barclays has not incorporated the potential impact of any legal challenge
into the provision estimate.
Over-issuance of securities in the US
In 2022, executive management became aware that Barclays Bank PLC had issued securities materially in excess of the set
amount under its US shelf registration statements.
In 2023, holders of VXX ETNs brought a purported class action in the SDNY against Barclays PLC, Barclays Bank PLC, and
former and current executives and board members in the US alleging, among other things, that Barclays’ failure to disclose
that these ETNs were unregistered securities misled investors and that, as a result, Barclays is liable for the holders’ alleged
losses following the suspension of further sales and issuances of the ETNs. The plaintiffs were granted leave to amend and
filed a new complaint in March 2024. Barclays’ motion to dismiss was granted in March 2025. The plaintiffs’ motion for
reconsideration was denied in June 2025. The plaintiffs appealed the decision, and in March 2026, the Second Circuit
affirmed the dismissal, thereby concluding the matter.
In 2024, a purported class action was filed in the SDNY against Barclays PLC, Barclays Bank PLC and former and current
executives. The plaintiff purports to bring claims on behalf of a class of short sellers, alleging that their short positions
suffered substantial losses when Barclays suspended new issuances and sales of VXX ETNs as a result of the over-issuance
of securities. Barclays’ motion to dismiss was granted in March 2025. The plaintiff appealed the decision granting Barclays'
motion to dismiss and, in December 2025, the Second Circuit affirmed the dismissal, thereby concluding the matter.
ABS related civil action
In February 2026, certain institutional investors filed a civil action in the SDNY against Barclays Bank PLC, BCI, and other
financial institutions in connection with the collapse of a US-based subprime auto lender, Tricolor Auto Acceptance, LLC.
The plaintiffs, who hold notes issued by the auto lender's securitisation trusts, allege that the banks (acting as warehouse
lenders and initial purchasers in the securitisations) either knew of, or were willfully blind to, red flags of the auto lender's
alleged fraud. The plaintiffs seek damages for alleged securities fraud in connection with the alleged losses on their
associated notes, and also assert fraudulent transfer claims against the lenders. The defendants' motion to dismiss the action
was granted in June 2026. The plaintiffs may appeal.
2. Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC
HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax
In 2018, HMRC issued notices that have the effect of either removing certain Barclays overseas subsidiaries that have
operations in the UK from Barclays’ UK VAT group or preventing them from joining it. Supplies between members of a UK
VAT group are generally free from VAT. The notices had both retrospective and prospective effect. Barclays appealed
HMRC's decisions to the First-Tier Tribunal (Tax Chamber) in relation to both the retrospective VAT assessments and the
ongoing VAT payments made since 2018. £181m of VAT (inclusive of interest) was assessed retrospectively by HMRC
covering the periods 2014 to 2018, of which approximately £128m is expected to be attributed to Barclays Bank UK PLC and
Financial Statement Notes
Barclays PLC 85
-- 87 of 99 --
£53m to Barclays Bank PLC. This retrospectively assessed VAT was paid in 2018 and an asset, adjusted to reflect expected
eventual recovery, is recognised. Since 2018 Barclays has paid, and recognised as an expense, VAT on intra-group supplies
from the relevant subsidiaries to the members of the VAT group. In 2024, the court upheld HMRC’s denial of VAT grouping
relating to one of the overseas subsidiaries. Barclays appealed this decision to the Upper Tribunal, which upheld HMRC's
denial of VAT grouping in June 2026. Barclays has not sought to appeal this decision, but has other appeals filed in the Tax
Chamber, both for this subsidiary and other overseas subsidiaries.
UK bank levy
In November 2024, HMRC updated its published guidance on the treatment of beneficiary accounts for the purposes of the
exclusion of protected deposits from the UK bank levy charge. HMRC’s interpretation of the UK bank levy legislation differs
from Barclays’ interpretation of the legislation, which has been applied in Barclays’ UK bank levy returns and which Barclays
continues to consider is correct. In December 2024, HMRC wrote to notify Barclays of its intention to challenge this
treatment. Engagement with HMRC continues, and HMRC has not issued formal assessments.
3. Barclays PLC, Barclays Bank PLC and Barclays Bank Ireland PLC
Potential indemnity claim relating to the sale of Barclays Consumer Bank Europe
In January 2025, Barclays Bank Ireland PLC completed the sale of certain assets and liabilities, specifically the Consumer Bank
Europe, its German consumer finance business, to BAWAG P.S.K., a wholly-owned subsidiary of BAWAG Group AG
(BAWAG). As part of the transaction, Barclays Bank Ireland PLC provided BAWAG with a capped indemnity in relation to
transfer taxes on certain assets. Discussions with the relevant taxation authority remain at an early stage and no formal
assessment has been issued.
4. Barclays PLC
Civil action in respect of statements concerning Barclays' former CEO
In 2023, a purported class action was filed in federal court in California against Barclays PLC and a number of current and
former senior executives of Barclays PLC. It was amended in 2024 to assert US securities law claims against Barclays PLC and
individual defendants, and a UK securities law claim against Barclays PLC. The complaint seeks to hold the defendants
responsible for declines in the price of Barclays PLC’s American depositary receipts and Barclays PLC's ordinary shares, which
the plaintiffs claim occurred as a result of alleged misstatements and omissions in Barclays’ public disclosures relating to its
former CEO’s relationship with Jeffrey Epstein. Barclays PLC and an individual defendant's motion to dismiss was granted in
part and denied in part in June 2025, while another individual defendant's motion to dismiss was denied. The defendants
moved for reconsideration or, alternatively, leave to appeal, which is pending before the court. The plaintiffs filed a second
amended complaint in July 2025, repleading the UK securities law claim against Barclays PLC and which Barclays PLC has
moved to dismiss.
General
The Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other
overseas jurisdictions. It is subject to legal proceedings brought by and against the Group which arise in the ordinary course
of business from time to time, including (but not limited to) disputes in relation to contracts, securities, guarantees, debt
collection, consumer credit, fraud, trusts, client assets, competition, data management and protection, intellectual property,
money laundering, financial crime, employment, environmental and other statutory and common law issues.
The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other
proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer
protection measures, the effectiveness of systems and controls, measures to combat money laundering and financial crime,
compliance with legislation and regulation, wholesale trading activity and other areas of banking and business activities in
which the Group is or has been engaged. The Group is cooperating with the relevant authorities and keeping all relevant
agencies briefed as appropriate in relation to these matters and others described in this note on an ongoing basis.
At the present time, Barclays PLC does not expect the ultimate resolution of any of these other matters to have a material
adverse effect on the Group’s financial position. However, in light of the uncertainties involved in such matters and the
matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters
(including formerly active matters or those matters arising after the date of this note) will not be material to Barclays PLC’s
results, operations or cash flows for a particular period, depending on, among other things, the amount of the loss resulting
from the matter(s) and the amount of profit otherwise reported for the reporting period.
Financial Statement Notes
Barclays PLC 86
-- 88 of 99 --
17. Related party transactions
Related party transactions in the half year ended 30 June 2026 were similar in nature to those disclosed in the Barclays PLC
Annual Report 2025. No related party transactions that have taken place in the half year ended 30 June 2026 have materially
affected the financial position or the performance of the Group during this period, and there have been no changes to the
related party transactions described in the Barclays Annual Report 2025 that have materially affected the financial position or
the performance of the Group during this period.
18. Assets and liabilities included in disposal group classified as held for sale
The assets and liabilities classified as held for sale as at 30 June 2026 were £nil.
Comparative balances have been accounted for in line with the requirements of IFRS 5 and relate to the sale of the AA
portfolio within USCB. On 24 April 2026, Barclays exited its AA co-branded credit card partnership, generating a gain on sale
of c.£225m.
As at
30.06.26
As at
31.12.25
Assets included in disposal groups classified as held for sale £m £m
Loans and advances to customers — 5,801
Intangible assets — 11
Other assets — 120
Total assets classified as held for sale — 5,932
Net assets classified as held for sale — 5,932
Financial Statement Notes
Barclays PLC 87
-- 89 of 99 --
The Group’s management believes that the non-IFRS performance measures included in this document provide valuable
information to the readers of the financial statements, as they enable the reader to identify a more consistent basis for
comparing the businesses’ performance between financial periods, and provide more detail concerning the elements of
performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of
the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is
monitored by management.
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should
consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure Definition
Loan: deposit ratio Total loans and advances at amortised cost divided by total deposits at amortised cost.
Period end tangible equity refers to:
Period end tangible shareholders'
equity (for Barclays Group)
Shareholders' equity attributable to ordinary shareholders of the parent, adjusted for the deduction
of goodwill and intangible assets.
Period end allocated tangible equity
(for businesses)
Allocated tangible equity is calculated as 13.5% (2025: 13.5%) of RWAs for each business, adjusted
for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the
Barclays Group uses for capital planning purposes. Head Office allocated tangible equity represents
the difference between the Barclays Group’s tangible shareholders’ equity and the amounts
allocated to businesses.
Average tangible equity refers to:
Average tangible shareholders’
equity (for Barclays Group)
Calculated as the average of the previous month’s period end tangible shareholders' equity and the
current month’s period end tangible shareholders' equity. The average tangible shareholders’ equity
for the period is the average of the monthly averages within that period.
Average allocated tangible equity
(for businesses)
Calculated as the average of the previous month’s period end allocated tangible equity and the
current month’s period end allocated tangible equity. The average allocated tangible equity for the
period is the average of the monthly averages within that period.
Return on tangible equity (RoTE) refers to:
Return on average tangible
shareholders’ equity (for Barclays
Group)
Annualised Group attributable profit, as a proportion of average tangible shareholders’ equity. The
components of the calculation have been included on page 89.
Return on average allocated tangible
equity (for businesses)
Annualised business attributable profit, as a proportion of that business's average allocated tangible
equity. The components of the calculation have been included on pages 90 to 91.
Operating costs A measure of total operating expenses excluding litigation and conduct charges and UK regulatory
levies.
Cost: income ratio Total operating expenses divided by total income.
Loan loss rate Quoted in basis points and represents total impairment charges divided by total gross loans and
advances held at amortised cost (including portfolios reclassified to assets held for sale) at the
balance sheet date. The components of the calculation have been included on pages 92 to 94.
Net interest margin Annualised net interest income divided by the sum of average customer assets. The components of
the calculation have been included on page 24.
Tangible net asset value per share Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity
instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The
components of the calculation have been included on page 96.
Profit before impairment Calculated by excluding credit impairment charges or releases from profit before tax.
Net New Assets Under Management The net inflows and outflows of client balances within Discretionary Portfolio Management and
Advisory mandates. Excludes market performance and foreign exchange translation but includes
reinvested dividend payments.
Assets under Management (AUM) Total market value of client investment balances managed within investment mandates where
Barclays provides discretionary portfolio management or advisory services. Total Assets Under
Management excludes uninvested cash held under an investment mandate and reported within
deposits.
Assets under Supervision (AUS) Total market value of client investment balances where Barclays provides custodian or transactional
services.
Group net interest income excluding
Barclays Investment Bank and Head
Office
A measure of Barclays Group net interest income, excluding the net interest income reported in
Barclays Investment Bank and Head Office.
Income over average risk weighted
assets
Represents total income as a proportion of average risk weighted assets. Average risk weighted
assets calculated as the average of the previous month’s period end risk weighted assets and the
current month’s period end risk weighted assets. Average risk weighted assets for the period is the
average of the monthly averages within that period.
Appendix: Non-IFRS Performance Measures
Barclays PLC 88
-- 90 of 99 --
Returns
Half year ended 30.06.26
Barclays UK
Barclays UK
Corporate
Bank
Barclays
Private Bank
and Wealth
Management
Barclays
Investment
Bank
Barclays US
Consumer
Bank Head Office
Barclays
Group
Return on average tangible equity £m £m £m £m £m £m £m
Attributable profit/(loss) 1,214 388 148 2,315 429 (303) 4,191
£bn £bn £bn £bn £bn £bn £bn
Average equity 16.1 3.8 1.2 29.9 4.2 9.9 65.1
Average goodwill and intangibles (4.0) — (0.1) — (0.7) (3.6) (8.5)
Average tangible equity 12.1 3.8 1.1 29.9 3.5 6.3 56.7
Return on average tangible equity 20.1% 20.6% 26.1% 15.5% 24.2% n/m 14.8%
Half year ended 30.06.25
Barclays UK
Barclays UK
Corporate
Bank
Barclays
Private Bank
and Wealth
Management
Barclays
Investment
Bank
Barclays US
Consumer
Bank Head Office
Barclays
Group
Return on average tangible equity £m £m £m £m £m £m £m
Attributable profit/(loss) 1,090 284 184 2,075 128 (238) 3,523
£bn £bn £bn £bn £bn £bn £bn
Average equity 15.7 3.4 1.2 29.2 4.1 8.2 61.8
Average goodwill and intangibles (4.0) — (0.1) — (0.6) (3.6) (8.3)
Average tangible equity 11.7 3.4 1.1 29.2 3.5 4.6 53.5
Return on average tangible equity 18.6% 16.8% 33.2% 14.2% 7.3% n/m 13.2%
Appendix: Non-IFRS Performance Measures
Barclays PLC 89
-- 91 of 99 --
Barclays Group
Return on average tangible shareholders' equity
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Attributable profit 2,259 1,932 1,195 1,457 1,659 1,864 965 1,564
£bn £bn £bn £bn £bn £bn £bn £bn
Average shareholders' equity 64.8 65.5 64.8 63.3 62.1 61.4 59.7 59.1
Average goodwill and intangibles (8.7) (8.3) (8.3) (8.2) (8.2) (8.3) (8.2) (8.1)
Average tangible shareholders' equity 56.1 57.2 56.5 55.1 53.9 53.1 51.5 51.0
Return on average tangible shareholders' equity 16.1% 13.5% 8.5% 10.6% 12.3% 14.0% 7.5% 12.3%
Barclays UK
Return on average allocated tangible equity
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Attributable profit 623 591 706 647 580 510 781 621
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 16.2 15.9 15.9 15.9 15.8 15.7 15.1 14.5
Average goodwill and intangibles (4.0) (3.9) (4.0) (4.0) (4.0) (4.0) (3.9) (3.9)
Average allocated tangible equity 12.2 12.0 11.9 11.9 11.8 11.7 11.2 10.6
Return on average allocated tangible equity 20.4% 19.7% 23.8% 21.8% 19.7% 17.4% 28.0% 23.4%
Barclays UK Corporate Bank
Return on average allocated tangible equity
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Attributable profit 201 187 168 196 142 142 98 144
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 3.8 3.8 3.5 3.4 3.4 3.3 3.2 3.1
Average goodwill and intangibles — — — — — — — —
Average allocated tangible equity 3.8 3.8 3.5 3.4 3.4 3.3 3.2 3.1
Return on average allocated tangible equity 21.3% 19.9% 19.1% 22.8% 16.6% 17.1% 12.3% 18.8%
Barclays Private Bank and Wealth
Management
Return on average allocated tangible equity
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Attributable profit 75 73 35 72 88 96 63 74
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 1.2 1.2 1.2 1.2 1.2 1.2 1.2 1.1
Average goodwill and intangibles (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.1) (0.1)
Average allocated tangible equity 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.0
Return on average allocated tangible equity 26.9% 25.5% 12.6% 26.4% 31.9% 34.5% 23.9% 29.0%
Appendix: Non-IFRS Performance Measures
Barclays PLC 90
-- 92 of 99 --
Barclays Investment Bank
Return on average allocated tangible equity
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Attributable profit 1,204 1,111 294 723 876 1,199 247 652
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 30.0 29.7 29.6 28.6 28.7 29.6 29.3 29.5
Average goodwill and intangibles — — — — — — — —
Average allocated tangible equity 30.0 29.7 29.6 28.6 28.7 29.6 29.3 29.5
Return on average allocated tangible equity 16.0% 15.0% 4.0% 10.1% 12.2% 16.2% 3.4% 8.8%
Barclays US Consumer Bank
Return on average allocated tangible equity
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Attributable profit 253 176 144 118 87 41 94 89
£bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 4.1 4.3 4.2 4.0 4.0 4.2 4.0 3.8
Average goodwill and intangibles (0.8) (0.5) (0.6) (0.5) (0.6) (0.6) (0.6) (0.5)
Average allocated tangible equity 3.3 3.8 3.6 3.5 3.4 3.6 3.4 3.3
Return on average allocated tangible equity 30.2% 18.8% 15.8% 13.5% 10.2% 4.5% 11.2% 10.9%
Appendix: Non-IFRS Performance Measures
Barclays PLC 91
-- 93 of 99 --
Loan loss rates
Half year ended 30.06.26
Barclays UK
Barclays UK
Corporate
Bank
Barclays
Private Bank
and Wealth
Management
Barclays
Investment
Bank
Barclays US
Consumer
Bank Head Office
Barclays
Group
Loan loss rate £m £m £m £m £m £m £m
Credit impairment (charges)/
releases (338) (19) (3) (323) (713) 2 (1,394)
£bn £bn £bn £bn £bn £bn £bn
Gross loans and advances held at
amortised cost (including portfolios
reclassified as held for sale)1 239.8 31.4 15.1 137.2 25.0 1.9 450.4
Loan loss rate (bps) 28 12 4 47 575 n/m 62
Half year ended 30.06.25
Barclays UK
Barclays UK
Corporate
Bank
Barclays
Private Bank
and Wealth
Management
Barclays
Investment
Bank
Barclays US
Consumer
Bank Head Office
Barclays
Group
Loan loss rate £m £m £m £m £m £m £m
Credit impairment (charges)/
releases (237) (31) 11 (139) (711) (5) (1,112)
£bn £bn £bn £bn £bn £bn £bn
Gross loans and advances held at
amortised cost (including portfolios
reclassified as held for sale)1 228.5 28.2 14.8 126.8 27.4 2.7 428.4
Loan loss rate (bps) 21 22 (15) 22 523 n/m 52
1 Includes gross loans and advances to customers and banks, in addition to debt securities.
Appendix: Non-IFRS Performance Measures
Barclays PLC 92
-- 94 of 99 --
Barclays Group
Loan loss rate
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Credit impairment charges (571) (823) (535) (632) (469) (643) (711) (374)
£bn £bn £bn £bn £bn £bn £bn £bn
Gross loans and advances held at amortised cost
(including portfolios reclassified as held for sale) 450.4 449.9 441.3 437.5 428.4 430.4 429.6 408.3
Loan loss rate (bps) 51 74 48 57 44 61 66 37
Barclays UK
Loan loss rate
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Credit impairment charges (160) (178) (74) (102) (79) (158) (283) (16)
£bn £bn £bn £bn £bn £bn £bn £bn
Gross loans and advances held at amortised cost
(including portfolios reclassified as held for sale) 239.8 233.6 231.9 230.9 228.5 227.5 227.5 218.4
Loan loss rate (bps) 27 31 13 18 14 28 49 3
Barclays UK Corporate Bank
Loan loss rate
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Credit impairment charges (16) (3) (1) (5) (12) (19) (40) (13)
£bn £bn £bn £bn £bn £bn £bn £bn
Gross loans and advances held at amortised cost
(including portfolios reclassified as held for sale) 31.4 31.0 30.2 29.2 28.2 27.0 25.8 25.2
Loan loss rate (bps) 20 4 1 7 17 28 62 21
Barclays Private Bank and Wealth
Management
Loan loss rate
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Credit impairment (charges)/releases (5) 2 (2) (1) 2 9 (2) (7)
£bn £bn £bn £bn £bn £bn £bn £bn
Gross loans and advances held at amortised cost
(including portfolios reclassified as held for sale) 15.1 15.1 15.1 15.2 14.8 14.8 14.7 14.3
Loan loss rate (bps) 13 (6) 5 3 (5) (25) 5 19
Appendix: Non-IFRS Performance Measures
Barclays PLC 93
-- 95 of 99 --
Barclays Investment Bank
Loan loss rate
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Credit impairment charges (44) (279) (22) (144) (67) (72) (46) (43)
£bn £bn £bn £bn £bn £bn £bn £bn
Gross loans and advances held at amortised cost
(including portfolios reclassified as held for sale) 137.2 137.4 131.0 129.8 126.8 129.6 124.9 116.5
Loan loss rate (bps) 13 82 7 44 21 23 15 15
Barclays US Consumer Bank
Loan loss rate
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Credit impairment charges (346) (367) (431) (379) (312) (399) (298) (276)
£bn £bn £bn £bn £bn £bn £bn £bn
Gross loans and advances held at amortised cost
(including portfolios reclassified as held for sale) 25.0 30.3 30.6 29.8 27.4 28.9 30.0 26.7
Loan loss rate (bps) 555 491 558 505 456 562 395 411
Appendix: Non-IFRS Performance Measures
Barclays PLC 94
-- 96 of 99 --
Income over average RWAs
Barclays Investment Bank
Half year ended 30.06.26 Half year ended 30.06.25
£m £m
Income 7,986 7,180
£bn £bn
Average RWAs 203.2 198.8
Income over average RWAs 7.9% 7.2%
Barclays Investment Bank
Q226 Q126 Q425 Q325 Q225 Q125 Q424 Q324
£m £m £m £m £m £m £m £m
Income 3,958 4,028 2,792 3,083 3,307 3,873 2,607 2,851
£bn £bn £bn £bn £bn £bn £bn £bn
Average RWAs 204.5 202.0 202.1 194.9 196.1 201.4 199.9 201.8
Income over average RWAs 7.7% 8.0% 5.5% 6.3% 6.7% 7.7% 5.2% 5.7%
Appendix: Non-IFRS Performance Measures
Barclays PLC 95
-- 97 of 99 --
Tangible net asset value per share As at
30.06.26
As at
31.12.25
As at
30.06.25
£m £m £m
Total equity excluding non-controlling interests 79,358 77,784 75,906
Other equity instruments (13,275) (12,725) (13,266)
Goodwill and intangibles (8,912) (8,284) (8,186)
Tangible shareholders' equity attributable to ordinary shareholders of the parent 57,171 56,775 54,454
m m m
Shares in issue 13,507 13,867 14,180
p p p
Tangible net asset value per share 423 409 384
Appendix: Non-IFRS Performance Measures
Barclays PLC 96
-- 98 of 99 --
Results timetable1 Date
Ex-dividend date 6 August 2026
Dividend record date 7 August 2026
DRIP last election date 24 August 2026
Dividend payment date 15 September 2026
Q3 2026 Results Announcement 22 October 2026
For qualifying ADR holders, the 2026 half year dividend of 5.9p per ordinary share becomes 23.6p per ADS (representing four shares).
The ex-dividend date for ADR holders is 7 August 2026. The dividend record and dividend payment dates for ADR holders are as shown
above. The dividend fee chargeable by the ADR depositary to ADR holders is 4.5% of gross dividend.
A Dividend Re-Investment Plan (DRIP) is provided by Equiniti Financial Services Limited. The DRIP enables the Company’s shareholders to
elect to have their cash dividend payments used to purchase the Company’s shares.
More information can be found at shareview.co.uk/info/drip
DRIP participants will usually receive their additional ordinary shares (in lieu of a cash dividend) three to four days after the dividend
payment date. Qualifying ADR holders should contact Computershare Shareowner Services for further details regarding the DRIP.
Barclays PLC ordinary shares ISIN code: GB0031348658
Barclays PLC ordinary shares TIDM Code: BARC
% Change2
Exchange rates 30.06.26 31.12.25 30.06.25 31.12.25 30.06.25
Period end - GBP/USD 1.33 1.34 1.37 (1) % (3) %
YTD average - GBP/USD 1.35 1.32 1.30 2 % 4 %
3 month average - GBP/USD 1.34 1.33 1.35 1 % — %
Period end - GBP/EUR 1.16 1.15 1.17 1 % (1) %
YTD average - GBP/EUR 1.15 1.17 1.19 (2) % (3) %
3 month average - GBP/EUR 1.16 1.14 1.18 2 % (2) %
Share price data
Barclays PLC (p) 507 476 337
Barclays PLC number of shares (m) 13,507 13,867 14,180
For further information please contact
Investor relations Media relations
Marina Shchukina +44 (0) 20 7116 2526 Tom Hoskin +44 (0) 20 7116 4755
More information on Barclays can be found on our website: home.barclays
Registered office
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.
Registrar
Equiniti, Highdown House, Yeoman Way, Worthing, West Sussex, BN99 6DA, United Kingdom.
Tel +44 (0)371 384 2055 (UK and International telephone number)3.
American Depositary Receipts (ADRs)
Computershare Shareowner Services, P.O. Box 43304, Providence, RI 02940-3304, United States of America
General Toll Free: +1-866-723-8257
General Direct: +1-781-575-2833
www.computershare.com/investor
Delivery of ADR certificates and overnight mail
Computershare Shareowner Services, 150 Royall Street, Suite 101, Canton, MA 02021-1054
1 Note that these dates are provisional and subject to change.
2 The change is the impact to GBP reported information.
3 Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.
Shareholder Information
Barclays PLC 97
-- 99 of 99 --